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Craniofacial anomalies account for approximately one-third of all birth defects. 
Two examples of syndromes associated with craniofacial malformations are Treacher 
Collins syndrome and Acrofacial Dysostosis, Cincinnati type which have phenotypic 
overlap including deformities of the eyes, ears, and facial bones. Mutations in TCOF1, 
POLR1C or POLR1D may cause Treacher Collins syndrome while mutations in POLR1A 
may cause Acrofacial Dysostosis, Cincinnati type. TCOF1 encodes the nucleolar 
phosphoprotein Treacle, which functions in rRNA transcription and modification. Previous 
studies demonstrated that Tcof1 mutations in mice result in reduced ribosome biogenesis 
and increased neuroepithelial apoptosis. This diminishes the neural crest cell (NCC) 
progenitor population which contribute to the development of the cranial skeleton. In 
contrast, apart from being subunits of RNA Polymerases (RNAP) I and/or III, nothing is 
known about the function of POLR1A, POLR1C, and POLR1D during embryonic and 
craniofacial development. I therefore examined zebrafish with mutations in polr1a, polr1c, 
and polr1d to understand the function of RNAPI during embryogenesis. Remarkably, these 
genes are dynamically expressed during embryonic development and display enriched 
expression in craniofacial regions, such as the pharyngeal arches, demonstrating that they 
may have tissue specific functions. Homozygous mutant polr1a, polr1c, and polr1d 
zebrafish display reduced cranial cartilage formation due to elevated tp53-dependent cell 
death of NCC progenitors and a diminished population of cranial NCC. In addition, mutant 
embryos have altered ribosome biogenesis, as demonstrated by reduced rRNA 
transcription and polysome profiling, which impact the survival and proliferation of cranial 
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NCC. Taken together, this suggests diminished ribosome biogenesis, nucleolar stress, and 
Tp53-dependent neuroepithelial apoptosis underlie the loss of NCC needed to generate the 
normal cranioskeletal elements, consistent with the Tcof1 studies. In support of this 
mechanism, genetic inhibition of tp53 is one approach for improving the skeletal 
deficiencies in polr1c and polr1d mutants. These zebrafish models represent the first study 
of RNAPI during craniofacial development and demonstrate that tissue specific phenotypes 
can arise from disruptions of global processes like ribosome biogenesis. The polr1a, 
polr1c, and polr1d zebrafish will be useful for further examining RNAPI function as well 
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Craniofacial anomalies occur in approximately 1/100 live births and the 
consequences of these anomalies can require significant medical interventions. 
Understanding the process of craniofacial development is important for determining the 
etiology and potential mechanisms for prevention of craniofacial anomalies, which can be 
isolated or syndromic. Two examples of syndromes with craniofacial anomalies are 
Treacher Collins syndrome (TCS) and Acrofacial Dysostosis, Cincinnati Type which will 
be described in detail in Chapters III and IV. TCS may result from mutations in TCOF1, 
POLR1C, or POLR1D while Acrofacial dysostosis, Cincinnati Type is associated with 
mutations in POLR1A. POLR1A, POLR1C, and POLR1D are all subunits of RNA 
Polymerase I, which synthesizes ribosomal RNA. These syndromes are characterized as 
both neurocristopathies and ribosomopathies, which arise from deficiencies in neural crest 
cells and ribosome biogenesis, respectively. In this thesis, I examine the roles of neural 
crest cell development and ribosome biogenesis in zebrafish models of TCS and Acrofacial 
Dysostosis, Cincinnati Type. 
Neural Crest Cells and Neurocristopathies 
Neural crest cells (NCC) are a migratory stem and progenitor cell population 
established early in development around the time of gastrulation and continue to develop 
through late organogenesis. In many vertebrate models, NCC are induced at the neural 
plate border, which folds to form the neural tube, and the neural crest progenitors reside 
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in the dorsal portion of the neural tube (Bronner-Fraser, 1994; Le Douarin and Kalcheim, 
1999). NCC then undergo an epithelial-to-mesenchymal transition and migrate out of the 
neural tube to distant sites throughout the embryo, eventually contributing to a number of 
different tissues. These tissues include the bones, cartilage, and connective tissue in the 
head and face, pigment cells, and neurons and glia (Le Douarin and Kalcheim, 1999; 
Knecht and Bronner-Fraser, 2002) (See Figure I-1). Since the NCC contribute to such a 
wide array of tissues, they have been called a fourth germ layer (Hall, 2000). The phases 
of NCC development can be generally categorized into formation, migration, and 
differentiation. Perturbation of NCC development at any of these stages can result in a 
number of disorders classified as neurocristopathies, which are defined by disrupted 
development of NCC or NCC-derived tissues. The craniofacial anomalies present in TCS 
and Acrofacial dysostosis, Cincinnati type are indicative of altered NCC development, as 
the craniofacial skeleton is primarily derived from NCC, and these syndromes are 
therefore classified as neurocristopathies. Portions of this introduction were published as 
a book chapter on neurocristopathies (Watt and Trainor, 2014). In the following sections, 
I describe NCC development, with an emphasis on their roles in zebrafish, and use 
neurocristopathies to demonstrate the importance of NCC formation, migration, and 




Figure I-1 Neural crest cell development occurs during zebrafish embryogenesis.  
NCC development begins with the induction of NC specifiers at the neural 
plate border at approximately 10 hours post fertilization (hpf). The neural 
plate thickens to form the neural keel and NCC begin migration around 12 
hpf as they delaminate out from dorsal regions of the neural keel. The neural 
keel folds together to form the neural rod, which then hollows to form the 
neural tube by 18 hpf. Migration continues and overlaps with the beginning 
of NCC differentiation at about 24 hpf. At this time, NCC are being specified 
towards different lineages including bone, cartilage, connective tissue, 
neurons, glia, and pigment cells. These tissues continue to develop into the 
larval stages of zebrafish development (beyond 72 hpf). Images adapted from 





NCC formation requires a complex series of signaling and tissue interactions in the 
developing embryo. In this section, I describe the induction of NCC and the tissues and 
signals involved in this process.  
NEURAL INDUCTION 
NCC formation begins during gastrulation stages in which the three germ layers - 
endoderm, mesoderm, and ectoderm - are established and give rise to the majority of the 
tissues in the body. Cellular movements during gastrulation generate these different germ 
layers, and in zebrafish embryos this process begins at approximately 5 hours post 
fertilization (hpf) and is completed around 10 hpf (Kimmel et al., 1995; Gilbert, 2010). 
Establishing polarity across the embryo is important for the generation of the different germ 
layers. For example, Nodal signaling is important for establishing mesoderm (Schier and 
Talbot, 2001), while different levels of BMP are important in establishing ectoderm 
(Nguyen et al., 1998; Schumacher et al., 2011). The ectoderm is segregated into neural and 
non-neural regions, with NCC induction occurring at the border between these regions. 
The neural ectoderm gives rise to the neural plate, which will eventually become the central 
nervous system, while the non-neural ectoderm will become the epidermis. 
In zebrafish, formation of the neural plate occurs during gastrulation and can be 
observed along the anterior-posterior axis of the embryo by 10 hpf (Figure I-1) (Kimmel 
et al., 1995). In contrast to avian or frog embryos, in which the neural plate folds in a 
process called primary neurulation (Le Douarin and Kalcheim, 1999), the zebrafish neural 
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plate undergoes a process called secondary neurulation. The neural plate thickens towards 
the midline to form the neural keel, which is observed at 12 hpf (Araya et al., 2015). At 12 
hpf, two layers are visible in the head: the dorsal ectoderm, which will produce NCC, and 
the ventral mesoderm/endoderm (Schilling and Kimmel, 1994). By 15 hpf, the neural keel 
has folded into a neural rod, and a lumen forms in the neural rod to form the neural tube 
by 17-18 hpf with the NCC progenitors located in the dorsal portion of the neural tube 
(Figure I-1) (Raible et al., 1992; Lowery and Sive, 2004; Araya et al., 2015).  
TISSUES AND SIGNALS IN NCC FORMATION 
The induction of the genetic program for neural plate border (NPB) and NCC 
specification requires the appropriate production of signaling molecules from the 
surrounding tissues. Signals from the three germ layers are integrated for the induction of 
NCC (LaBonne and Bronner-Fraser, 1999). Bone morphogenetic protein (BMP) is one 
particular signal which has been implicated in formation of NCC, however, BMP alone is 
not sufficient to induce NCC (LaBonne and Bronner-Fraser, 1998; LaBonne and Bronner-
Fraser, 1999). Additional signals required include Wnts, fibroblast growth factors (Fgfs), 
and retinoic acid (RA) although the timing, location and amount of these signals varies 
between organisms (Streit et al., 2000; Mayor and Aybar, 2001; Villanueva et al., 2002; 
Lewis et al., 2004).   
Formation of the neural plate and NPB in zebrafish requires intermediate levels of 
BMP signaling and a combination of Fgf and Wnt signals (Figure I-2) (Garnett et al., 2012). 
Studies in Xenopus embryos show a gradient of BMP patterns the ectoderm, in which low 
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levels lead to neural plate formation, intermediate levels lead to NCC induction, and high 
levels lead to epidermis formation (Mayor and Aybar, 2001). In addition, expression of 
BMP antagonists within the mesoderm help modulate levels of BMP (Marchant et al., 
1998). Studies of BMP pathway mutations in zebrafish also demonstrate that a gradient of 
BMP is established and intermediate levels are required for NCC generation (Schumacher 
et al., 2011). For example, mutation of the BMP ligand bmp2b results in a failure of NCC 
induction and demonstrates a requirement for BMP in the generation of NCC (Nguyen et 
al., 1998). Surprisingly, the presence of mesoderm is not absolutely required for NCC 
induction in zebrafish. Upon elimination of mesoderm using Nodal signaling mutants, 
NCC specifier genes are still expressed; however, the domains of expression are altered 
and the levels of migratory NCC are reduced in mutant embryos (Ragland and Raible, 
2004). This suggests that there may be important roles for mesoderm at later stages of NCC 
development such as in migration and differentiation. In addition to BMP, Fgf signaling 
also functions to pattern the early zebrafish embryo, as inhibition of Fgf signaling results 
in expansion of bmp2b expression (Fürthauer et al., 2004). This expansion of bmp2b 
expression would then be expected to alter BMP levels and impact NCC induction, 
however NCC were not investigated in this study. In a separate study, NCC induction was 
investigated in response to alterations in Wnt signaling at specific times using a heat-shock 
inducible Wnt inhibitor. Inhibition of Wnt signaling specifically at the end of gastrulation 
(approximately 10 hpf), prevented expression of the NCC specifier foxd3 (Lewis et al., 
2004).  
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Recently, the integration of BMP, Wnt, and Fgf signals in establishing the NPB and 
NCC progenitors was investigated. Experiments using heat-shock activation of dkk1, a Wnt 
antagonist, and heat-shock activation of bmp2b at 6 hpf and 8 hpf revealed that both Wnt 
and BMP signaling were required for accurate expression of zic3, a NPB specifier gene 
(Garnett et al., 2012). However, pax3a expression, another NPB specifier gene, was not 
strongly affected by dkk1 over-expression, suggesting a different responsiveness to Wnt 
signaling (Garnett et al., 2012). Fgf signaling is known to be important in NPB formation 
in Xenopus, so its role in zebrafish NPB was investigated using the Fgf inhibitor SU5402.  
Expression of pax3a was reduced upon SU5402 treatment, but zic3 levels were not affected 
(Garnett et al., 2012). Altogether, this indicates a different responsiveness to the Wnt, Fgf, 
and BMP signals during NPB specification, but that all of these signals play a role in the 
proper expression of the NPB specifier genes – both the domain as well as the levels of 
expression.  
Thus, the combination of BMP, Wnt, and Fgf signals are required at the proper time 
and at the correct level in order for the NBP to become competent to generate expression 
of NCC specifiers and form NCC. The transcription factors tfap2a and foxd3, which also 
have roles in NCC migration and differentiation, are two of the earliest NCC specifiers in 
zebrafish. Expression of foxd3 is observed during gastrulation at the NPB (Odenthal and 
Nüsslein-Volhard, 1998), and tfap2a expression is observed at gastrulation stages as well 
(Barrallo-Gimeno et al., 2004). Loss of tfap2a alone leads to apoptosis of NCC progenitors, 
while loss of foxd3 alone leads to diminished NCC derived tissues such as the craniofacial 
skeleton and peripheral nervous system (Wang et al., 2011). The combined loss of tfap2a 
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and foxd3 results in the absence of the pre-migratory NCC population, confirming a role 
for these factors in NCC induction (Wang et al., 2011). Tfap2a and Foxd3 then function to 
activate a series of NCC specifier genes which have roles in NCC development and 






Figure I-2 A model of zebrafish neural plate formation.  
The neural plate (white) is established while the border regions (green) 
receive Wnt, Fgf, and BMP signals. An intermediate level of BMP is 
necessary for induction of NCC from the NPB. Regions beyond the NPB will 
form the epidermis (gray). Figure adapted from Garnett et al., 2012. 
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NCC Migration 
The migration of NCC involves initiation of NCC specifier genes followed by an 
epithelial to mesenchymal transition (EMT) which enables the NCC to migrate out from 
the neural tube and into specific regions of the embryo. In this section I highlight the 
migration of the cranial NCC, the hox and dlx signaling complexes involved in patterning 
the head, and some of the NCC specifier genes and other signaling molecules involved in 
NCC migration. 
NCC SPECIFIER GENES 
Cell autonomous expression of NCC specifier genes are required to generate 
migratory NCC (Reviewed in (Betancur et al., 2010; Rogers et al., 2012). Many of the 
NCC specifier genes have multiple roles during NCC development including NPB 
specification, migration, and differentiation. Some of these genes are Sox9, Sox10, Foxd3, 
Twist, and Snail2. Sox9 has been shown to be important in NCC specification in Xenopus 
(Spokony et al., 2002) and then later in the differentiation of NCC into cartilage in zebrafish 
and mice (Yan et al., 2002) (Bi et al., 2001; Mori-Akiyama et al., 2003). Zebrafish have 
two copies of the sox9 gene, sox9a and sox9b, which are both capable of functioning as 
transcription factors. These genes are expressed in distinct, though overlapping, patterns 
during zebrafish development. sox9b is expressed within premigratory NCC at 14 hpf, 
while sox9a is expressed within the somites. sox9a expression is not required for NCC 
specification or migration in zebrafish (Yan et al., 2002), but mutations in sox9b lead to 
diminished expression of other migratory NCC markers (Yan et al., 2005). At 24 hpf, both 
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sox9a and sox9b are expressed in similar regions of the brain, however, only sox9a is 
expressed in the cranial mesenchyme which will contribute to the formation of the 
pharyngeal arches and thus the craniofacial skeleton. At later stages (2-3 dpf) both sox9a 
and sox9b are expressed in the craniofacial cartilage condensations, although sox9a is 
expressed at a higher level (Chiang et al., 2001). Zebrafish with mutations in sox9a have 
little expression of col2a1 and almost no craniofacial skeleton; zebrafish with mutations in 
sox9b have slightly more craniofacial cartilage, while double mutants have no pharyngeal 
skeleton (Yan et al., 2002). Corresponding with a more important role in skeletal 
differentiation, mutations in SOX9 in humans lead to the disorder campomelic dysplasia 
which is characterized by underdevelopment of the skeleton, bent long bones, cleft palate, 
and micrognathia (Wagner et al., 1994).  
Another Sox gene, Sox10, has roles in NCC formation, maintenance, and 
differentiation (Kelsh, 2006). It is expressed early in development in humans (Bondurand 
et al., 1998), mice (Kuhlbrodt et al., 1998; Southard-Smith et al., 1998), zebrafish (Dutton 
et al., 2001), chick (Cheng et al., 2000), and frog (Honoré et al., 2003). Sox10 has multiple 
roles during NCC development including formation of  pigment cells and enteric ganglia 
(Bondurand et al., 1998; Kuhlbrodt et al., 1998; Southard-Smith et al., 1998; Dutton et al., 
2001; Aoki et al., 2003) as well as maintaining multipotency of neural crest stem cells 
(Kelsh, 2006), influencing fate decisions of the melanocyte lineage (Bondurand et al., 
2000; Potterf et al., 2000; Elworthy et al., 2003), and maintaining pluripotency in migrating 
enteric nervous system progenitors (Bondurand et al., 2006). In zebrafish, sox10 is 
expressed in the premigratory NCC at the NPB at the 1-somite stage and is maintained in 
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migratory NCC (Dutton et al., 2001). At later stages, sox10 is expressed in melanocyte, 
neuron, and glial precursor cells, but not within the craniofacial cartilage. However, ectopic 
Sox10 expression is observed in craniofacial cartilage in some transgenic lines such as 
Tg(7.2kb-sox10:gfp) (Hoffman et al., 2007). Consistent with the expression within 
melanocytes and neurons, the zebrafish sox10 mutant, known as colorless, fails to develop 
the enteric nervous system and lacks the majority of pigment cells (Dutton et al., 2001). 
This is in agreement with the roles for SOX10 in humans where mutations in SOX10 can 
result in Waardenburg syndrome (WS). WS is characterized by pigmentation defects of the 
skin and hair and sensorineural hearing loss  and is frequently associated with Hirschsprung 
disease, which is classified by varying degrees of colonic aganglionosis (Pingault et al., 
2010). In the zebrafish, the NCC that would normally adopt non-ectomesenchymal NCC 
fates, such as melanocytes, fail to migrate and differentiate and instead undergo apoptosis 
resulting in the sox10 mutant phenotype (Dutton et al., 2001; Elworthy et al., 2005).  
NCC must undergo an EMT to segregate and migrate away from the neural tube. 
This transition requires down-regulation of cell adhesion molecules such as E-cadherin and 
N-cadherin, and interactions with signaling molecules. Some of the NCC specifiers have 
roles in EMT such as Foxd3 and Snail2 (snai2 in zebrafish).  
Foxd3 is expressed in premigratory and migratory NCC in mice (Labosky and 
Kaestner, 1998; Yamagata and Noda, 1998). Early in development, Foxd3 acts to specify 
NCC and is required for maintenance of multipotent NCC progenitors (Dottori et al., 2001). 
Activation of cell adhesion molecules, such as N-cadherin, Cadherin7, Laminin, and 
Integrinb1, by Foxd3 is necessary for NCC migration (Cheung et al., 2005). Foxd3 is also 
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expressed in the forming dorsal root ganglion (Lister et al., 2006) and suppresses the 
development of the melanocyte lineage (Thomas and Erickson, 2009). In zebrafish, foxd3 
is expressed within the NPB and then in the premigratory NCC, but is downregulated in 
migratory NCC, and is also found in the somites as development proceeds (Stewart et al., 
2006). Zebrafish with mutations is foxd3 show normal NCC induction, but diminished 
expression as well as a disrupted pattern of the migratory NCC markers sox10 and crestin 
(Stewart et al., 2006). At later stages, foxd3 mutants have deficiencies in the NCC-derived 
neurons and craniofacial cartilage (Stewart et al., 2006). NCC-derived tissue defects are 
the result of increased cell death in a subpopulation of the premigratory NCC within the 
hindbrain region and potentially also the reduced ability of NCC to migrate in the correct 
pattern. These results emphasize the importance of foxd3 expression within the 
premigratory NCC population and suggest a role for foxd3 in activating genes important 
for NCC migration and survival. 
Snail2 (also known as Slug) primarily functions in NCC specification and initiation 
of EMT and is expressed in migratory NCC, but not premigratory (Jiang et al., 1998). In 
mouse cell lines, Snail was shown to repress E-cadherin (Cano et al., 2000) while studies 
in chick embryos showed that Snail2 directly represses Cadherin6, a cell adhesion 
molecule, enabling NCC migration (Taneyhill et al., 2007).  Zebrafish snail genes include 
snail1a, snail1b (previously named snail2), and snai2. snai2 expression can be found at 
the neural plate border as well as paraxial mesoderm (Thisse et al., 2001). After 
gastrulation, snail1a is expressed in muscle pioneer precursors (Thisse et al., 1993) while 
snail1b is expressed at the neural plate border, including within NCC precursors, and is 
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later expressed in NCC (Thisse et al., 1995). The distinct but overlapping domains of 
snail1a and snail1b expression enable them to function together in the migration of axial 
mesendoderm (Blanco et al., 2007). Morphilino knockdown of snail1b resulted in an 
increase in Cdh1 (E-cadherin), indicating Snail1b functions as a repressor of E-cadherin 
and would then function in enabling EMT (Blanco et al., 2007). Another cadherin, 
cadherin6 is expressed in hindbrain and NCC of zebrafish embryos and has been shown to 
function in promoting EMT through regulating F-actin (Clay and Halloran, 2014). The 
alternate function of cadherin6 in promoting EMT in zebrafish stands in contrast to the 
down regulation of Cadherin6 in chick (Taneyhill et al., 2007). These differences illustrate 
that adhesion molecules like Cadherin6 may have different functions depending on the 
developmental timing, such as prior to EMT or after EMT, and embryonic context. In 
humans, mutations in Snail2 have been reported to cause piebaldism, a disorder 
characterized by patches of unpigmented skin and hair (Sánchez-Martín et al., 2003). A 
potential mechanism is that melanocyte precursors are unable to undergo EMT and instead 
undergo apoptosis, similar to what occurs upon mutation of sox10. 
In summary, NCC specifier genes including sox9, sox10, foxd3 and Snail2 all have 
important functions in NCC migration. Expressing NCC specifiers at the appropriate level 
and time is important for NCC development to proceed. In addition, patterning within the 
embryo (discussed below) determines whether the NCC will migrate, survive, and 
differentiate into the correct elements.  
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CRANIAL NCC MIGRATION 
The migratory NCC emerge along the anterior–posterior axis of the embryo and 
NCC are generally divided into the cranial, vagal, and trunk populations. The cranial NCC 
are the first to undergo EMT and migrate, with the more posterior populations emerging 
sequentially. In zebrafish, the premigratory NCC express specifiers such as sox10 around 
12 hpf and then begin migration (Figure I-1). By 15 hpf, migration of cranial NCC can be 
observed with more posterior regions of NCC, such as the vagal and trunk populations, 
emerging sequentially (Schilling and Kimmel, 1994; Kimmel et al., 1995). By 24 hpf, some 
of the cranial NCC have migrated to reach their destinations where they differentiate into 
a number of different tissues while some of the trunk NCC are still in the process of 
migrating (Raible and Eisen, 1994; Kimmel et al., 1995). The cranial and trunk NCC 
migrate in different patterns, but there are common features such as the involvement of 
similar signaling molecules. The migration of cranial NCC will be discussed below. 
Cranial NCC migration requires a complex series of interactions between the NCC 
and the endoderm, mesoderm, and ectoderm. In the cranial region, NCC migrate out from 
the developing brain, which is divided into the diencephalon, mesencephalon, and 
hindbrain. The hindbrain is further divided into segments known as rhombomeres (r). On 
the ventral side of the embryo, structures called the pharyngeal arches (PA) form, which 
are a series of paired mesodermal outpocketings surrounded by the surface ectoderm and 
separated by portions of endoderm, known as the endodermal (or pharyngeal) pouches 
(Figure I-3). NCC which arise from the dorsal neural tube migrate in conserved pathways 
into the PA and both proper patterning of the PA and the cranial NCC are needed for normal 
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craniofacial development (Klymkowsky et al., 2010). This patterning involves both cell-
autonomous features of NCC, such as expression of NCC specifiers, as well as non-cell 
autonomous interactions with the surrounding endoderm, mesoderm, and ectoderm which 
provide signals to direct migration and differentiation (Cordero et al., 2011). In order for 
NCC to reach the correct locations, they must express NCC specifier genes and the embryo 




Figure I-3 Pharyngeal arch structure in zebrafish and humans.  
A) sox10:gfp labels NCC within the pharyngeal arches (PA) in a 36 hpf 
zebrafish embryo. B) Diagram of a cross-section through a zebrafish embryo 
reveals the paired structures of the PA. ep: endodermal pouch. Adapted from 
Kopinke et al. (Kopinke et al., 2006). C) Diagram of PA structures in a 
human embryo. PA1 in humans is divided into a maxillary and mandibular 
component. Adapted from Frisdal & Trainor (Frisdal and Trainor, 2014).  
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PATTERNING AND SIGNALING MOLECULES IN NCC MIGRATION 
The craniofacial region is patterned by signaling complexes, morphogens, and 
ligand/receptor interactions, all of which are required to ensure migration of the cranial 
NCC to the correct locations (Akimenko et al., 1994; Trainor and Krumlauf, 2001; Cordero 
et al., 2011; Frisdal and Trainor, 2014). Two major signaling complexes in this process are 
the homeobox (Hox) genes which give anterior-posterior positioning information and the 
distal-less homeobox (Dlx) genes which provide dorsal-ventral patterning to the 
pharyngeal arches (Figure I-4) (Schilling et al., 2001; Medeiros and Crump, 2012). Hox 
genes are expressed in a region-specific manner providing distinct arch identities. During 
development, the embryo establishes anterior-posterior segmental identity in large part 
through combinatorial expression of Hox genes. The Hox expression pattern is well 
characterized in the hindbrain, which is divided into seven segments called rhombomeres 
(r) and confers segmental identity to cranial NCC; this identity is critical for forming proper 
structures after NCC migration (Lumsden et al., 1991; Kontges and Lumsden, 1996). The 
anterior limits of Hox expression vary and there are different combinations of Hox 
expression in different rhombomeres. In zebrafish, hoxa2 is expressed in r2, while hoxb3 
is expressed in r4, and hoxb4 in r7 (Prince et al., 1998; Schilling et al., 2001; Hunter and 
Prince, 2002). NCC which come from the midbrain and r1 have no hox expression, while 
hoxa2 is expressed in NCC of r2 and r3, both hoxa2 and hoxb3 are expressed in r4 and r5 
and only hoxb3 is expressed in r6 (Schilling et al., 2001). These different combinations of 
hox expression persist in the NCC which populate the different PAs and function in the 
patterning of the elements derived from each arch.  
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Alterations of Hox gene expression result in homeotic transformations of NCC 
derivatives (Trainor and Krumlauf, 2000b; Minoux et al., 2009), whereby the elements of 
one segment of the embryo are replaced by those characteristic of another. Changes in 
retinoic acid may alter expression of the Hox genes, as exposure to excessive retinoic acid 
in vivo can shift expression of Hox genes anteriorly, altering the segmental identity of the 
embryo, and resulting in homeotic transformations (Kessel and Gruss, 1991). Furthermore, 
some Hox gene enhancer regions contain retinoic acid response elements. These response 
elements are bound by a heterodimer consisting of a retinoid X receptor (RXR) and a 
retinoic acid receptor (RAR). RARs are expressed by NCC, with RARα and RARγ being 
important for development of skeletal structures (Lohnes et al., 1994; Dupé and Pellerin, 
2009). This is demonstrated by pharyngeal arch defects in the absence of RA. For example, 
zebrafish with a mutation in raldh2, an enzyme involved in RA synthesis, fail to form 
cartilage elements from PA 3-7 (Begemann et al., 2001), confirming other studies showing 
pharyngeal patterning requires RA signaling (Lohnes et al., 1994; Mark et al., 2004). 
Altogether, this shows that RA signaling and its action on Hox gene expression is important 
in establishing anterior-posterior identity in the embryo. 
The dorsal-ventral identity of the pharyngeal aches are patterned by the Dlx genes 
(Minoux and Rijli, 2010; Medeiros and Crump, 2012). Six Dlx genes have been identified 
in mammals which are expressed in overlapping domains within the pharyngeal arches, 
and their functions in mice have been examined by Depew et al. (Stock et al., 1996; Depew 
et al., 2005).  In zebrafish, the dlx genes consist of dlx1a, dlx2a, dlx2b, dlx3b, dlx4a, dlx4b, 
dlx5a, and dlx6a and are similarly organized to those in mice. These genes are expressed 
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within different domains in the PA and the combination of dlx signals is important for the 
development of PA structures, most notably the craniofacial skeleton. dlx1 and dlx2 are 
expressed throughout PA 1 and 2, and are the only dlx genes expressed in the dorsal most 
region of the arch (Figure I-4 B). In more ventral domains, dlx3, 4, 5, and 6 are expressed 
in different regions in combination with either msxe or hand2 (see Figure I-4 B). msxe is a 
muscle segment homeobox gene while hand2 is a transcription factor and both of these 
genes function downstream of endothelin signaling and are required for ventral cartilage 
formation (Miller et al., 2003). The combination of different dlx genes are necessary for 
the dorsal-ventral patterning and development of the craniofacial skeleton. The ventral 
domain is defined by expression of hand2 and will eventually give rise to Meckel’s 
cartilage, part of the lower jaw, and the ceratohyal, which has homology to the hyoid. The 
intermediate domain, which contains the jaw joint, is defined by expression of all of the 
dlx genes, with the borders defined by dlx4a expression (Talbot et al., 2010). Finally, the 
dorsal domain is defined by dlx2a and dlx4a expression and will give rise to skeletal 
structures including the palatoquadrate and hyomandibula. Alterations of the dorsal ventral 
gene expression pattern within the arches can result in homeotic transformations. For 
example, mutations in hand2 show a duplication of the palatoquadrate, revealing a loss of 
ventral elements and a gain of dorsal elements (Talbot et al., 2010). Hence, similar to hox 
genes, expression of dlx genes in the correct domains is important for proper patterning 





In addition to hox and dlx genes, signaling via Fgfs, BMPs, and sonic hedgehog 
(Shh) from the different germ layers are required to act as guidance cues for proper NCC 
migration and PA development. In avian embryos, the endoderm serves as a source of 
BMP7, an inducing signal to form the epibranchial placodes which contribute to formation 
of the sensory cranial ganglia (Begbie et al., 1999). The mesoderm serves as a source of 
RA (Deschamps and van Nes, 2005)and provides maintenance signals for Hox gene 
expression (Trainor and Krumlauf, 2000a), while the ectoderm serves as a source of Fgf8 
(Trumpp et al., 1999). Fgfs serve as NCC survival factors (Trumpp et al., 1999; Abu-Issa 
et al., 2002; Macatee et al., 2003), and as chemoattractants to direct NCC migration 
(Kubota and Ito, 2000). Fgf8 has been shown to be important in the specification of NCC 
 
 
Figure I-4 hox and dlx expression in the 36 hpf zebrafish embryo.  
A) hox expression within the zebrafish hindbrain provides anterior-posterior 
identity and patterns the NCC which populate the pharyngeal arches. PA1 is 
populated by NCC coming from the midbrain (mb) and rhombomere (r) 1. 
hoxa2 expression is in r2-r5 while hoxb3 is expressed starting in r4. B) dlx 
gene expression within PA1 and PA2 defines dorsal-ventral identity. 
Adapted from (Medeiros and Crump, 2012). 
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spatial identity in the first pharyngeal arch by establishing anterior posterior polarity 
(Tucker et al., 1999). Fgf8 together with BMP4 signaling patterns the pharyngeal arches 
by regulating expression of genes such as nkx3.2 (previously known as bapx1) which 
contributes to dorsal-ventral patterning and the positioning of the jaw joint (Miller et al., 
2003; Wilson and Tucker, 2004). Shh signaling from the endoderm is also part of the 
signaling network in the head, and can induce expression of Fgf8 (Haworth et al., 2004; 
Haworth et al., 2007).  
The Fgf, Shh, and BMP signals function to positively or negatively regulate other 
signaling molecules which have roles in segregating and guiding the cranial NCC streams. 
These include Endothelin1, Sema/Neuropilin, Sdf1b/Cxcr4, and Eph/ephrin. Endothelin1 
(Edn1) is a secreted peptide expressed in the pharyngeal arch ectoderm, mesoderm, and 
endoderm (Nair et al., 2007) and is induced by BMP shortly after NCC migration 
(Alexander et al., 2011).  The receptor for Edn1, endothelin receptor A (Ednra), is 
expressed by NCC. Edn1 is thought to serve as a positional signal as well as having a role 
in the post-migratory NCC (Miller et al., 2000; Kimmel et al., 2001; Kimmel et al., 2003; 
Walker et al., 2007). Ventral fates are induced by edn1 expression, and edn1 is particularly 
important in determining mandibular versus maxillary identity in the first pharyngeal arch. 
It does so by activating Dlx5/Dlx6 which subsequently activate Hand2, a ventral marker in 
the arch (Sato et al., 2008). Negative regulation of edn1 is mediated by tbx1, a transcription 
factor important in the formation of the aortic arches (Piotrowski et al., 2003), although 
this has not been shown in mice. Jagged-Notch signaling, which helps determine dorsal 
skeletal fates, is repressed by Edn1, which is important for ventral skeletal development 
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(Zuniga et al., 2010) and so the combination of these signals establishes dorsal and ventral 
domains within the PA.  
Sema/Neuropilin signaling is also involved in proper segregation of the cranial 
NCC streams. In zebrafish, the nrp2a and nrp2b receptors are expressed in NCC targeting 
PA 1-3, while ligands sema3f and sema3g are expressed in NCC-free zones (Yu and 
Moens, 2005). In mice, Npn2 (expressed in migrating NCC) and Sema3F signaling is also 
required for cranial NCC development (Gammill et al., 2007). Sema3d has also been shown 
to have a role in NCC migration through controlling proliferation (Berndt and Halloran, 
2006). Cranial NCC migration is also guided by chemokine signaling, which was recently 
examined in zebrafish. The chemokine, stromal cell derived factor (Sdf1b, also known as 
Cxcl12), is expressed in the pharyngeal arch endoderm while the receptor, Cxcr4, is 
expressed in the cranial NCC in zebrafish embryos (Olesnicky Killian et al., 2009). 
Expression of receptors on NCC while ligands are expressed in endoderm, mesoderm, 
and/or ectoderm helps guide NCC to the pharyngeal arches.  
A fourth example of this is the Eph receptors, which are membrane bound and have 
tyrosine kinase activity. Eph receptors function in the pattered migration of NCC in the 
pharyngeal arch streams (Smith et al., 1997; Davy et al., 2004). In Xenopus, EphA4 and 
EphB1 are expressed in migrating NCC and mesoderm of the third, or third and fourth 
arches, respectively. The ephrin-B2 ligand, which is also membrane bound and interacts 
with these receptors, is expressed in the adjacent second arch NCC and mesoderm. Thus 
ephrin-B2 functions to guide migrating cranial NCC-expressing Eph receptors to their 
destination in the pharyngeal arches (Smith et al., 1997). Ephrin-B1 acts cell autonomously 
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in NCC to regulate craniofacial development (Davy et al., 2004). In addition, it has been 
shown that EphB1 physically interacts with the gap junction protein connexin43, which is 
required for cell sorting (Davy et al., 2006). However, roles for Eph/ephrin signaling in 
NCC have not been identified in zebrafish.  
Thus, the expression of many genes within the pharyngeal arch region as well as 
within the NCC themselves are important for guiding cranial NCC to the correct locations.  
The patterning and migration of NCC involves numerous signals which act both cell 
autonomously and non-cell autonomously and are expressed in NCC as well as surrounding 
tissues. Hox and Dlx genes function to provide anterior-posterior and dorsal-ventral 
patterning to the pharyngeal arches. Gradients of BMP, Fgf, and Shh expression function 
to regulate expression of other genes involved in PA patterning. Finally, receptor-ligand 
interactions including Edn1/Ednra, Sema/Neuropilin, and Cxcr4/Sdf1 are also important in 
NCC finding the correct migratory path. Mutations in NCC specifier genes or signaling 
molecules and their receptors may only affect one of the stages of NCC development, or 
multiple stages. The functions of some of these NCC specifiers in NCC differentiation are 




NCC migration and differentiation occur simultaneously, with specification of 
NCC fate sometimes beginning before migration. For example, melanoblasts are specified 
upon or soon after segregation from the neural tube. Similar mechanisms of differentiation 
exist in the cranial and trunk NCC populations, with the cranial population being 
distinguished by the ability to give rise to cartilage and bone. In this section, I discuss the 
differentiation of three major NCC lineages: neurons, pigment cells, and cartilage/bone. 
DIFFERENTIATION OF NEURONS 
The peripheral nervous system is one of the major systems formed by NCC. The 
peripheral nervous system can be subdivided into different systems including the sensory 
nervous system, which conveys information to the central nervous system about things 
sensed by the body, and the autonomic nervous system (ANS), which is related to 
involuntary organ control and functions such as breathing and digestion. The enteric 
nervous system, sympathetic nervous system, and parasympathetic nervous system are all 
further subdivisions of the ANS.  
Neurons of the sensory nervous system develop in three waves and have different 
functions. The first wave gives rise to mechanoreceptive (touch) and proprioceptive 
(movement and spatial position) neurons of larger diameters, the second wave to 
mechanoreceptive, thermoreceptive (temperature), and nociceptive (pain) neurons of 
smaller diameters, and the third to nociceptive neurons (Pavan and Raible, 2012). Several 
genes including the neurogenin (neurog) transcription factors are known to have roles early 
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in sensory neuron specification; these function with other factors such as Brn3a and Isl, 
which promote expression of genes involved in differentiation such as Runx1 and Runx3 
(Pavan and Raible, 2012). The neurotrophins (NGF, BDNF, NT3, NT4) and receptor 
tyrosine kinases (TrkA, TrkB, TrkC) are involved in both sensory and autonomic 
differentiation. The Trk receptors form homodimers upon ligand binding, leading to 
transphosphorylation and initiation of a phosphorylation signaling cascade. This cascade 
will activate AKT, which is important for cell survival, and MAPK, which activates 
transcription factors to regulate genes involved in survival and neuronal differentiation 
(Brodeur et al., 2009). For example, the ligand NGF binds to the TrkA receptor and is 
necessary for the survival and differentiation of sympathetic neurons (Brodeur et al., 2009). 
BMP and Wnt signals are important as NCC migrate towards the dorsal aorta to 
form the dorsal root ganglia and sympathetic ganglia. Constitutively active expression of 
β-catenin in NCC in mice led to differentiation into ectopic sensory neurons (Lee et al., 
2004), which is in contrast to the constitutive activation in zebrafish leading to melanocytes 
over neural lineages (Dorsky et al., 1998). The differences in these studies may be due to 
the different organisms and method of increasing β-catenin expression as the timing of Wnt 
signals is critical in segregating the neural from melanocyte lineages. β-catenin signal 
activation in premigratory NCC suppresses melanocyte specification, while β-catenin 
activation in migratory NCC suppresses formation of neural derivatives (Hari et al., 2012). 
In addition to Wnts, BMP signaling is important in the development of the sympathetic 
nervous system. BMPs are required for sympathetic neuron differentiation in chick 
embryos (Schneider et al., 1999) and induce expression of Phox2b in neural crest stem cells 
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(Lo et al., 1999), a transcriptional activator which promotes neuronal differentiation 
(Dubreuil et al., 2008). Conditional deletion of BMP receptor IA in NCC in mice results in 
diminished levels of Phox2b and results in death at the dorsal aorta (Morikawa et al., 2009).  
Similar to the sympathetic nervous system, development of the ANS requires 
several different transcription factors. One of the earliest required factors is the achaete-
shute complex (Mash1 in mice and zash1 in zebrafish) which is important for neuronal 
differentiation and maintenance (Guillemot et al., 1993; Sommer et al., 1995). Mash1 is in 
a feedback loop with Phox2. Downstream of BMP signaling, Phox2a, Phox2b, Gata2/3, 
and Hand2 all interact in the development of the ANS. Phox2b regulates many of the other 
transcription factors involved in differentiation including Gata2/3 (Tsarovina et al., 2004) 
and binds the DBH  (dopamine-β-hydroxylase) promoter and indirectly activates TH 
(tyrosine hydroxylase) and Ret. TH and DBH are both enzymes involved in the synthesis 
of the neurotransmitter noradrenaline (Pattyn et al., 1999). Ret is a receptor tyrosine kinase 
for GDNF (glial cell line derived neurotrophic factor), which promotes neuronal survival. 
Ret and GDNF are especially important in enteric nervous system development as 
mutations in these genes can result in Hirschsprung disease (Doray et al., 1998; Shen et al., 
2002). Phox2a and Hand2 have both been implicated in the activation of DBH and TH, and 
Gata2, which is expressed during later neuronal differentiation, is also known to activate 
TH (Stanke et al., 1999; Tsarovina et al., 2004; Lucas et al., 2006).  
The cranial ganglia are a part of the peripheral nervous system and are derived from 
both NCC and cranial placodes. The cranial placodes are ectodermal thickenings and 
include the lens, olfactory, trigeminal, otic, and epibranchial placodes; the epibranchial 
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placodes include the facial, glossopharyngeal, and vagal placodes (Figure I-5). The otic 
and olfactory placodes give rise to the sensory structures of the ear and nose while the 
trigeminal and epibranchial placodes contribute to the formation of the cranial ganglia. The 
cranial ganglia in 5 dpf zebrafish consist of the trigeminal, statoacoustic, facial, vagal, 
glossopharyngeal, and the anterior and posterior lateral line ganglia (Figure I-5 B). Studies 
in chick embryos have shown that NCC contribute to the proximal regions of the trigeminal 
and epibranchial ganglia as well as glial cells (D'Amico-Martel and Noden, 1983). Lineage 
tracing studies in zebrafish have confirmed that NCC contribute to the cranial ganglia 
(Kague et al., 2012). Thus the coordinated development of NCC and placodes are important 
for the formation of the cranial ganglia. 
Interactions between placode and NCC populations occur throughout neurogenesis 
in the developing embryo. The preplacodal region, which gives rise to the placodes, lies 
adjacent to the anterior neural plate, close to the neural plate border where NCC are 
specified. This close proximity to NCC continues during development as the further 
posterior placodes form. Various studies have examined the importance of NCC in placode 
and ganglia development. In Xenopus embryos, ablation of premigratory NCC disrupts the 
directional migration of the epibranchial placodes (Theveneau et al., 2013). Reciprocally, 
replacing the placodal region with non-placodal ectoderm inhibits migration of NCC 
(Theveneau et al., 2013). Similar experiments in mice show that ablating the neural fold 
leads to a displaced and misshapen trigeminal placode that is missing the NCC component 
(Stark et al., 1997). The role of NCC in placode and cranial ganglia development are also 
evidenced my numerous animal models in which cranial ganglia are disrupted as a result 
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of disruptions in NCC development (Vitelli et al., 2002; Dixon et al., 2006; Culbertson et 
al., 2011; Weaver et al., 2015).  
Several signals regulate the interactions between NCC and placodes. BMP and Fgf 
signaling from the surrounding tissues is important for inducing the factors necessary for 
placode development (Holzschuh et al., 2005; Nechiporuk et al., 2005; Nechiporuk et al., 
2007). In zebrafish, the placodes are defined by expression of neurog1 starting around 9 
hpf (Andermann et al., 2002) and subsequently pax2a (Nechiporuk et al., 2007) is 
expressed within the epibranchial placodes and foxi1 is expressed in the otic placode 
(Solomon et al., 2003). Interactions between the migratory NCC and the migrating placodal 
cells involves multiple signals including Sdf1/Cxcr4 (Olesnicky Killian et al., 2009; 
Theveneau et al., 2013), Neuropilin/Semaphorin (Gammill et al., 2007; Maden et al., 
2012), and Robo/Slit (Shiau et al., 2008). Once the epibranchial ganglia are induced, 
phox2a and phox2b are important for their survival and differentiation, as these 
transcription factors activate genes in the neuronal differentiation cascade such as TH and 
DBH (Pattyn et al., 1997; Guo et al., 1999; Pattyn et al., 1999).  
In summary, NCC contribute to form the peripheral nervous system of the embryo 
in the trunk and head. In the head, NCC contribute to cranial ganglia formation, which are 
also partly derived from the cranial placodes. Differentiation of NCC into neurons and glia 
of the peripheral nervous system requires their migration to the appropriate locations, 
which is mediated in part by Wnt, Fgf, and BMP signals. These signals are involved in 




DIFFERENTIATION OF PIGMENT CELLS 
Pigment cells such as melanocytes are another cell type derived from NCC. 
Zebrafish have three types of pigment cells: melanocytes, xanthophores, and iridophores. 
Melanocytes provide black/brown pigmentation, xanthophores are yellow, and iridophores 
are an iridescent silver. As melanocytes are also found in mammals and their development 
is the best understood of the pigment cell types, I use them as an example of pigment 
differentiation. Most melanoblasts, the precursor to melanocytes, are progressively 
specified during development, with specification occurring upon or soon after exit from 
the neural tube. The ongoing fate restriction involves a bipotent glia-melanocyte precursor 
 
 
Figure I-5 A model of placode development and cranial ganglia. 
A) NCC (blue) and placodes (red) in a generic vertebrate embryo. At this 
stage NCC are migrating into the PA and interact with the placodes, which 
are labeled. These cell populations interact in the development of the 
cranial ganglia. Adapted from (Steventon et al., 2014). B) Cranial ganglia 
within a 5 dpf zebrafish embryo labeled with pan-neuronal marker Hu. The 
ganglia are located posterior to the eye and include the trigeminal (Tg), 
anterior lateral line (aLLg), facial (F), statoacoustic (SA), posterior lateral 
line (pLLg), glossopharyngeal (G), and vagal (V) ganglia.  
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as well as a tripotent melanocyte-neural-adrenergic precursor (Thomas and Erickson, 
2008). Mitf (micropthalmia-associated transcription factor) is considered the master 
regulator of melanocyte gene expression and is necessary for melanoblast specification. 
Different genes and morphogens are expressed during the formation and migration of the 
melanocyte precursors to activate expression of Mitf and its downstream target 
genes(Dorsky et al., 2000; Hornyak et al., 2001; Thomas and Erickson, 2008; Curran et al., 
2009; Adameyko et al., 2012). 
Activation of Mitf by Sox10 and Pax3 is important in melanocyte development. 
Pax3 and Mitf act in parallel on different aspects of melanocyte development, with Pax3 
promoting proliferation of progenitor cells and Mitf promoting survival of committed 
melanoblasts (Hornyak et al., 2001). Pax3 plays a role in multiple aspects of NCC 
development including NCC formation, premigratory NCC, and differentiation into glia 
and melanocytes. Mice with mutations in Pax3 have defects in NCC-derived tissues, 
including pigmentation (Epstein et al., 1991). Morpholino-mediated knockdown of pax3 
in zebrafish specifically disrupts xanthophore development, leading to an absence of 
xanthoblasts (Minchin and Hughes, 2008). Notably, pax3 morphants display reduced mitfa 
expression, which may indicate a conserved function of pax3 in its activation, although 
direct regulation has not been shown. Sox10 is also involved in activation of Mitf along 
with Pax3 (Bondurand et al., 2000; Potterf et al., 2000). Mutations in Sox10 both in mice 
and zebrafish result in pigmentation defects (Southard-Smith et al., 1998; Dutton et al., 
2001). In zebrafish, the pigmentation defects in sox10-/- embryos can be rescued upon 
reintroduction of mitfa. Furthermore, Sox10 binding sites in the mitfa promoter indicate a 
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direct role for Sox10 in the activation of mitfa (Elworthy et al., 2003). Mutations in PAX3 
as well as SOX10 result in Waardenburg syndrome (Hoth et al., 1993; Pingault et al., 2010), 
confirming a role for these genes in pigmentation. Foxd3 and Sox2 are two other genes that 
also have roles in the activation of Mitf and these genes are typically active in neuronal and 
glial derivatives of NCC. Conditional deletion of Foxd3 or Sox2 from NCC results in a 
switch from glial to melanocyte fate in mice (Adameyko et al., 2012; Nitzan et al., 2013). 
In zebrafish, mutation of foxd3 results in disruption of neuronal and cartilage derivatives, 
but not melanocytes (Stewart et al., 2006). Mechanistic studies in zebrafish revealed that 
there are Foxd3 binding sites in the mitfa promoter region which allow Foxd3 to repress 
mitfa transcription (Curran et al., 2009). In vitro evidence demonstrates that Sox2 binds 
and represses activity at the Mitf promoter (Adameyko et al., 2012). 
The proper migration of melanoblasts is important in distinguishing the melanocyte 
lineage from the neuronal/glial lineage and involves expression of Kit, endothelin, and Wnt 
signaling. Kit is a receptor tyrosine kinase expressed in melanocyte precursors (Keshet et 
al., 1991) for the Kit ligand (Kitl) and is important for the survival and migration of 
melanoblasts. In the absence of the Kit receptor or ligand, melanocyte precursors remain 
in the migration staging area and fail to survive (Wehrle-Haller and Weston, 1995). Mice 
carrying mutations in Kit or Kitl show an absence of NCC derived melanocytes (Chabot et 
al., 1988; Geissler et al., 1988; Huang et al., 1990; Zsebo et al., 1990). Similarly, kit 
mutations in zebrafish result in pigmentation defects and these are accordingly known as 
the sparse mutants (Parichy et al., 1999). Not all zebrafish pigment cells are dependent on 
kit expression, but in those that are, Kit acts cell autonomously to promote melanocyte 
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migration. Parichy et al. also showed a role for kit in melanocyte survival. Studies in mice 
have revealed a role for endothelin signaling in melanoblast migration, although these 
signaling events are also involved in formation of the enteric nervous system and are not 
unique to the melanocyte lineage. NCC expressing EDNRB will proliferate in the presence 
of EDN3 and disruptions in endothelin signaling result in Waardenburg Syndrome and/or 
Hirschsprung Disease. One of the important functions of EDNRB in melanocyte 
development is activation of the Ras signaling cascade. Signaling through MAPK will lead 
to proliferation, while signaling through PI3K will provide anti-apoptotic factors. Wnt 
signaling also functions in melanocyte specification. Overexpression of β-catenin in 
zebrafish leads to enhanced melanocyte formation and diminished neural and glial cell 
formation, while inhibition of Wnt results in diminished melanocyte formation (Dorsky et 
al., 1998). In addition, the zebrafish homolog of Mitf, nacre, is directly activated by Wnt 
signaling (Dorsky et al., 2000).  
In summary, expression of Mitf is the first step in the gene cascade needed to 
produce the melanin pigment. Tyr, Tyrp1, and Dct are the major enzymes involved in 
melanin synthesis. Finally, transporter proteins are needed to transport melanin from the 
melanocyte to the neighboring keratinocytes (See Sommer, 2011 for review). The 
specification of melanocytes, and therefore expression of Mitf, involves Wnt, endothelin, 
and Kit signaling. Thus, the production of melanocytes involves genetic interactions and 
signaling cascades to specify melanoblasts from NCC and guide their migration and 
differentiation. 
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DIFFERENTIATION OF CARTILAGE AND BONE 
In contrast to the neuronal and pigment lineages which occur in trunk and cranial 
NCC, a unique feature of cranial NCC is their ability to differentiate into craniofacial 
cartilage and bone. Endochondral and intramembranous are two methods of ossification in 
the formation of bone. In endochondral ossification, chondrocytes form an initial 
cartilaginous template which undergoes hypertrophy and is replaced by osteoblasts and 
occurs in the long bones of the skeleton and some of the facial bones, such as the ceratohyal 
of the zebrafish. In intramembranous ossification, an initial condensation of mesenchyme 
calcifies directly to form the bone such as occurs in the flat bones of the cranium. The 
mammalian cranial vault consists of two frontal bones, two parietal bones, and one 
occipital bone and this anatomy is conserved in zebrafish. Sutures maintain separation 
between the calvarial bones and regulate skull growth. A combination of NCC and paraxial 
mesoderm form the cranial vault and sutures; the frontal bones are derived from NCC while 
the remaining calvarial bones form from the mesoderm (Jiang et al., 2002; Yoshida et al., 
2008).   
A recent study by Kague et al. examined craniofacial cartilage and bone elements 
in the zebrafish using the Cre-lox system to permanently label NCC and identify the origins 
of the different cartilage elements (Kague et al., 2012). The zebrafish skeleton (as shown 
in Figure I-6) consists of the viscerocranium, or the more ventral components, and the 
neurocranium, which lies dorsally. The viscerocranium consists of cartilage elements 
derived from pharyngeal arches 1-7 and all of these elements are NCC-derived. Meckel’s 
cartilage and the palatoquadrate are derived from PA1 which have homology to jaw 
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elements in a human skeleton. The elements derived from PA2 have homology with jaw 
support structures and include the ceratohyal, basihyal, hyosymplectic, and interhyal. In 
particular, there is homology of the palatoquadrate to the incus and the hyomandibular to 
the stapes, which are bones of the middle ear. NCC from PA 3-7 form the ceratobranchial 
cartilage elements. In the neurocranium, the anterior region is derived from NCC while the 
parachordal plate appears to be of mixed NCC and mesodermal origin. The ethmoid plate 
and trabecular cartilage have homology with the primary palate and nasal capsule in 
mammals (Swartz et al., 2011). The use of transgenic labeling and high-resolution imaging 
also revealed the mode of ossification in the cranioskeletal elements. Many of the cartilage 
elements of the craniofacial skeleton form by endochondral ossification including the 
ceratohyal, ceratobranchials, quadrate, and ethmoid. Other elements, such as the jaw 
including the maxilla, form by intramembranous ossification. A variety of signaling events 





Figure I-6 Zebrafish cartilage anatomy. 
A) 5 dpf zebrafish craniofacial cartilage stained with Alcian blue. B) 
Schematic of 5 dpf cartilage elements as shown in A. C) Cartilage elements 
of the viscerocranium. Cartilage elements in green are derived from PA1, 
red from PA2, and blue from PA3-7. D) Cartilage elements of the 
neurocranium include the ethmoid plate (ep) in yellow, trabeculae (tr) in 
orange, and the parachordal(pch) in teal. Abbreviations: bb: basibranchial; 
bh: basihyal cb: ceratobranchial; ch: ceratohyal; hb: hypobranchial; hs: 
hyosymplectic; ih: interhyal; m: Meckel’s cartilage; not: notochord; pq: 




The commitment of NCC to differentiate into cartilage is marked by expression of 
Sox9 (Bi et al., 1999), which is also involved earlier in NCC development (see previous 
section on NCC migration). Msx2 inhibits Sox9 in the mandibular region to prevent 
differentiation until cranial NCC migration is complete (Takahashi et al., 2001). Sox9 
along with Sox10 will activate expression of the type II collagen, Col2a1 (Ng et al., 1997). 
Two other Sox genes, Sox6 and LSox5, are known to coordinate with Sox9 in promoting 
cartilage development in mice (Lefebvre, 2010), but these genes have not been shown to 
function in cartilage development in zebrafish. Sox9 will also stimulate expression of 
Runx2, an early marker of bone formation. Runx2 is key in initiating the expression of 
other late osteogenic markers such as osterix, osteocalcin, osteopontin, and alkaline 
phosphatase (ALP) as well as type I collagen (Col1a1). Mice carrying a mutation in Runx2 
fail to form any bone and have only cartilaginous skeletons (Komori et al., 1997), 
demonstrating the essential function of Runx2 in osteogenesis.  
Many signaling pathways and transcription factors have been shown to influence 
the expression of Runx2. Msx2, a target of BMP signaling, is important for inducing Runx2 
expression in the frontonasal NCC (Han et al., 2007). Dlx5 was also found to increase 
expression of Runx2 by BMP signaling in chick embryos (Holleville et al., 2007). Runx2 
is also negatively regulated. Twist1 is another gene involved in osteoblast gene expression 
which inhibits osteoblast differentiation through regulating Runx2 (Yoshida et al., 2005). 
Knockdown of twist1a and twist1b leads to increased runx2b expression in zebrafish, while 
overexpression of twist1a or twist1b had the opposite effect (Yang et al., 2011). This 
suggests that, as in mice, twist1 inhibits runx2 in zebrafish. 
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The BMP, Hh, Fgf, and TGFβ (Transforming Growth Factor β) signaling pathways 
have all been shown to influence expression of transcription factors related to formation of 
cartilage and bone. The balance of these signals functions to guide and pattern NCC during 
migration and later to control chondrocyte differentiation. BMPs, along with endothelins, 
are important for establishing ventral identity within the PAs to pattern the ventral skeletal 
elements while Notch/Jagged establishes dorsal identities (Miller et al., 2000; Zuniga et 
al., 2010; Alexander et al., 2011). Expression of a dominant negative form of the BMP 
receptor bmpr1a showed defects in ventral cartilage elements such as Meckel’s, confirming 
a role in dorsal-ventral patterning (Alexander et al., 2011). In addition to their role in 
patterning, BMP signals have an important role in differentiation. Bmpr1a and Bmpr1b are 
both expressed in chondrocyte condensations in mice(Yoon et al., 2005). Skeletal 
development is severely disrupted in mice carrying mutations in both the BMP receptors 
Bmpr1a and Bmpr1b, while a mutation in only one of the receptors has milder phenotypes, 
suggesting overlapping functions for these receptors. Interestingly, the double mutant 
embryos severely disrupt the formation of the endochondral skeleton while 
intramembranous forming bones, such as those of the skull, are less affected (Yoon et al., 
2005). Examination of these mice reveal a lack of Sox9, LSox5, and Sox6 expression, which 
are important in the differentiation of cartilage, and demonstrate that BMP signaling is 
needed for the survival and proliferation of chondrocytes (Yoon et al., 2005).  
In addition to BMPs, Hh signaling is important in endochondral bone formation. 
Specifically, the Indian hedgehog (Ihh) signaling pathway is implicated in chondrocyte 
proliferation and differentiation. Ihh signaling is important for expression of the secreted 
 37 
factor parathyroid hormone-related peptide (PTHrP), which is known to have a role in 
formation of hypertrophic chondrocytes during endochondral ossification (St-Jacques et 
al., 1999). ihha and ihhb are expressed in hypertrophic chondrocytes of zebrafish, showing 
a conserved role for these genes in chondrocyte maturation (Avaron et al., 2006). A severe 
decrease specifically in endochondral bone formation is evident in ihha mutant zebrafish, 
while dermal bone formation is able to proceed, exhibiting the importance of ihh in 
endochondral ossification. Alternatively, mutations in the patched genes, ptc1 and ptc2, 
lead to increased Hh signaling and show premature bone formation (Hammond and 
Schulte-Merker, 2009). Consistent with this, Ihh mutant mice display rounded skulls, 
shortened faces, and shortened limbs and tails, with the endochondral skeleton being more 
severely affected. Differentiation markers Runx2, Col1α, ALP, and Ocn are reduced in    
Ihh-/- embryos and suggest an important role for Ihh in chondrocyte proliferation and 
osteoblast differentiation. Decreased expression of Bmp2 and Bmp4 in the calvarial bones 
of Ihh-/- embryos also suggest that Ihh functions upstream of these BMP ligands (Lenton 
et al., 2011). Therefore, the Ihh pathway functions in ossification along with the BMP 
pathway in endochondral osteogenesis.  
BMP interacts with other signaling pathways in chondrogenesis such as Fgfs. 
Studies in mice have revealed that the Fgf receptor, Fgfr3, is involved in the degradation 
of Bmpr1a (Qi et al., 2014). Fgfr3 activation is associated with negative regulation of 
chondrocyte proliferation and differentiation (Deng et al., 1996). In contrast to this negative 
regulation, other Fgfs are involved in stimulating BMP expression. For example, Fgf2 
stimulates BMP2 expression in osteoblasts, and this is regulated by Runx2 (Choi et al., 
 38 
2005). In zebrafish, inhibition of Fgf using SU5402 results in agenesis of the pharyngeal 
and neurocranial cartilages. fgf3 and fgf8 were shown to be especially important as 
morpholino knockdown of these genes led to nearly complete absence of cartilage in 
morphant zebrafish (Walshe and Mason, 2003). The Fgf receptors (Fgfrs) are important in 
the intramembranous ossification of the calvarial bones. Their functions in development 
are discussed with respect to craniosynostosis syndromes in the following section. 
Along with Fgfs, the TGFβ pathway, which signals through Smad proteins, is 
another signaling pathway involved in intramembranous cranial bone development. TGFβ 
ligands bind to type II receptors (TGFβR2) which heterodimerizes with type I receptors to 
initiate a phosphorylation signaling cascade.  TGFβR2 is expressed in the NCC-derived 
ectomesenchyme and cranial sutures in mice. Wnt1-Cre (NCC) conditional inactivation of 
TGFβR2 in mice results in cardiovascular defects and craniofacial defects including 
calvarial defects, a small mandible, and cleft palate (Sasaki et al., 2006). Interestingly, 
Fgfr2 was downregulated in Wnt1-Cre; Tgfbr2 mice, indicating Fgf functions downstream 
of TGFβ. Further study of the Wnt1-Cre; Tgfbr2 mice showed that Tgfbr2 functions in 
proliferation and differentiation, but not migration or survival of NCC (Sasaki et al., 2006). 
Similarly, zebrafish tgfb3 is expressed in migratory NCC and neurocranial cartilage. 
Morpholino knockdown of tgfb3 results in impaired chondrogenesis, also suggesting a role 
for TGFβ signaling in cartilage differentiation (Cheah et al., 2010), although not 
specifically in intramembranous ossification. In support of these in vivo studies, in vitro 
studies have shown that Runx2 responds to both TGFβ1 and BMP2 signals in the formation 
of osteoblasts (Lee et al., 2000).  
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In summary, expression of sox9 indicates an early commitment to the chondrogenic 
lineage, followed by runx2, which is involved in osteogenesis. Pharyngeal arch patterning, 
such as that by dlx genes and endothelin signaling, has an important function in generating 
the correct skeletal elements from each arch. Finally, Runx2 is regulated by multiple 
signaling pathways in the formation of both endochondral and intramembranous bones 
including BMP and Ihh. Thus a variety of signals are required for the formation of 
craniofacial bone and cartilage from NCC. 
 
NCC Development in Neurocristopathies 
Alterations in the development of NCC result in a collection of syndromes known 
as neurocristopathies. Depending on which phase of NCC development is disrupted, 
different phenotypes may arise. In the following section I present an example of 
neurocristopathies which arise from deficiencies of NCC formation (Postaxial acrofacial 
dysostosis), migration (DiGeorge Syndrome), and differentiation (craniosynostosis). 
NCC FORMATION: POSTAXIAL ACROFACIAL DYSOSTOSIS 
Postaxial Acrofacial Dysostosis (also known as Miller syndrome) is characterized 
by postaxial limb deformities and craniofacial anomalies including orofacial clefts, 
micrognathia, and malar hypoplasia. Given the NCC contribution to these structures, 
Postaxial Acrofacial Dysostosis is classified as a neurocristopathy. Remarkably, mutations 
in dihydroorotate dehydrogenase (DHODH) are responsible for Postaxial Acrofacial 
Dysostosis, an enzyme which is involved in the synthesis of uracil, one of the bases of 
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RNA (Ng et al., 2010). Given the ubiquitous nature of RNA synthesis, the specific 
phenotypes arising from DHODH mutations are surprising. Dhodh is strongly expressed 
in the pharyngeal arches, forelimbs, hindlimbs, and somites in mouse embryos which is 
consistent with the tissues affected by Postaxial Acrofacial Dysostosis (Rainger et al., 
2012). A DHODH inhibitor, leflunomide, has been used to examine its function during 
zebrafish development. Leflunomide treatment disrupts the development of NCC 
derivatives including melanocytes and glia while the development of mesodermal tissues 
are not disrupted (White et al., 2011). Expression of foxd3 is severely reduced and 
expression of migratory NCC markers sox10 and crestin are absent (White et al., 2011). 
Although further study is necessary to understand the function of DHODH, these results 
suggest it plays an important and tissue-specific role early in NCC development. 
NCC MIGRATION: 22Q11 DELETION SYNDROME 
The importance of patterning and signal integration in the development of the 
pharyngeal arches can be demonstrated by the Tbx1 mutant, which is a model of DiGeorge 
syndrome/22q11.2 deletion syndrome (DGS). DGS is characterized by cardiac defects and 
occasionally mild craniofacial defects, cleft palate, and hypothyroidism. Tbx1 is expressed 
in the pharyngeal endoderm, the mesodermal core of the pharyngeal arches, and a region 
known as the second heart field, which is important for outflow tract development (Garg 
et al., 2001; Vitelli et al., 2002). Homozygous mutations of Tbx1 in mice lead to similar 
features of DGS including cardiac outflow tract abnormalities and abnormal facial 
structures (Jerome and Papaioannou, 2001). Although not expressed by NCC, Tbx1 
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influences the expression of other genes implicated in NCC migration, as evidenced by the 
Tbx1-/- mice (Xu et al., 2004; Calmont et al., 2009). Loss of Tbx1 impacts tissue-specific 
gene expression and alters the environment through which NCC migrate (Vitelli et al., 
2002; Calmont et al., 2009). One of the genes which may be indirectly regulated by tbx1 is 
edn1, as shown by studies in zebrafish (Piotrowski et al., 2003). Zebrafish tbx1 mutants 
fail to develop pharyngeal pouches 2-6, confirming a role for tbx1 function in the endoderm 
(Piotrowski et al., 2003). Another example of altered gene expression is a change in Gbx2, 
a transcription factor for the guidance molecule Slit. Tbx1 controls the expression of Gbx2 
at the time of the fourth PAA specification (Calmont et al., 2009), and Tbx1-/- embryos 
show reduced Gbx2 expression especially in the fourth pharyngeal arch. Ablation of Gbx2 
in the pharyngeal surface ectoderm (using Ap2a-Cre) disrupted cardiac NCC migration and 
formation of the fourth PAA. Slit2, a Robo ligand, was found to be downregulated in both 
Tbx1-/- and Gbx2-/- mice. Robo1, the receptor expressed on NCC, was also found to be 
downregulated and its expression pattern more disorganized in mutant mice, showing an 
alteration in migratory cardiac NCC in Tbx1-/- mice (Calmont et al., 2009). These studies 
demonstrate that alterations in the tissues surrounding NCC can disrupt their normal 
development. Thus, defective NCC migration in neurocristopathies could be cell 
autonomous or non-cell autonomous.  
NCC DIFFERENTIATION: CRANIOSYNOSTOSIS 
Disruption of the balance of morphogenic signals can alter craniofacial 
development. The influence of these morphogens on craniofacial bone development, 
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particularly the FGFs, is demonstrated by the craniosynostosis syndromes which are 
defined by the premature fusion of the cranial sutures. Most craniosynostosis syndromes 
are associated with mutations in the FGF receptors (FGFR) -1, -2, and -3 as well as TWIST 
(Saethre-Crouzon syndrome), MSX2 (Boston-type CS), and EFNB1 (craniofrontonasal 
dysplasia). In suture development, osteoblast proliferation, differentiation, apoptosis, and 
mineralization must be balanced; disruption of any one of these processes can impact suture 
formation. Fgfrs are receptor tyrosine kinases and activate signaling cascades through PI3K 
as well as MAPK. Specificity in Fgf signaling is obtained through alternative splicing, 
tissue-specific expression patterns, and other modifications. For example, alternative 
splicing of Fgfr2 is tissue specific with b forms in epithelial cells and c forms in 
mesenchymal cells (Orr-Urtreger et al., 1993). All Fgfrs are expressed in the mesenchyme. 
Fgfr1 is expressed in the calvarial mesenchyme and later in osteoblasts, Fgfr2 is expressed 
at sites of ossification while Fgfr3 is expressed at low levels in the sutural osteogenic front 
(Iseki et al., 1999; Johnson et al., 2000). Homozygous mutations in Fgfr1 and Fgfr2 are 
pregastrulation lethal in mice, however, Fgfr3-/- mice are viable and fertile and do not 
display skull abnormalities (Colvin et al., 1996; Deng et al., 1996). Conditional deletion of 
Fgfr2 in osteoblast lineages reveals that Fgfr2 is required for osteoblast proliferation but 
not differentiation or survival (Yu et al., 2003). 
In addition to the Fgfrs, Twist1 is expressed in the sutural mesenchyme and has a 
role in differentiation by regulating Runx2 (Yoshida et al., 2005). Msx2 is regulated by 
both BMP and TGFβ signaling. Studies of the Msx2 mouse mutant show that a foramen in 
the skull vault is due to a defect in differentiation followed by a proliferation defect and 
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not due to a defect in NCC or apoptosis. An enhancement of the defect in differentiation 
and proliferation, resulting in a larger foramen, was seen in Twist1+/-; Msx2+/- embryos. 
Diminished differentiation was demonstrated by reduced expression of Runx2 and ALP. 
However, Msx2 expression was not affected in Twist1+/- embryos and Twist1 expression 
was not affected in Msx2+/- embryos, suggesting that these genes function in parallel 
pathways (Ishii et al., 2003). Twist1+/- mice have increased Fgfr2 expression and activation 
as well as increased BMP signaling (Connerney et al., 2008). These CS mouse models 
demonstrate that there are multiple signaling interactions in formation of cranial cartilage 
and bone, and that Runx2 plays a key regulatory role in this process. 
Altogether, these neurocristopathies show how different alterations of NCC 
development can result in the distinct phenotypes. Some are likely the result of cell-
autonomous functions of the gene involved, such as in Postaxial Acrofacial Dysostosis, 
while others are the result of alterations in the NCC migratory environment, as in DiGeorge 
syndrome. Finally, craniosynostosis models have shown morphogens such as BMP and Fgf 
are critical for the correct timing of differentiation into bone by NCC. 
Summary 
Development of NCC and NCC-derived tissues requires expression of specific 
genes at the proper time and in the correct location; failure to do so can result in 
neurocristopathies, which can be distinguished in part by which stage of NCC development 
is disrupted (See (Watt and Trainor, 2014)). Neurocristopathies which disrupt NCC 
formation can lead to severe malformations, and tend to be associated with more ubiquitous 
 44 
cellular processes. Postaxial Acrofacial Dysostosis is one such example whereby mutations 
in DHODH disrupt uracil synthesis. Disruption of NCC migration may take several forms 
including a failure of EMT to begin migration, disruptions in cell-cell signaling needed for 
appropriate migration, which can be either cell-autonomous or non-cell autonomous, as in 
DiGeorge syndrome. NCC differentiation into various tissue types also requires cell-
autonomous and non-cell autonomous signaling interactions. The expression levels and 
integration of these signals is important in differentiation as demonstrated by 
craniosynostosis syndromes.  Thus, investigating NCC development in vertebrate models 
is important for providing insight into the pathogenesis of neurocristopathies. Furthermore, 
an understanding of NCC may aid in the design of therapies to prevent the phenotypes 
which arise from disruptions of NCC development, such as the craniofacial phenotypes of 
TCS and Acrofacial dysostosis, Cincinnati type. 
 
Ribosomopathies and Ribosome Biogenesis 
Ribosomopathy syndromes, such as TCS and Acrofacial dysostosis, Cincinnati 
Type, are characterized by disruption of ribosome biogenesis. Ribosome biogenesis, or the 
process of making a ribosome, is important for cell growth and proliferation as ribosomes 
perform essential functions in translating messenger RNA (mRNA) into polypeptides in 
the cell. Ribosomes consist of four rRNAs, over 70 ribosomal proteins (RPs), as well as 
additional factors (Lafontaine and Tollervey, 2001; Kressler et al., 2010). RNA polymerase 
I (RNAPI) is responsible for the transcription of the 28S, 18S, and 5.8S rRNAs, a process 
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which occurs in the nucleolus, while RNA polymerase III (RNAPIII) transcribes the 5S 
rRNA. A eukaryotic ribosome consists of two subunits - the 40S (small subunit) and the 
60S (large subunit) - in which RPs are assembled onto the rRNA in the nucleolus. Once 
the pre-40S and pre-60S have formed, they are exported to the cytoplasm where the mature 
ribosome both decodes the mRNA and forms the peptide bonds between amino acids 
(Lafontaine and Tollervey, 2001). The process of ribosome biogenesis can be divided into 
several steps: transcription of ribosomal DNA, covalent modifications to the pre-rRNA, 
processing of the pre-rRNA to form mature rRNA, assembly of the rRNA and ribosomal 
proteins, and transport of the maturing ribosomes to the cytoplasm (Lafontaine and 
Tollervey, 2001; Tschochner and Hurt, 2003). Disruption of any of these steps can lead to 
disorders termed ribosomopathies (See Figure I-7). The process of ribosome biogenesis is 
described below with an emphasis on transcription of rRNA and the functions of RNAPI 
and RNAPIII.  
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The nucleolus is the site of ribosome biogenesis 
The nucleolus is the site of three key processes in ribosome biogenesis: pre-rRNA 
transcription, rRNA processing, and ribosomal ribonucleoprotein assembly (Boulon et al., 
2010). Ribosome biogenesis requires the coordination of all the RNA polymerases – 
RNAPI synthesizes the 25S, 18S, and 5.8S rRNAs, RNAPIII synthesizes the 5S rRNA, 
 
Figure I-7 Schematic of ribosome biogenesis and ribosomopathies.  
Ribosome biogenesis requires transcription of the rRNA, processing, 
assembly of the large and small subunits, and finally export to the cytoplasm. 
Disruptions of this process result in ribosomopathies, three of which are 
indicated. Figure from Watt and Trainor (Watt and Trainor, 2014).  
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and RNAPII synthesizes the mRNA of the ribosomal proteins. Each of these processes 
occurs in a particular region of the nucleolus. The nucleolus consists of a granular 
component, the dense fibrillar center, and the fibrillar center (Figure I-8). rDNA 
transcription by RNAPI occurs at the periphery of the fibrillar center, while unengaged 
rDNA transcription machinery, such as UBF (Upstream Binding Factor), can be localized 
within the fibrillar center. Within the dense fibrillar center, the 47S rRNA undergoes 
cleavage and early processing events. Proteins involved in this process, such as Nopp140, 
will localize to the dense fibrillar center. The 5S rRNA and some ribosomal proteins will 
also localize to the dense fibrillar center for early modifications and assembly. Ribosome 
assembly then continues in the granular component with the inclusion of more ribosomal 
proteins and the formation of the pre-40S, or small subunit (SSU), and the pre-60S, or large 
subunit (LSU). Proteins which lie within the granular component include 
B23/nucleophosmin, nucleostemin, and Nop52. These LSU and SSU precursors are then 
exported into the cytoplasm where maturation and assembly is completed and the 
ribosomes then function in protein synthesis (Reviewed in (James et al., 2014)).  
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RNA Polymerase I 
Transcription of the 47S rRNA by RNAPI occurs within the nucleolus and is 
important to understand as it is one of the rate-limiting steps of ribosome biogenesis 
(Laferté et al., 2006). In the following section, the structure, function, and regulation of 
RNAPI will be described. 
 
 
Figure I-8 Structure of the nucleolus and sub-compartments.  
The nucleolus consists of the granular center (GC), the fibrillar center 
(FC), and the dense fibrillar center (DFC). RNAPI transcription occurs at 
the periphery of the FC, while RNAPIII transcription of the 5S rRNA 
occurs in the nucleoplasm. Ribosomal proteins and the 5S rRNA are 
transported into the DFC to begin ribosome assembly. Ribosome assembly 
after rRNA processing continues in the GC, and then pre-ribosomes are 
exported into the cytoplasm. Figure adapted from (James et al., 2014). 
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RNAPI STRUCTURE AND FUNCTION 
RNAPI is an enzyme consisting of fourteen subunits and is responsible for the 
transcription of the 47S rRNA. The structure of eukaryotic RNAPI has been extensively 
examined in yeast (Engel et al., 2013; Fernandez-Tornero et al., 2013), which revealed a 
10-subunit core consisting of A190, A135, AC40, AC19, A12.2, Rpb5, Rpb6, Rpb8, 
Rpb10, and Rpb12. A190, A135, and A12.2 are unique to RNAPI while AC19 (Polr1d) 
and AC40 (Polr1c) are shared by RNAPI and RNAPIII. The 5 Rpb subunits are shared 
amongst RNAPI, II, and III. Two additional subunits, A14 and A43, form a stalk 
subcomplex while A49 and A34.5 form a TFIIF-like subcomplex (Figure I-9A). 




Figure I-9 Schematic of RNA Polymerase I. 
A) Diagram of interactions among the 14 subunits of RNA Polymerase I. B) 





The different subunits of RNAPI have different functions when it comes to 
assembly of RNAPI and its interaction with the rDNA. The A14/A43 complex was shown 
to be important for interacting with Transcription Initiation Factor IA (TIF-IA), which is 
required for RNAPI transcription (Engel et al., 2013). The A49/A34.5 complex stabilizes 
A12.2, which forms part of the active site of RNAPI, and is also responsible for making 
contact with the DNA and mediating RNA cleavage by RNAPI. Together with A12.2, the 
A190 and A135 subunits are important for forming the catalytic site of the enzyme (Figure 
I-9B).  
Yeast RNAPI subunits Alternate name Human RNAPI subunits 
A190 Polr1a hRPA190 
A135 Polr1b hRPA135 
AC40 Polr1c hRPA40 
AC19 Polr1d hRPA19 
A12.2 Polr1h hRPB12 
Rpb5 Polr2e hRPB5 
Rpb6 Polr2f hRPB6 
Rpb8 Polr2h hRPB8 
Rpb10 Polr2l hRPB10 
Rpb12 Polr2k hRPB12 
A14  hRPB4 
A43 Polr1f hRPA43 
A49 Polr1e PAF53 
A34.5 Polr1g PAF49 (CAST) 
 
Table I-1 RNAPI subunits in yeast and alternative names. 
Alternate names listed in the second column are used in zebrafish. 
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TRANSCRIPTION BY RNAPI 
The first step in RNAPI transcription is the formation of the pre-initiation complex 
which consists of, at a minimum, TIF-IA (also known as RRN3 in yeast), Transcription 
Initiation Factor IB (TIF-IB, known as selectivity factor SL1 in humans), and upstream 
binding factor (UBF). These proteins interact with each other, RNAPI, and the rDNA prior 
to transcription. The rDNA sequence is present in tandem repeats with approximately 300 
copies present within the human genome (Stults et al., 2008). In humans, the rDNA repeats 
are located on acrocentric chromosomes. An rDNA repeat (Figure I-10) consists of a 
transcription start site, the upstream control element (UCE) and the core promoter. This 
region is followed by the 47S rDNA region which consists of the 5’ externally transcribed 
sequence (5’ETS), 18S rRNA, internally transcribed sequence 1 (ITS1), 5.8S rRNA, 
internally transcribed sequence 2 (ITS2), 28S rRNA, and the 3’ETS. Finally, there are 
terminator elements (T) prior to the start of another rDNA repeat.  
 
 
Figure I-10 Structure of an rDNA repeat.  
The rDNA promoter region consists of the Upstream Control Element 
(UCE) and the core promoter (CORE), upstream of the transcription start 
site (arrow). RNAPI will transcribe the 47S rRNA gene which consists of 
External Transcribed Spacer (ETS) and Internal Transcribed Spacer (ITS) 
regions along with the 18S, 5.8s, and 28S rRNAs. Following the 47S 




The three main initiation factors will interact with the rDNA in different ways to 
stimulate rDNA transcription. TIF-IA interacts with RNAPI (Cavanaugh et al., 2002; 
Beckouet et al., 2008) and binds TIF-IB (Miller et al., 2001). More recent evidence 
suggests that TIF-IA binds DNA and that this function is required for RNAPI transcription 
(Stepanchick et al., 2013). TIF-IB binds the UCE and helps confer promoter specificity 
and is essential for recruiting RNAPI to the transcription start site (Rudloff et al., 1994; 
Friedrich et al., 2005). TIF-IB also has a role in stabilizing the interaction between UBF 
and the rDNA promoter (Friedrich et al., 2005). UBF, which is required for transcription 
initiation (Jantzen et al., 1990), binds throughout the rDNA (O’Sullivan et al., 2002) and 
interacts with TIF-IB and RNAPI (Hanada et al., 1996; Panov et al., 2006b; Penrod et al., 
2015). Together, these interactions help form a stable pre-initiation complex at the rDNA 
promoter. 
Once the pre-initiation complex has formed, RNAPI must escape the promoter and 
initiate transcription. Phosphorylation of TIF-IA, releasing it from RNAPI, is an important 
part of this process (Bierhoff et al., 2008), while UBF has a role in stimulating promoter 
escape (Panov et al., 2006a). After promoter escape and initiation of transcription, the 
rRNA transcripts are rapidly produced as an estimated 8-10 million transcripts are needed 
every 24 hours in a mammalian cell to sustain normal levels of ribosome biogenesis 
(Goodfellow and Zomerdijk, 2013). UBF may also have a role in elongation through 
remodeling of the rDNA chromatin. Additional factors have been implicated in chromatin 
remodeling of the rDNA including histone chaperones such as nucleolin (Rickards et al., 
2007; Cong et al., 2012) and nucleophosmin (Murano et al., 2008), which help keep rDNA 
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in a euchromatic state, and topoisomerases such as Topoisomerase IIα, a known component 
of mammalian RNAPIβ (Panova et al., 2006). The process of termination may occur by 
different mechanisms in different species. The A12.2 subunit is important for termination 
because of its ability to cleave RNA (Prescott et al., 2004). In mammals, binding of 
transcription termination factor TTF-I to the terminator elements causes pausing of RNAPI 
(Grummt et al., 1986) and then RNAPI dissociates from the rDNA (Jansa and Grummt, 
1999). A similar mechanism occurs in yeast, however, another potential mechanism exists. 
In this mechanism, the pre-rRNA is cleaved by Rnt1, and then the cleavage product is 
recognized by Rat1 which continues digestion. When Rat1 reaches the elongating RNAPI, 
the transcription complex becomes unstable and dissociates from the rDNA, resulting in 
termination (Braglia et al., 2011).  
In summary, the process of RNAPI transcription involves the formation of the pre-
initiation complex, promoter escape, elongation, and termination. Some of the factors 
involved in initiation are involved in other steps of the transcription process. How these 
factors change roles is in part due to alterations in phosphorylation, which then regulate 
RNAPI transcription. 
REGULATION OF RNAPI AND RDNA TRANSCRIPTION 
Regulation of transcription by RNAPI is a topic of much interest as rRNA 
production is crucial for ribosome biogenesis within the cell. Nutrient availability, growth 
factors, and environmental stressors are all known to affect rRNA transcription by RNAPI. 
Initiation factors influence rRNA transcription in both a long-term and short-term manner. 
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Long-term changes, such as the number of active rRNA genes, are determined by the levels 
of UBF (Sanij et al., 2008). Short-term changes, such as the rate of transcription from each 
rDNA repeat, are regulated in part by phosphorylation of TIF-IA (Cavanaugh et al., 2002).  
The regulation of UBF, both the activity and amount present, is important for the 
regulation of ribosome biogenesis. Low levels of UBF are associated with diminished 
rDNA transcription. Phosphorylation of UBF through either the EGF pathway by ERK 
(Stefanovsky et al., 2001) or IGF pathway by PI3K (Drakas et al., 2004) at different sites 
can increase rDNA transcription. Alternatively, phosphorylation of UBF through the 
mTOR pathway increases the interaction between TIF-IB and UBF (Hannan et al., 2003). 
Notably, UBF is also known to interact with Treacle, one of the proteins that may be altered 
in TCS (Valdez et al., 2004).  
TIF-IA is also regulated by phosphorylation at specific residues, which can be 
either activating or inhibiting of rDNA transcription. Phosphorylation through the MAPK 
pathway (Zhao et al., 2003a) leads to increased rDNA transcription whereas 
hypophosphorylation of TIF-IA through the mTOR pathway upon nutritional stress leads 
to diminished rRNA transcription (Mayer et al., 2004). Under conditions of oxidative or 
ribotoxic stress, phosphorylation of TIF-IA by c-jun N-terminal protein kinase 2 (JNK2) 
disrupts the interaction of TIF-IA with TIF-IB and RNAPI and then directs TIF-IA from 
the nucleolus into the nucleoplasm (Mayer et al., 2005). Under these conditions, only the 
activity of TIF-IA is altered, not the levels, making this easily reversible in the cell. 
Inhibition of TIF-IA is also capable of triggering a stress response which leads to increased 
levels of the tumor suppressor p53 and p53-dependent apoptosis (Yuan et al., 2005). 
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Alterations in growth factors, energy levels, and stress therefore regulate both UBF 
and TIF-IA by phosphorylation to regulate rDNA transcription. Regulation of TIF-IB has 
not been as thoroughly examined, however, deacetylation of TIF-IB by SIRT1 has been 
shown to render it inactive (Muth et al., 2001). SIRT1 is a member of the sirtuins, which 
are deacetylases that have multiple roles in the cell including gene expression and cell 
survival under stress. Another member of the sirtuin family, SIRT7, will interact with 
RNAPI and is associated with activation of transcription (Ford et al., 2006). Interestingly, 
SIRT7 has also been implicated in the regulation of RNAPI during the cell cycle. RNAPI 
transcription is high during G2 and S phase, low during M phase, and then gradually 
recovers during G1. This process is in part regulated by phosphorylation of UBF and TIF-
IB by cdk/cyclin complexes (Grummt, 2003). SIRT7 interacts specifically with UBF and 
is important in the resumption of rDNA transcription after mitosis (Grob et al., 2009). Thus, 
all three factors involved in initiating RNAPI transcription are regulated in different ways 
under different conditions. A combination of phosphorylation, dephosphorylation, 
acetylation, and deacetylation regulates these factors and their ability to form the initiation 
complex under conditions of stress, nutrient depravation, cell cycle progression, or the 
presence of certain growth factors. As much of the work has been completed in in vitro 
models, it remains to be seen how alterations in these regulations might affect embryonic 
development. 
 56 
RNAPIII structure and function 
 Another key factor in the regulation of ribosome biogenesis is the synthesis of 5S 
rRNA by RNAPIII, which also has a role in transcribing tRNAs and ncRNAs. RNAPIII is 
the largest of the polymerases containing seventeen subunits, but also the least studied due 
to the difficulty in obtaining its crystal structure. Similar to RNAPI, RNAPIII consists of a 
10-subunit core containing C160, C128, AC40, AC19, Rpb5, Rpb6, Rpb8, Rpb10, Rpb12, 
and C11. The subunits unique to RNAPIII are listed in  
Table I-2. The exact positions and functions of each subunit of RNAPIII have yet to be 
identified, but electron cryomicroscopy studies have given insight as to the organization of 
the enzyme (Fernández-Tornero et al., 2011). Studies of some of the subcomplexes of 
RNAPIII have revealed various roles in transcription initiation, elongation and termination. 
Similar to RNAPI, the two largest subunits C160 and C128 form the active center of the 
enzyme, while C11 has RNA cleavage activity (Chédin et al., 1998). Studies in zebrafish 
have suggested an interaction between the homologs of the C128 (Polr3b) and C11 (Polr3k) 
subunits, which is important for pancreas development (Yee et al., 2007). C17 and C25 
form a dimer which is involved in initiation of RNAPIII transcription (Jasiak et al., 2006). 
The C37/C53 dimer is homologous to the A49/A34.5 dimer in RNAPI and has roles in 
initiation, elongation, and termination (Kassavetis et al., 2010). Finally, the C82/34/31 
heterotrimer is involved in nucleic acid binding and transcription initiation (Fernández-




Transcription initiation is a more complex, variable process for RNAPIII. Unlike 
RNAPI which only transcribes one gene, RNAPIII transcribes multiple different genes. 
The specificity for each different gene comes in part through the usage of different 
promoters to transcribe the RNAs. Type 1 promoters transcribe the 5S rRNA, Type 2 
promoters tRNAs, and Type 3 promoters include the U6 snRNA (Figure I-11). The 
structure of the Type 1 promoter is unique in that it is the only promoter to contain an 
internal control region (ICR) which contains an intermediate element (IE), C box, and A 
box. This unique combination allows the transcription initiation factor TFIIIA to bind the 
5S rDNA, and TFIIIA does not bind Type 2 or Type 3 promoters. TFIIIA also helps recruit 
another transcription initiation factor, TFIIIC, to the promoter. Type 2 promoters contain 
both an A box and a B box, which is bound by TFIIIC. Finally, Type 3 promoters are the 
only RNAPIII promoter which is external to the gene. These promoters contain a proximal 
sequence element (PSE) and TATA box. Some genes may also contain a distal sequence 
Subunit Alternate names RNAPI homolog 
C160 Polr3a, hRPC160, RPC1 A190 
C128 Polr3b hRPC128, RPC2 A135 
C11 Polr3k, hRPC11 A12.2 
C17 hRPC9 A14 
C25 Polr3h, hRPC8 A43 
C37 Polr3e, hRPC5 A49 
C53 Polr3d, hRPC4 A34.5 
C31 Polr3g, hRPC7, RPC32  
C82 Polr3c, hRPC3, RPC62  
C34 Polr3f, hRPC6, RPC39  
 
Table I-2 Unique subunits of RNAPIII. 
Seven of the RNAPIII subunits have RNAPI homologs, while the remaining 
subunits are unique to RNAPIII. 
 
 58 
element (DSE) to aid in regulation of transcription initiation at the promoter, although this 
has only been observed in vertebrates and not in yeast. Type 3 promoters do not require 
TFIIIA or TFIIIC for transcription initiation but instead, utilize a form of TFIIIB and the 
small nuclear RNA activating protein complex (SNAPc), which binds the PSE (Schramm 
and Hernandez, 2002). TFIIIB interacts with RNAPIII and is part of the initiation complex 
at Type 1 and Type 2 promoters as well. Thus, Type 1 promoters require an initiation 
complex consisting of TFIIIA, TFIIIB, and TFIIIC while Type 2 promoters utilize TFIIIB 
and TFIIIC and Type 3 promoters utilize only TFIIIB (Orioli et al., 2012). Once initiated, 
conformational changes to RNAPIII are hypothesized to aid in the transition to elongation. 
Termination by RNAPIII is relatively simple and occurs upon encountering a series of T 
residues; the minimum number of residues is 4 in vertebrates or 5 in yeast (Richard and 
Manley, 2009).  
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Binding of TFIIIA, TFIIIB, and TFIIIC to initiate RNAPIII transcription is 
regulated in a similar manner to the factors involved in RNAPI transcription. As TFIIIB is 
involved in transcription initiation from all of the RNAPIII promoters, much of the 
regulation of transcription initiation is dependent on modifications of TFIIIB. For example, 
phosphorylation of TFIIIB by ERK leads to an increase in TFIIIB activity (Felton‐Edkins 
et al., 2003). Expression of c-Myc, a proto-oncogene, will also increase transcription by 
RNAPIII (Gomez-Roman et al., 2003). Tumor suppressors such as p53 and the 
retinoblastoma protein (Rb) will diminish RNAPIII activity through modifications or 
binding of TFIIIB. When hypophosphorylated, Rb will bind TFIIIB and disrupt its 
interactions with RNAPIII and TFIIIC (Chu et al., 1997; Sutcliffe et al., 2000; Gjidoda and 
 
 
Figure I-11 Three types of promoters are used by RNAPIII to transcribe different 
RNA products.  
Type 1 promoters contain an internal control region (ICR) consisting of an 
A box (A), an intermediate element (IE), and a C box (C). Type 2 
promoters consist of an A box and B box (B). Type 3 promoters may 
contain a distal sequence element (DSE), and also contain a proximal 
sequence element (PSE) and a TATA box. Termination of the genes is in 




Henry, 2013). A similar mechanism exists for inhibition by p53, which also binds TFIIIB 
(Crighton et al., 2003).  
In addition to these specific regulators, Maf1 is an important general negative 
regulator of RNAPIII. The activity of Maf1 is regulated by its level of phosphorylation. 
Under favorable growth conditions, Maf1 is phosphorylated and is primarily localized 
within the cytoplasm. In a mammalian model, mTOR localizes to tRNA and 5S rRNA 
genes through an interaction with TFIIIC. mTOR then functions to phosphorylate Maf1, 
preventing it from inhibiting RNAPIII transcription (Kantidakis et al., 2010). Under stress 
conditions such as starvation, replicative stress, or oxidative stress, the nuclear localization 
signals of Maf1 become dephosphorylated and Maf1 enters the nucleus. It interacts with 
and ultimately inhibits RNAPIII transcription (Vannini et al., 2010). Thus, under stress 
conditions, the production of 5S rRNA and tRNAs are reduced while under favorable 
conditions, phosphorylated Maf1 does not inhibit transcription of RNAPIII genes. 
Altogether, the regulation of RNAPIII and RNAPI by similar factors including stress and 
growth conditions helps the cell to maintain appropriate levels of ribosome biogenesis.  
 
Nucleolar Stress and Ribosomopathies 
Ribosome biogenesis is a complex process which must be precisely controlled 
within the cell. Disruptions in ribosome formation may lead to ribosomopathies, while 
over-production of ribosomes is one hallmark of cancer cells. Alterations in ribosome 
production can lead to nucleolar stress, which is defined by disruption of the nucleolar 
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structure. Rubbi & Milner defined nucleolar stress in their studies of nucleoli (Rubbi and 
Milner, 2003). They found that inhibiting UBF, which blocked RNAPI transcription of 
rRNAs, disrupted nucleolar structure and ultimately led to p53 activation and cell cycle 
arrest. This is consistent with the idea that maintaining a balance of rRNAs and ribosomal 
proteins is important for ribosome biogenesis and cell growth.  
P53 RESPONDS TO CELLULAR STRESS 
p53 activation is a common response to a number of cellular stresses such as 
replication and translation stress, DNA damage, and hypoxia, which then acts to suppress 
proliferation and activate apoptosis (Vazquez et al., 2008). One well-studied mechanism 
of the p53 response to nucleolar stress involves MDM2, which is required to suppress p53 
activation (Ringshausen et al., 2006). Under normal conditions, MDM2 binds p53 and 
functions to ubiquinate p53, targeting it for degradation by the proteasome (Oliner et al., 
1993; Honda et al., 1997; Kubbutat et al., 1997). The balance between ribosomal protein 
and rRNA synthesis is tightly regulated; if disrupted, this can lead to accumulation of 
ribosomal proteins, some of which bind MDM2 and prevent its inhibition of p53 (Marechal 
et al., 1994; Lohrum et al., 2003; Zhang et al., 2003; Dai et al., 2004; Jin et al., 2004; Chen 
et al., 2007; Donati et al., 2011a). In particular, a complex of RPL5, RPL11, and the 5S 
rRNA are important in this process (Donati et al., 2013). Bound to MDM2, this complex 
leads to p53 stabilization. If binding to MDM2 is disrupted, it prevents the p53 response 
(Jaako et al., 2015).  
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p53 functions as a transcription factor to induce genes involved in cell cycle arrest 
and apoptosis. One example is Cdkn1a (also known as p21) which is a cyclin-dependent 
kinase inhibitor. Activation of p21 inhibits cyclin dependent kinase complexes and results 
in G1 or G2 arrest (Deng et al., 1995; Abbas and Dutta, 2009). Induction of other genes 
such as Bbc3 (also known as Puma), Bax, and p53AIP1 by p53 lead to activation of 
apoptosis. Bbc3 directly binds anti-apoptotic Bcl-2 family proteins, which then displaces 
Bax and/or Bak proteins enabling them to form pores on the mitochondrial membrane, 
eventually leading to caspase activation (Yu and Zhang, 2009). Similarly, p53AIP1 will 
also bind Bcl-2 and lead to cytochrome c release from the mitochondria (Matsuda et al., 
2002). Altogether, these transcriptional changes result in activation of the apoptosis 
pathway through mitochondria (Figure I-12).  
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A recent study of MYBB1A, a regulator of p53, showed that the decision between 
cell cycle arrest and apoptosis may be in part dependent on the type of disruption of rRNA. 
Disrupting 47S rRNA transcription through depletion of RNAPI transcription factors 
resulted in apoptosis. However, depletion of rRNA processing factors resulted in cell cycle 
arrest at G1. MYBB1A functions to acetylate p53 and does so even when rRNA 
transcription is disrupted, but not when there is a disruption of rRNA processing. The 
 
Figure I-12 The apoptotic response is triggered by nucleolar stress.  
Disruptions in ribosome biogenesis cause nucleolar stress and RPL5, 
RPL11, and the 5S rRNA will bind MDM2, preventing its role in p53 
degradation. p53 will then act as a transcription factor for target genes 
including Bbc3 and Bax. Bbc3 will bind Bcl-2 and Bcl-XL which normally 
function in an anti-apoptotic manner. This allows Bax/Bak to form a pore 
leading to mitochondrial outer membrane permeabilization (MOMP). 
Cytochrome c is then released from the mitochondria, leading to a cascade 
of events eventually resulting in apoptosis. Portions of the figure are 
adapted from (Nikoletopoulou et al., 2013). 
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difference in acetylation may have a role in the differential binding of p53 in eliciting cell 
cycle arrest versus apoptotic target gene activation (Kumazawa et al., 2015).  
Interestingly, activation of the ribosomal protein-Mdm2-p53 pathway may occur in 
the absence of nucleolar disruption. Mutations in RPS6, which disrupt assembly of the 40S 
subunit, do not alter nucleolar integrity, but do activate p53 (Fumagalli et al., 2009). 
Although the mechanisms may not be completely understood, there is a well-established 
link between ribosome biogenesis, p53 activation, and subsequent cell cycle arrest and 
apoptosis which underlies multiple ribosomopathies. 
RIBOSOMOPATHY: DIAMOND BLACKFAN ANEMIA 
Disruptions of ribosome biogenesis underlie the ribosomopathy syndrome 
Diamond Blackfan anemia (DBA). DBA arises due to mutations in ribosomal proteins 
including RPS17, RPS19, RPS24, RPL5, RPL11, and RPL35A, (reviewed in (Lipton and 
Ellis, 2009; Narla and Ebert, 2010), however, the genetic mutation is unknown in about 
half of DBA patients. These mutations disrupt either 40S or 60S assembly (Figure I-7). 
The primary characteristics of DBA include anemia, reticulocytopenia, macrocytosis, and 
a selective decrease or absence of erythroid precursors, while additional features may 
include thumb abnormalities, craniofacial, and cardiac defects (Lipton and Ellis, 2009). 
Mutations in RPL5 and RPL11, which function in the aforementioned ribosomal protein-
Mdm2-p53 pathway, are associated with cardiac and craniofacial anomalies more often 
than mutations in the other ribosomal proteins linked to DBA (Gazda et al., 2008). 
Morpholino knockdown or mutation of rpl11 in zebrafish results in craniofacial anomalies 
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as well as diminished expression of neurogenic markers, metabolic and hematopoietic 
defects, consistent with the human DBA phenotype (Danilova et al., 2011) (Chakraborty 
et al., 2009). In support of a mechanism of nucleolar stress and p53 activation, inhibition 
of p53 could ameliorate the mutant phenotypes of zebrafish and mice models of DBA 
carrying mutations in rpl11 or Rps19 (Danilova et al., 2008; Chakraborty et al., 2009; Jaako 
et al., 2011). Given the global nature of ribosome biogenesis, the presence of specific 
phenotypes in DBA are surprising and represent an interesting area of study. Mutations in 
ribosomal proteins would be expected to impair growth of all tissues, such as in the 
Drosophila minute mutants (Marygold et al., 2007). However, in humans and vertebrate 
models, only specific tissues are affected. Even more interesting is that within the 
ribosomal protein mutations which cause DBA, only some have associations with 
craniofacial anomalies. One explanation for the tissue-specificity of the phenotype is that 
the ribosomal proteins may have tissue-specific roles. In support of this idea, differential 
expression of ribosomal proteins during development has been observed in chick (Kirby et 
al., 1995) and mice (Kondrashov et al., 2011). The complexities of ribosome biogenesis 
demonstrated by ribosomopathies are just beginning to be understood in vertebrate models. 
The future study of these models will be important in developing an understanding of the 




The process of ribosome biogenesis is a highly regulated process and one of the 
most energy-consuming processes in the cell. The production of rRNAs by RNAPI and 
RNAPIII in the nucleolus are regulated by similar factors including nutrient availability or 
cell stressors such as DNA damage. Disruption of ribosome biogenesis often leads to 
nucleolar stress and activation of a p53 response. This common mechanism underlies 
different ribosomopathies. However, ribosomopathies have a wide range of phenotypes 
affecting different tissues (See reviews by (Narla and Ebert, 2010) and (Hannan et al., 
2013)). Why there seem to be tissue-specific defects as a result of a disruption in a global 
process remains a topic of much interest. Many studies of ribosome biogenesis in yeast or 
human cell lines have provided information on the basic functions of the proteins involved 
in ribosome biogenesis. However, they have not provided an understanding of the process 
in the context of development. It is important to understand the function of ribosomal genes 




Craniofacial anomalies present in a number of syndromes and can range from mild 
to severe. The current therapies available for improving the quality of life of individuals 
with craniofacial anomalies are primarily surgically based. Examining the mechanisms 
underlying the pathogenesis of craniofacial anomalies has the potential to reveal new 
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therapies for their prevention. In this thesis, I set out to understand the functions of polr1a, 
polr1c, and polr1d during embryonic development in order to understand the pathogenesis 
of TCS and Acrofacial dysostosis, Cincinnati type. In Chapter III, I investigate the impact 
of mutations in polr1c and polr1d in NCC development and ribosome biogenesis and the 
mechanisms underlying TCS. In Chapter IV, I describe the identification of a new 
syndrome, Acrofacial dysostosis, Cincinnati type, which we named and published in 2015 
(Weaver et al., 2015) and investigate the consequences of mutations in polr1a in NCC and 
ribosome biogenesis. These studies provide new information about the function of the 
RNAPI subunits during embryonic development as well as mechanistic insight into the 
pathogenesis of two rare congenital syndromes. 
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II. MATERIALS AND METHODS 
 Zebrafish 
CARE AND MAINTENANCE 
Adult zebrafish (Danio rerio) were housed and maintained in the Stowers Institute 
Zebrafish Facility according to IACUC standards (Protocol # 2015-0138). Zebrafish 
embryos were raised at 28.5°C and staged according to (Kimmel et al., 1995). When 
necessary, 1-Phenyl-2-thiourea (0.002%) was added to the embryo media to prevent 
pigment development.  
STRAINS   
The polr1ahi3639Tg, polr1chi1124Tg, and polr1dhi2393Tg zebrafish were generated by an 
insertional mutagenesis screen (Amsterdam et al., 2004) which used a retroviral construct 
(Chen et al., 2002) (see Figure II-1A). Theoretically, the viral exonic sequence within the 
insertion is spliced into the mRNA, and result in a frameshift mutation (Amsterdam, 2003; 
Amsterdam et al., 2004) (Figure II-1B). In the case of the polr1ahi3639Tg, polr1chi1124Tg, and 
polr1dhi2393Tg zebrafish, the insertion was found to be in the 5’UTR, exon 2, and the first 
intron, respectively. The location of the mutations in these genes disrupts all of the known 
splice variants (Figure II-2).  Adult polr1ahi3639Tg, polr1chi1124Tg, and polr1dhi2393Tg zebrafish 
were maintained as heterozygotes, which were phenotypically wild-type. Homozygosity 
of any one of these alleles was found to be embryonic lethal. 
The insertional mutant lines were crossed with transgenic reporter lines including 
Tg(fli1a:egfp), referred to as fli1a:egfp, and Tg(7.2kb-sox10:gfp), referred to as sox10:gfp. 
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fli1a:egfp labels endothelial cells as well as cranial NCC derivatives including the jaw 
mesenchyme (Lawson and Weinstein, 2002). The sox10:gfp transgene contains a fragment 
7.2 kb upstream of the sox10 promoter and drives gfp expression in  NCC (Hoffman et al., 
2007) and was obtained from the Schilling Laboratory. The tp53M214K zebrafish line was 
obtained from the Piotrowski Laboratory and carries a mutation in the DNA binding 
domain of Tp53 and disrupts its activity (Berghmans et al., 2005). Each of these fish 






Figure II-1. Theory behind insertional mutagenesis. 
A) Structure of the retroviral construct used for insertional mutagenesis. 
(adapted from Chen et al., 2002) B) Schematic of the consequence of an 
insertional event. The gene trap construct (GTC) which has inserted into a 
gene, becomes spliced into the mRNA product, resulting in a frameshift 
mutation, represented by the black box (adapted from Amsterdam, 2003.) 
Abbreviations: BPS: branch point sequence; CMV: CMV promoter; GT: 
gene trap viral vector; 3’LTR: 3’ long terminal repeat; 5’L: 5’ partial long 




FIN CLIPS AND GENOTYPING 
 In order to maintain heterozygous zebrafish colonies of polr1ahi3639Tg, 
polr1chi1124Tg, polr1dhi2393Tg and tp53M214K, adult zebrafish were fin-clipped and genotyped. 
Adult zebrafish were anaesthetized in MS-222 prior to fin clips, and a fresh razor blade 
was used to remove a small portion of the caudal fin of each fish. The fish were allowed to 
recover from anesthesia and then housed individually until genotyping was completed. Fin 
clips were placed in lysis buffer (10 mM Tris, 50 mM KCl, 0.03% Tween-20, 0.15% NP-




Figure II-2: Schematic of the insertion locations in polr1ahi3639Tg, polr1chi1124Tg, and 
polr1dhi2393Tg zebrafish.  
 Insertion of the gene trap construct (GT) is within the 5’UTR of polr1a 
(red). The GT is within the second exon of polr1c (blue), and within the 
first intron of polr1d (green). 
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ProK at 94°C, 2μl of the lysis reaction was used for PCR. The presence of wild-type and 
mutant alleles was detected using the primers listed in Table II-1. Mutant embryos used in 





LIVE EMBRYO IMAGING 
Embryos younger than 18 hpf were mounted in 2% methyl cellulose and submerged 
in E2 media. Older embryos were anaesthetized with MS-222, mounted in 2% methyl 
cellulose while submerged in E2 media with MS-222, and then imaged with light 
microscopy.  
 Forward Primer (5’  3’) Reverse Primer (5’  3’) 
polr1a mutant CTCCCAGAACACAGTCACACG GCTAGCTTGCCAAACCTACAGGT 
polr1a wt CTCCCAGAACACAGTCACACG GTTTCATCAGCGGAGAACAGG 
polr1c mutant CTATTGCTTTTGTCGCATAAAGCG GCTAGCTTGCCAAACCTACAGGT  
polr1c wt CTATTGCTTTTGTCGCATAAAGCG CTCCAGTGTGTTTTCATCTGAAC 
polr1d mutant CAGTCACAACGTGCGACATGC GCTAGCTTGCCAAACCTACAGGT 
polr1d wt CAGTCACAACGTGCGACATGC GGTAAACGAGTTGATTTACGCATTG 
tp53 mutant GATAGCCTAGTGCGAGCACACTCTT AGCTGCATGGGGGGGAA 
tp53 wt GATAGCCTAGTGCGAGCACACTCTT AGCTGCATGGGGGGGAT 
 




IN SITU HYBRIDIZATION 
Regions of polr1a, polr1c, and polr1d were amplified using the primers found in 
Table II-2. These amplified regions were cloned into the TOPO II vector (Invitrogen). The 
resulting plasmids were used to generate both sense and anti-sense probes for in situ 
hybridization. In situ hybridization was completed according to standard protocols. Briefly, 
embryos were permeabilized with ProK, and hybridized in probes diluted to 2.5ng/μl in 
hybridization buffer and incubated overnight at 66-68°C.  The probe was removed and 
embryos were washed in maleic acid buffer and blocked for a minimum of 1 hour prior to 
incubation in AP-Fab (1:5000, Roche). Signal was detected using NBT/BCIP and the 
development reaction was stopped upon the presence of any visible background signal in 
the sense probe controls. Embryos were cleared through a glycerol series and imaged with 




Alcian blue and Alizarin red staining was performed according to Walker and 
Kimmel (Walker and Kimmel, 2007). Tails were removed after staining for genotyping. 
probe Forward primer (5’  3’) Reverse primer (5’  3’) 
polr1a CTCCGCTGATGAAACAAGAAA CAAACGATTAATAGGCCTGTACCTG 
polr1c CAACGTGGATGAAATTCGTG CACCTTCCTTCCGTTCACAT 
polr1d GGCTGAGCTTGGACAGAAAC CAGTGTCCACATGCTCACAA 
 
Table II-2: Primers to generate in situ probes. 
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Embryos were further cleared in 75% glycerol for imaging on the light microscope. For 
flat mounts, embryos were dissected with insect pins and mounted in 75% glycerol.  
IMMUNOHISTOCHEMISTRY 
Whole-mount immunostaining was completed according to Westerfield, 2000 (The 
Zebrafish Book) using the primary antibodies listed in Table II-3. Fluorescent secondary 
antibodies, either Alexa-488 or Alexa-546 (1:500, Invitrogen) were used for detection. 
TUNEL was performed according to Crump et al. (Crump et al., 2004) with slight 
modifications. Embryos were permeabilized overnight in methanol at -20°C, rehydrated 
and treated with ProK. Following permeabilization, embryos were incubated for 1 hour on 
ice followed by 1 hour at 37°C in either the Fluorescein or the TdT/TMR red reaction.  
Embryos were mounted in 1% agarose and imaged using confocal microscopy. 
 
 
Primary Antibody dilution Host source 
GFP 1:500 Rabbit Invitrogen 
HuC/D 1:200 Mouse, monoclonal Invitrogen 
pHH3 1:2000 Mouse, monoclonal Millipore 
Sox10 1:500 Rabbit, polyclonal GeneTex 
Sox9a 1:500 Rabbit, polyclonal GeneTex 
Zn-8 1:250 Mouse DSHB 
 





Protein samples of 100 fish/sample were collected at various stages. Embryos less 
than 3 dpf were deyolked prior to protein extraction in deyolking buffer (55 mM NaCl, 
1.8mM KCl, and 1.25 mM NaHCO3). Embryos were homogenized and suspended in 
sample buffer (100mM Tris, 4% SDS, 10% glycerol, 5% β-mercaptoethanol, protease 
inhibitors (Sigma)) and used for Western Blotting according to standard protocols (The 
Zebrafish Book, zfin.org). Primary antibodies used are listed in Table II-4. Blots were 
incubated with ECL™-Horseradish peroxidase secondary antibodies (1:5000; GE 
Healthcare), followed by reaction with Amersham ECL™ Prime Western Blotting 
Detection Reagent (GE Healthcare), according to the manufacturer’s instructions. Western 
blots were developed on autoradiography film (MidSci), and films were scanned and 
quantified using ImageJ. Alternatively, fluorescent secondary antibodies were used 
(Alexa-680 anti-mouse and Alexa-800 anti-rabbit, Invitrogen) at a dilution of 1:20,000. 
Images were taken using the LICOR system and then quantified using ImageJ. Protein 







RNA was collected from zebrafish embryos using the Qiagen miRNeasy Micro Kit 
and tested for quality on an Agilent 2100 Bioanalyzer. The Superscript III kit (Invitrogen) 
was used to synthesize cDNA for qPCR using the random hexamer primers. Primers for 
the genes investigated are listed in Table II-5. rRNA primer sequences were obtained from 
Azuma et al. (Azuma et al., 2006). Power Sybr (Life Technologies) reaction mix and the 
ABI 7900HT real time PCR cycler were used to measure cDNA amplification. Five 
biological replicates were run in technical triplicate for each experiment. No template and 
no reverse-transcriptase samples were run as negative controls. β-actin, canx, and elf served 
as controls for qPCR experiments. Data was analyzed using Biogazelle software and the 
Mann-Whitney test was used to determine statistical significance.  
RNA-SEQ 
RNA was collected from zebrafish embryos using the Qiagen miRNeasy Micro Kit 
and tested for quality on an Agilent 2100 Bioanalyzer. Samples with an RNA integrity 
(RIN) score greater than 8.0 were used for library construction. RNA-Seq for polr1c and 
Antibody dilution source 
Zfish Tp53 1:500 Anaspec 
α-tubulin 1:10000 Sigma 
RPS6 1:1000 Santa Cruz Biotechnology 
Phospho-RPS6 1:1000 Cell Signaling Technology 
 
Table II-4: Primary antibodies used in Western Blotting.  
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polr1d embryos was conducted at 24 hpf. Three samples with five embryos per sample 
were collected for both wild-types and mutants. RNA-Seq for polr1a embryos was 
conducted at 15 hpf and 24 hpf. Five samples of five embryos per sample were collected 
for wild-types and mutants at both time points.  
RNA underwent poly(A) selection prior to library construction and sequencing. 
Amplification and sequencing was completed using the Illumina HiSeq2500 platform. 
Sequences were aligned to the zebrafish Zv9 genome. For pathway analysis, the input gene 
sets had a p-value of at least 0.05 and fold change of at least 1.5. SPIA was used to examine 




gene Forward primer Reverse primer 
β-actin ACATCAGGGAGTGATGGTTGGCAT AGTCACAATACCGTGCTCAATGGG 
canx ACGATACCGCAGAGAATGGAGACA TCCTGTTTCTGGGAGACCTCCTCA 
elf CTCAAATGGCATGGATGTTGCCCA GGTCTTGGTTTGCGCACTTTGGTT 
18S CCGCTAGAGGTGAAATTCTTG CAGCTTTCGAACCATACTCC 
5'ETS CCGGTCTACCTCGAAAGTC CGAGCAGAGTGGTAGAGGAAG 
ITS1 CTCGGAAAACGGTGAACCTG GTGTTCGTTTCAGGGTCCG 
ITS2 CCTAAGCGCAGACCGTCAC AGCGCTGGCCTCGGAGATC 
polr1a CACCTGGAGAAGAAATCCAAG GATGTGCTTGACAGGGTCAG 
polr1c GAGCAACGTGGATGAAATTCG GCCAATCATATCAAACTCCAGTG 
polr1d TGAGCTTGGACAGAAACACG ATTTTGCTTTCTGATGGGTGTG 
tp53 CGAGCCACTGCCATCTATAAG TGCCCTCCACTCTTATCAAATG 
 




150 embryos per sample were collected at 3 dpf and identified by phenotype. 
Embryos were deyolked and rinsed with ice cold PBS and then dissociated in ice-cold lysis 
buffer (10mM Tris-HCl, 5 mM MgCl2, 100 mM KCL, 1% TritonX-100, 2 mM DTT, 
100ug/ml cycloheximide, 200U/ml RNasin (Promega), and protease inhibitor (Sigma)). 
Homogenized zebrafish were then centrifuged at 15,000 x g at 4°C for 10 minutes and the 
supernatant of the zebrafish lysate was kept for analysis. Lysates were loaded onto a 10-
50% (w/vol) sucrose gradient prepared in 20 mM HEPES-KOH pH 7.4, 5 mM MgCl2, 100 
mM KCl, 2mM DTT, 20 U/mL RNasin (Promega), and 100 µg/mL cycloheximide.  The 
gradients were ultra-centrifuged at 4°C in an SW-41 Ti rotor (Beckman) at 40,000 rpm for 
2 hours.  To evaluate UV absorbance profiles, each gradient was passed through a UA-6 
absorbance reader system (Teledyne ISCO) using a syringe pump (Brandel).  The 
absorbance at 254 nm was recorded using WinDaq data acquisition software (DATAQ 
INSTRUMENTS) and the profiles were plotted in Microsoft Excel.  
Imaging 
LIGHT MICROSCOPY 
Embryos were mounted and imaged using a Leica MZ16 microscope equipped with 
a Nikon DS-Ri1 camera and NIS Elements BR 3.2 imaging software. Manual z-stacks were 
generated for individual embryos and then processed using Helicon Focus6 software to 
generate a single image.  
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CONFOCAL MICROSCOPY 
Embryos were mounted in 1% agarose and imaged using a Zeiss upright 700 
confocal microscope and images were taken and processed using Zen software. Laser 
settings were determined using mutant embryos, and the same settings were used to image 
control and mutant embryos. 
IMAGE PROCESSING 
Additional image processing was completed in Adobe Photoshop for assembly of 
figures. Any modifications of brightness/contrast were applied to both control and mutant 
embryos to more clearly present the data. 
IMARIS QUANTIFICATION 
To quantify regions of interest in confocal images, IMARIS software was used. The 
surfaces generated from the images used the automated settings. Within the region of 
interest determined by the surface, the software calculated several measurements including 







III. POLR1C AND POLR1D ZEBRAFISH MODELS OF 
TREACHER COLLINS SYNDROME 
 
Introduction 
Treacher Collins syndrome (TCS), also known as Franceschetti-Klein syndrome or 
mandibulofacial dysostosis, is a disorder affecting craniofacial development and is 
estimated to occur at 1:50000 live births. TCS is characterized by downward slanting 
palpebral fissures, anomalies of the external and middle ear, cleft palate, and hypoplasia of 
the facial bones, particularly the mandible and zygomatic complex. There is wide 
phenotypic variation among individuals with TCS and there is no correlation between 
phenotype and genotype (Altug Teber et al., 2004; Trainor et al., 2008). Mutations in 
TCOF1 (Treacher Collins-Franceschetti syndrome 1) account for approximately 80% of 
TCS cases and are inherited in an autosomal dominant manner (Gladwin et al., 1996; The 
Treacher Collins Syndrome Collaborative et al., 1996; Edwards et al., 1997; Wise et al., 
1997; Marsh et al., 1998; Altug Teber et al., 2004). TCOF1 encodes the protein Treacle, 
which localizes to the nucleolus (Marsh et al., 1998; Winokur and Shiang, 1998) where it 
interacts with Upstream Binding Factor (UBF) to stimulate transcription of ribosomal 
DNA (rDNA) by RNA Polymerase I (Valdez et al., 2004),  establishing a role for ribosome 
biogenesis in TCS.  
More recently, mutations in POLR1C and POLR1D, which encode subunits of 
RNA Polymerases I and III (RNAPI and RNAPIII), were identified by whole genome 
sequencing in a group of individuals with characteristics of TCS, but no mutation in 
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TCOF1 (Dauwerse et al., 2011). The mutations identified in POLR1C suggest autosomal 
recessive inheritance. Affected individuals carried two separate mutations in POLR1C, 
generally with one allele inherited from an unaffected mother and the other from an 
unaffected father. The mutations identified in POLR1D suggest it can be inherited in either 
an autosomal dominant or autosomal recessive manner (Dauwerse et al., 2011; Schaefer et 
al., 2014). Initially, autosomal dominant mutations were identified in POLR1D including 
a premature stop codon, nonsense mutations, and missense mutations occurring within 
exon 3, with the exception of one mutation in the second intron (Dauwerse et al., 2011). 
Exon 3 contains the dimerization domain of POLR1D, so these mutations are likely to 
impede the normal binding and function of the protein. A later study identified a patient 
with autosomal recessive inheritance, again with the mutation occurring within exon 3 
(Schaefer et al., 2014). These studies show that TCS is a genetically heterogeneous 
syndrome. The variation in penetrance in affected individuals is hypothesized to be due to 
modifier genes or potentially another mutation at an unlinked locus that is required for the 
TCS phenotype.  
Previous studies to model TCS in mice and zebrafish have examined the role of 
Tcof1 during craniofacial development. In mice, mutations in Tcof1 result in many of the 
same cranioskeletal anomalies as human TCS such as a small mandible and cleft palate 
(Dixon et al., 2006). During mouse embryonic development, Tcof1 is expressed in a broad 
but dynamic manner throughout development with strong expression in the 
neuroepithelium at embryonic day (E) 8.5, corresponding to the generation of NCC, as well 
as in the frontonasal and branchial arch mesenchyme at E9.5 (Dixon et al., 2006). This 
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expression pattern demonstrates a role for Tcof1 during NCC formation and migration. 
Tcof1+/- embryos have a decreased population of NCC, and this is due to apoptosis and 
decreased proliferation in the neuroepithelium (Dixon et al., 2006). In a subsequent study, 
microarray analysis of Tcof1+/- embryos revealed an increase in genes which are associated 
with p53-dependent transcription; these genes have roles in cell cycle regulation, apoptosis, 
and DNA repair (Jones et al., 2008). An increase in p53 activity and specific neuroepithelial 
apoptosis was observed in Tcof1+/- mice compared to wild-type siblings (Jones et al., 2008). 
Furthermore, it was shown that Tcof1+/- embryos have diminished production of mature 
28S rRNA and it was hypothesized that decreased ribosome biogenesis in NCC underlies 
the pathogenesis of TCS (Jones et al., 2008). Pharmacological inhibition of p53 using 
pifithrin-α, as well as genetic inhibition using p53+/- mice, reduced neuroepithelial 
apoptosis and rescued the TCS phenotype in Tcof1+/- mice (Jones et al., 2008). Despite this 
rescue, an increase in ribosome biogenesis was not observed upon p53 inhibition, and 
further study is necessary to understand the role of ribosome biogenesis in the pathogenesis 
of TCS. A proposed model of TCS in zebrafish was generated using morpholino injections 
against a gene which has since been identified as nolc1 (Weiner et al., 2012). In this model, 
they found that during early embryonic development, nolc1 mRNA expression was 
ubiquitous and at later stages, expression was seen within the pharyngeal arches. Consistent 
with the Tcof1+/- mouse model, hypoplastic skeletons and elevated levels of p21, a 
downstream target of p53, were observed in nolc1 morphants but ribosome biogenesis was 
not investigated.  
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The role of Tcof1 in the pathogenesis of TCS has been well studied, however, the 
function of Polr1c and Polr1d in the TCS phenotype is unknown. It is surprising that 
mutations in these subunits of RNAPI and RNAPIII would lead to a specific craniofacial 
phenotype in humans. Studies in yeast have shown that polr1c and polr1d interact to form 
a dimer and are essential for growth (Lalo et al., 1993), but these genes have not been 
investigated in a vertebrate model. In order to understand the role of these genes in 
craniofacial development, I investigated the function of polr1c and polr1d in zebrafish. 
Results 
DYNAMIC EXPRESSION OF POLR1C AND POLR1D 
To understand the importance of polr1c and polr1d in craniofacial development, I 
first examined the mRNA expression of these genes at various stages of zebrafish 
embryonic development. Early stages revealed ubiquitous expression as would be expected 
(Figure III-1). Maternal expression of polr1c and polr1d is evident at stages <1 hour post 
fertilization (hpf), and expression is ubiquitous through gastrulation and neural plate 
formation. Remarkably, a more restricted expression pattern is apparent at 24 hpf, with 
enriched expression in the eye and brain. At 36 hpf, enriched expression is visible in the 
pharyngeal arch region, which will eventually give rise to the craniofacial cartilage. 
Beyond 48 hpf, polr1c and polr1d are expressed at low levels throughout the embryo. The 
elevated expression of polr1c and polr1d in the craniofacial region suggests that higher 
levels are necessary in these regions for normal development. Thus a disruption of either 
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Figure III-1 Expression of polr1c and polr1d during embryonic development is 
dynamic.  
Both genes show maternal expression at early stages (A,B) and are 
ubiquitously expressed at 6 hpf (C,D) and 11 hpf (E,F). At 24 hpf, 
expression becomes enriched in regions such as the eye and midbrain-
hindbrain boundary (G,H). Elevated expression can be seen in the 
pharyngeal arches at 36 hpf (I,J) and then lower levels are observed at 




MUTATIONS IN POLR1C AND POLR1D IN ZEBRAFISH 
Given the enriched expression of polr1c and polr1d in craniofacial regions, I 
hypothesized that polr1c and polr1d are important in craniofacial development. To 
understand the role of polr1c and polr1d during embryonic development, I examined two 
mutant zebrafish: polr1chi1124Tg and polr1dhi2393Tg; hereafter referred to as polr1c- and 
polr1d-. These mutant zebrafish were generated by insertional mutagenesis (Amsterdam, 
2003; Amsterdam et al., 2004) which severely disrupts the production of mRNA (Figure 
III-2) resulting in hypomorphic alleles. The mutation in polr1c is located in exon 2 while 
the mutation in polr1d is located in the first intron (http://web.mit.edu/hopkins/). The 
polr1c and polr1d mutant embryos begin to show a phenotype around 24 hpf (Figure III-3, 
A-D) and are recognizable by a smaller eye and a disrupted midbrain-hindbrain boundary. 
Notably, these affected tissues are consistent with areas where polr1c and polr1d 
expression is enriched at 24 hpf. Mutant embryos also display varying degrees of what 
appears to be necrotic tissue in the head. By 5 days post fertilization (dpf), craniofacial 
anomalies are apparent in polr1c and polr1d mutants (Figure III-3, E-G). The mutant 
embryos have a smaller head and eye; however, the body size is generally the same size as 
control embryos. In addition, these zebrafish have smaller jaws, liver defects, develop 
pericardial edema, and fail to inflate the swim bladder. polr1c and polr1d mutant embryos 
die between 9-10 dpf, likely due to cardiovascular defects.  
In order to understand if mutations in polr1c and polr1d result in similar 
craniofacial defects as human TCS patients, I examined cartilage and bone using Alcian 
blue and Alizarin red. Mutant embryos show a clear hypoplasia of the craniofacial cartilage 
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elements at 5 dpf (Figure III-4). While cartilage elements from pharyngeal arches 1 and 2 
are present, these elements are smaller and the ceratohyal is reversed in mutant embryos. 
Consistent with the human TCS phenotype, the jaws of polr1c and polr1d mutant embryos 
are smaller (Figure III-4, D-F). The palatoquadrate and Meckel’s cartilage are not as 
elongated in the mutant embryos. Cartilage derived from more posterior arches is more 
severely affected and ceratobranchials 2-5 show very little Alcian stain (Figure III-4, G-I). 
In addition, the portions of the neurocranium which are NCC-derived, including the 
trabeculae and the ethmoid plate (Eberhart et al., 2006), which has homology to the palate 
(Swartz et al., 2011), are also hypoplastic while the portions which have mesodermal origin 
are not as severely affected. To determine whether these anomalies arise at earlier stages 
of development, I also examined the cartilage at 3 dpf by Alcian blue (Figure III-5). At this 
stage, the cartilage elements are noticeably smaller (Figure III-5 A-C). The ceratohyal is 
already showing a slight reversal in the mutant embryos (Figure III-5 E,F) and there is the 
absence of ceratobranchial cartilage elements as well. The cartilage elements of the 
neurocranium are also smaller, especially the ethmoid plate (Figure III-5 H,I). Altogether, 








Figure III-2: Quantitative RT-PCR for polr1c and polr1d.  
qPCR data shows significantly reduced expression of polr1c (A) and polr1d (B) 









Figure III-3: Live phenotype of polr1c-/- and polr1d-/- zebrafish. 
A-D) At 24 hpf, smaller eyes and disrupted midbrain-hindbrain boundary 
region is evident in mutant embryos (B,D). E-G) By 5 dpf, mutants are 
distinguished by the smaller head, abnormal jaw, and failure to inflate the 








Figure III-4. Skeletal staining reveals hypoplastic cartilage in polr1c and polr1d 
mutant embryos.  
 A-C) Alcian blue and Alizarin red staining at 5 dpf reveals hypoplastic 
cartilage and bone in polr1c and polr1d mutant embryos compared to 
controls. D-F) The jaws of mutant embryos are smaller. G-I) Dissection 
of the viscerocranium reveals smaller cartilage elements derived from 
each of the pharyngeal arches in mutant embryos, as well as 
mispatterning of the ceratohyal. J-L) Dissection of the neurocranium 
reveals alterations in the NCC-derived portions of the cartilage, including 
the ethmoid plate. Abbreviations: M - Meckel’s cartilage; pq – 
palatoquadrate; ch – ceratohyal; cb – ceratobranchial; ep – ethmoid plate; 










Figure III-5. Cartilage is hypoplastic at 3 dpf in polr1c and polr1d mutants.  
 A-C) Alcian blue staining at 3 dpf reveals diminished cartilage formation 
in polr1c and polr1d mutant embryos. D-F) The cartilage elements 
derived from each of the pharyngeal arches are present in control embryos 
(D), while mutant embryos show hypoplastic elements from arches 1 and 
2, and the ceratobranchial cartilage elements derived from arches 3-7 are 
absent. G-I) In the neurocranium, the NCC-derived cartilage forming the 





NCC DEVELOPMENT  
As the majority of the craniofacial cartilage is NCC-derived, I next investigated 
whether NCC development was disrupted. The neural plate, labeled by sox2, forms in both 
polr1c and polr1d mutant embryos (Figure III-6). This suggests that the levels of polr1c 
and polr1d present at this stage are sufficient for neural plate formation, which occurs prior 
to NCC induction. sox10 and foxd3 were used to investigate early stages of NCC formation 
and migration, and do not show a significant reduction in mutant embryos. Expression of 
sox10 is found in premigratory NCC at early stages and in migratory NCC as somitogenesis 
progresses (Dutton et al., 2001). In situ hybridization for sox10 at 12 hpf reveals similar 
levels of NCC induction in polr1c and polr1d mutant embryos compared to control siblings 
(Figure III-7, A-H). foxd3 is expressed in premigratory NCC and down-regulated in the 
migrating cranial NCC (Odenthal and Nüsslein-Volhard, 1998; Kelsh et al., 2000). 
Correspondingly, the expression of foxd3 at 14 hpf, when it is expressed within the pre-
migratory cranial NCC and the paraxial mesoderm, also did not show significant alteration 
in the polr1c and polr1d mutant embryos (Figure III-7, I-P). Thus it seems the early genetic 
program for NCC formation occurs within polr1c and polr1d mutant embryos prior to the 
onset of the mutant phenotype. Another NCC marker, dlx2, is expressed in the NCC in the 
pharyngeal arches (Akimenko et al., 1994), which are precursors to the craniofacial 
cartilage. At 36 hpf, after the mutant phenotype is evident, the domain of dlx2 expression 
showed a slight reduction, which would indicate a smaller population of cells within the 
pharyngeal arches and is consistent with the hypoplastic craniofacial cartilage in mutant 
embryos (Figure III-7, Q-X). To determine if the reduced number of NCC within the 
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pharyngeal arches was due to a deficiency of migration, I investigated the pattern of NCC 
migration using sox10:gfp transgenic animals as well as an antibody against Sox10. Using 
polr1c; sox10:gfp and polr1d; sox10:gfp transgenic embryos, I found the timing and 
pattern of NCC migration appeared normal, with NCC migrating in the three typical 
streams in polr1c and polr1d mutant embryos (Figure III-8). Therefore the reduced number 
of NCC was not due to a failure to migrate to the correct location. Immunostaining for 
Sox10 at 24 hpf did not show a strong difference in expression, however this is at the onset 
of the mutant phenotype and there may be differences later in development (Figure III-9, 
A-C). Alternatively, at 24 hpf, some NCC are beginning to become fate-restricted. To 
investigate if the reduction in the NCC population in the pharyngeal arches at 36 hpf could 
be due to a reduction specifically within the cartilage precursor population, I investigated 
the expression of Sox9a. At 24 hpf, sox9a is expressed within the cranial mesenchyme 
which contributes to the formation of the pharyngeal arches and neurocranium as well as 
within the mesenchyme of the pharyngeal arch primordia (Chiang et al., 2001). 
Immunostaining for Sox9a at 24 hpf revealed a slight decrease in the domain of expression 
in the pharyngeal arches of polr1c mutants, but no distinguishable difference in polr1d 
mutant embryos (Figure III-9, D-F). Quantification of the volume of pharyngeal arches 1 
and 2 stained with Sox9a confirmed this observation, with the volume of polr1c embryos 
tending to be smaller, but not significantly (p = 0.06), and the volume of polr1d embryos 
being about the same as controls (p = 0.88) (Figure III-9 G, H). Although not significant at 
24 hpf, when the mutant phenotype is first distinguishable, this tendency for the arches to 
be smaller is indicative of presence of smaller arches at 36 hpf (Figure III-7, Q-X). 
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As NCC development is able to proceed from formation to differentiation, it is 
unlikely that polr1c and polr1d are specifically required for the proper genetic 
programming to occur in NCC. However, the reduced size and altered patterning of the 
craniofacial cartilage, especially of the ceratohyal and ceratobranchial cartilages, would 
suggest some alteration of the NCC population or pharyngeal arch patterning. 
Ceratobranchial cartilage elements fail to form properly in other zebrafish mutants, such 
as the tbx1 and prdm1a mutants. tbx1 mutants have a deficiency in formation of the 
endodermal pouches which results in fusions of the posterior ceratobranchial cartilage 
elements (Piotrowski and Nüsslein-Volhard, 2000). prdm1a mutants fail to form the 
posterior pharyngeal pouches and fail to develop ceratobranchial cartilage elements by 6 
dpf (Birkholz et al., 2009). To rule out the possibility that a difference in pharyngeal 
arch/pharyngeal pouch patterning was responsible for the phenotype in polr1c and polr1d 
embryos, I examined arch structure in the fli1a:egfp transgenic zebrafish stained with Zn-
8, which can be found in the endodermal pouches (Trevarrow et al., 1990; Warga and 
Nusslein-Volhard, 1999). This staining revealed no alteration of arch/pouch structure in 
mutant embryos (Figure III-10, A-C) as the pouches separated each arch. Quantification of 
the volume of pharyngeal arches 1 and 2 labeled by fli1a:egfp (Figure III-10, D-F) revealed 
that these arches were approximately 20% smaller in mutant embryos, which is consistent 
with the reduction in the dlx2 domain observed by in situ and indicative of a reduced 
number of NCC within the pharyngeal arches. polr1c-/- embryos averaged a volume of 3.55 
x 105 μm3 while control siblings averaged a volume around 4.47 x105 μm3 (p = 0.0088, t-
test; Figure III-10, G). Similarly, polr1d-/- embryos averaged a volume of 2.09 x 105 μm3 
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while control siblings averaged a volume of 2.49 x 105 μm3 (p = 0.022, Figure III-10, H). 
Given the proper patterning of the arches, it is possible that development of the 
ceratobranchial cartilage elements is simply delayed. Alcian blue and Alizarin red staining 
of polr1c and polr1d embryos at 9 dpf revealed the presence of all of the cartilage elements 
(Figure III-11, A-C). However, the size and location of the elements derived from 
pharyngeal arches 2-7 are smaller in mutant embryos (Figure III-11, E,F) compared to 
control siblings (Figure III-11 D). The amount of bone formation is also reduced in mutant 
embryos in both the viscerocranium and neurocranium. The branchiostegal rays and 
opercles are reduced in the viscerocranium while the parasphenoid shows reduced 
ossification in the neurocranium. Therefore, as pharyngeal arch/pouch patterning is normal 
and ceratobranchial cartilages do form by 9 dpf, although severely hypoplastic, it seems 
likely there is a delay in cartilage development in the mutant embryos. The severe 
hypoplasia of the ceratobranchial cartilage is also indicative of a reduced number of 
chondrocytes, as there must be enough present for stacking of the chondrocytes in 
formation of these cartilage elements. The smaller size of other cartilage elements and the 
reduction in bone formation also indicate that there are fewer chondrocytes, which is 
consistent with the earlier finding of a reduced number of NCC populating the pharyngeal 
arches. Altogether, these results suggest that polr1c and polr1d are not required for 
expression of the genes involved in NCC formation, migration, or differentiation. Instead, 
there appears to be a deficiency in the population of NCC within the pharyngeal arches, 





Figure III-6. In situ hybridization for sox2 at 11 hpf shows neural plate formation.  




Figure III-7. In situ hybridization for markers of neural crest development.  
 A-H) sox10 at 12 hpf shows induction of NCC occurs in mutant embryos. 
I-P) foxd3 at 14 hpf shows similar levels of pre-migratory NCC. Q-X) 
dlx2 at 36 hpf shows a slight reduction of the size of the pharyngeal 








Figure III-8. sox10:gfp transgenic zebrafish reveal a normal pattern of NCC migration in 
polr1c and polr1d mutant embryos.  
 Similar levels are observed at 14 hpf (A, D, G), and all three NCC streams are 
visible at 16 hpf (B, E, H). The migration into the the developing pharyngeal arch 











Figure III-9 NCC migration and pharyngeal arch volume at 24 hpf.  
 A-C) Immunostaining against Sox10 at 24 hpf does not show a 
significant difference in the amount of migratory NCC in polr1c and 
polr1d mutant embryos. D-F) Similarly, immunostaining against Sox9a 
also shows no significant difference in mutant embryos. G, H) 
Quantification of arch volume in polr1c and polr1d mutant embryos 
confirms no significant difference in Sox9a expression in pharyngeal 









Figure III-10. Pharyngeal arch patterning and volume at 36 hpf.  
 A-C) Immunostaining fli1a:egfp embryos with Zn-8 at 36 hpf reveals 
proper pharyngeal arch and pharyngeal pouch patterning. Zn-8 (red) can 
be seen separating the pharyngeal arches marked by fli1a:egfp. D-F) 
fli1a:egfp reveals the structure of the arches is slightly smaller. 
Quantification reveals a reduction in the volume of arch 1 and 2 in polr1c 
(G) and polr1d (H) mutants. Scale bar = 100 µm. * = p < 0.05 and error 









Figure III-11. Alcian blue and Alizarin red staining at 9 dpf reveals diminished cartilage 
and bone formation in polr1c and polr1d mutant embryos.  
 A-C) Deficiencies in the cartilage can be observed in mutant embryos. D-
F) Dissection of the viscerocranium reveals mispatterning of the 
ceratohyal, and hypoplasia of the ceratobranchial cartilages in polr1c and 
polr1d mutants. There is also hypoplasia of bone elements including the 
opercles and pharyngeal teeth. G-H) Dissection of the neurocranium 
reveals reduced ossification of the parasphenoid in mutant embryos. Scale 
bar = 200 μm. 
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CELL SURVIVAL AND PROLIFERATION 
Given the smaller pharyngeal arches in polr1c and polr1d mutant embryos, I next 
hypothesized that polr1c and polr1d have roles in NCC survival or proliferation. The 
importance of NCC survival in TCS has been demonstrated by the Tcof1 mouse model. In 
this model, neuroepithelial apoptosis underlies the loss of NCC necessary to form the 
craniofacial skeleton (Dixon et al., 2006). TUNEL staining on 24 hpf zebrafish embryos 
revealed increased apoptosis in both polr1c and polr1d mutant embryos (Figure III-12). 
Cross sections through the embryos reveal that the majority of cell death is localized to the 
neural tube (Figure III-12, D-F). To confirm that the migrating and differentiating NCC 
population was not undergoing apoptosis as well, TUNEL staining was completed in 
sox10:gfp transgenics. This showed no significant co-localization of cell death with 
expression of sox10:gfp at 24 hpf (Figure III-13, A-D), indicating the migratory NCC were 
not dying at 24 hpf. Additionally, staining was not observed within the developing cartilage 
at 48 hpf (Figure III-13, E-H) which suggests that the differentiating NCC are not 
undergoing apoptosis. Together this indicates that neuroepithelial apoptosis at 24 hpf 
reduces the NCC progenitor population, but the NCC that do survive are able to migrate 
and differentiate. Therefore, the death of NCC progenitors leads to a smaller number of 
NCC which migrate to the pharyngeal arches as evidenced by dlx2 (Figure III-7) and the 
volume of the arches of fli1a:egfp embryos (Figure III-10). The progenitors that do survive 
are able to migrate normally, as was seen with sox10:gfp (Figure III-8), and differentiate 
into cartilage, indicating that polr1c and polr1d primarily have a role in the survival of 
NCC.   
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Cell death can arise due to multiple stressors, one of which is nucleolar stress. 
Alterations in ribosome biogenesis, such as might be predicted exist due to mutations in 
RNAPI subunits,  are known to cause nucleolar stress and lead to activation of Tp53 (Rubbi 
and Milner, 2003). Furthermore, mutations in Tp53 are able to rescue the phenotype of 
Tcof1+/- mice, suggesting a role for Tp53-dependent cell death in the TCS phenotype (Jones 
et al., 2008). To determine if cell death observed was Tp53-dependent in polr1c and polr1d 
mutant embryos, I examined Tp53 levels by Western blot and quantitative RT-PCR 
(qPCR). qPCR at 36 hpf showed a significant increase in tp53 levels in mutant embryos 
(Figure III-12, G) and Western blot confirmed a strong increase in Tp53 levels in the 
mutant embryos at 5 dpf (Figure III-12, H). These results suggest that the apoptosis 
observed is Tp53-dependent, which is consistent with a mechanism of nucleolar stress and 
activation of Tp53. 
In addition to the death of NCC progenitors, I hypothesized that mutations in polr1c 
and polr1d might limit the proliferative capacity of the NCC in the pharyngeal arches, 
contributing to their reduced size. In order to understand how NCC were proliferating, I 
examined the levels of phospho-histone H3 (pHH3) in sox10:gfp transgenic zebrafish. 
Phosphorylation of histone H3 at Ser 10 occurs during late G2 to M phase and is used as a 
marker of proliferation (Hendzel et al., 1997). At 24 hpf, the levels of pHH3 staining 
appeared similar between control and mutant embryos (Figure III-14, A-C). The levels at 
36 hpf also appeared to be broadly similar between control and mutant embryos (Figure 
III-14, D-F). However, to determine if there was a difference in the level of proliferation 
within the NCC population that will contribute to the craniofacial skeleton, I examined the 
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percentage of pHH3-positive (pHH3+) cells within pharyngeal arches 1 and 2 at 36 hpf. 
IMARIS software was used to count the number of sox10:gfp cells and pHH3+ cells 
specifically within pharyngeal arches 1 and 2. The percentage of cells was calculated by 
dividing the number of pHH3+ cells by the number of sox10:gfp cells. polr1c control 
embryos had approximately 14% of cells proliferating within arches 1 and 2 while polr1c 
mutant embryos had approximately 6.7%, which was significantly lower (p=0.002, t-test). 
polr1d mutant embryos had a similar, although slightly higher, percentage of cells at 8.4% 
(Figure III-14, G). This data would suggest that Tp53-dependent cell death of NCC 
progenitors reduces the NCC population and then the NCC that do survive have reduced 
proliferation within the pharyngeal arches. Together, this underlies the hypoplasia of 
skeletal elements in the polr1c and polr1d mutant embryos and is consistent with the 
findings of the Tcof1+/- mice (Dixon et al., 2006; Jones et al., 2008), indicating a common 






Figure III-12 polr1c and polr1d mutant embryos display increased neuroepithelial cell 
death and upregulation of Tp53. 
  A-C) TUNEL staining at 24 hpf reveals increased neuroepithelial cell 
death in polr1c and polr1d mutant embryos. D-E) Cross sections reveal that 
cell death is largely occuring within the neural tube. G) Western blot 
reveals increased levels of Tp53 in polr1c and polr1d mutants. H) qPCR 
reveals an increase in the level of tp53 expression in polr1c and polr1d 
mutant embryos. * = p < 0.05 and error bars represent 95% confidence 













Figure III-13. TUNEL staining in sox10:gfp embryos shows increased cell death in 
mutant embryos which does not co-localize with the migratory NCC 
population.  
 A-D) At 24 hpf, increased cell death can be see in the neuroepithelial 
region of polr1c-/- and polr1d-/- embryos. E-F) At 48 hpf, increased cell 
death can be observed in regions of the brain and eye of mutant embryos, 









Figure III-14  Analysis of proliferation in polr1c and polr1d mutant embryos 
 A-C) Proliferation at 24 hpf in polr1c and polr1d mutant embryos occurs 
at similar levels. D-F) Proliferation at 36 hpf in mutant embryos also 
occurs at broadly similar levels, but there appears to be a difference in the 
number of pHH3+ cells within pharyngeal arches 1 and 2. G) 
Quantification revealed a significant decrease in the percentage of pHH3+ 
cells in pharyngeal arches 1 and 2 in polr1c mutant embryos. polr1d 
mutant embryos showed a similar level of proliferation as polr1c mutants. 




MUTATIONS IN POLR1C AND POLR1D ALTER RIBOSOME BIOGENESIS 
I next hypothesized that activation of the Tp53 pathway in polr1c and polr1d 
mutants may be caused by alterations in ribosome biogenesis, which has been associated 
with nucleolar stress (Rubbi and Milner, 2003). Polr1c and Polr1d are subunits of RNAPI 
and RNAPIII which are responsible for the production of rRNA, a rate-limiting step of 
ribosome biogenesis (Laferté et al., 2006). Mutations in polr1c and polr1d would likely 
disrupt the function of RNAPI and RNAPIII and the production of rRNA, so deficient 
ribosome biogenesis may underlie the Tp53 activation in the polr1c and polr1d mutant 
embryos. To determine if the mutations in polr1c and polr1d altered the function of 
RNAPI, I investigated the production of the 45S rRNA transcript using qPCR. Regions of 
this initial transcript, the 5’ ETS and ITS2, show a reduction in both polr1c and polr1d 
mutant embryos (Figure III-15 A,B). At 36 hpf, the 5’ETS is reduced by 38% in polr1c 
and 32% in polr1d mutants while ITS2 is reduced by 23% in polr1c mutants and 25% in 
polr1d mutants, relative to the levels expressed by control embryos. Additionally, the levels 
of the 18S, which recognizes both the region contained within the 45S transcript as well as 
the fully processed form, also showed diminished levels in mutant embryos. polr1c mutant 
embryos exhibited a 58% reduction in the level of 18S expressed by control embryos while 
polr1d mutant embryos exhibited a 39% reduction compared to controls. Altogether, these 
results suggest an overall decrease in the level of rRNA produced. As rRNA production is 
considered a rate-limiting step of ribosome biogenesis and accounts for as much as 60% of 
transcription in the cell (Warner, 1999), I hypothesized that polr1c and polr1d mutants 
would also display deficiencies in ribosome biogenesis. To confirm that the alterations in 
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rRNA production diminished overall ribosome biogenesis, I examined the polysome 
profiles of mutant embryos at 3 dpf. The polysome profiles revealed reductions in the size 
of the 80S and polysome peaks in polr1c (Figure III-15 C) and polr1d (Figure III-15 D) 
mutant embryos, but similar 40S and 60S peaks. The sizes of the 40S and 60S peaks 
indicate that there is not a problem with the incorporation of the mature rRNA into the 
small and large ribosomal subunits. If 40S or 60S assembly was altered, a difference in the 
height of the peak would be evident. For example, mutations nop10, which functions to 
modify the 18S rRNA for its assembly into the small subunit, result in a collapse of the 
40S peak (Pereboom et al., 2011). The reduced 80S peak height in polr1c and polr1d 
mutant embryos indicates a fewer number of mature assembled ribosomes while the 
shorter, broader polysome peaks would suggest fewer transcripts are being highly 
translated. Highly transcribed genes have a larger number of ribosomes present on the 
transcript and thus have higher sedimentations; conversely, if there are few transcripts 
being highly transcribed, these polysome peaks will be smaller and indicative of less 
overall transcription. Altogether, the polysome profiling results indicate an overall 
decrease in ribosome biogenesis in polr1c and polr1d mutant embryos, consistent with 
diminished production of the 47S rRNA (Figure III-15 A, B) and reduced proliferation 
(Figure III-14G). Although the global difference in ribosome biogenesis is not as 
dramatically altered as rRNA production, this may be due to a stronger difference in 
specific tissues. It could be that NCC or cranial tissue alone would show a stronger 
difference in ribosome biogenesis, however this remains to be investigated. Thus, reduced 
 109 
rRNA transcription and ribosome biogenesis likely results in reduced proliferation and an 






Figure III-15. qPCR and polysome profiling demonstrate diminished ribosome 
biogenesis in polr1c and polr1d mutant embryos.  
 A) qPCR shows reduced transcription of regions of the 45S rRNA 
transcript. polr1c mutants show a 39% reduction in the levels of 5’ETS, 
23% reduction in the levels of ITS2 and 58% reduction in the levels of the 
18S compared to controls. B) qPCR shows reduced transcription of regions 
of the 45S rRNA transcript in polr1d mutants. Mutants show a 32% 
reduction in the levels of 5’ETS, 25% reduction in the levels of ITS2 and 
39% reduction in the levels of the 18S compared to controls. C,D) 
Polysome profiling shows a reduction in the 80S peak and polysome peaks 
in polr1c (C) and polr1d (D) mutant embryos. Polysome profiling 





TP53 INHIBITION CAN IMPROVE THE PHENOTYPE OF POLR1C AND POLR1D MUTANT 
EMBRYOS 
As the data suggest that Tp53-dependent cell death of NCC progenitors underlies 
the craniofacial anomalies in polr1c and polr1d mutants, I hypothesized that genetic 
inhibition of tp53 would be able to ameliorate the mutant phenotype. polr1c and polr1d 
mutants were crossed to the tp53M214K mutant, hereafter referred to as tp53-, which carries 
a mutation in the DNA binding domain of Tp53 (Berghmans et al., 2005). TUNEL staining 
revealed reduced levels of cell death at 24 hpf in both polr1c-/-; tp53-/- and polr1d-/-;tp53-/- 
embryos (Figure III-16; Figure III-17). Cross sections confirmed a reduction in cell death 
within the neural tube in embryos with tp53 inhibition and that the reduction was dosage 
dependent (Figure III-16, E-H; Figure III-17 E-H). Analysis of the skeletal phenotypes at 
5 dpf showed a similar tp53 dosage-dependent improvement of cartilage formation in 
polr1c and polr1d mutant embryos (Figure III-18; data is shown only for polr1d for 
simplicity). Upon removal of one copy of tp53, mutant embryos have improved patterning 
of the jaw (Figure III-18, G) and elements of the viscerocranium including the ceratohyal 
and ceratobranchial cartilages (Figure III-18, K). Upon removal of both copies of tp53, this 
patterning is improved to a greater degree (Figure III-18, H, L). To examine the differences 
in cartilage development, polr1c and polr1d mutant embryos were classified into severe, 
mild, and wild-type phenotypes (Figure III-19). The severe phenotype mutants have a 
reversed ceratohyal, mild mutants have a ceratohyal that is either straight or slightly 
forward, and wild-type phenotype embryos have a ceratohyal in the proper orientation to 
the same degree as control siblings. Using these classifications, the percentage of embryos 
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displaying a severe phenotype was reduced to 32% of polr1c-/-; tp53+/- embryos and 22% 
of polr1d-/-; tp53+/- embryos. Furthermore, 19% of polr1c and 24% of polr1d mutant 
embryos showed a wild-type phenotype. Upon inhibition of both copies of tp53, the 
percentage of severe phenotype embryos was reduced to 9.5% of polr1c-/-; tp53-/- embryos 
and 0% in polr1d-/-; tp53-/- embryos. The percentages of wild-type phenotype embryos 
increased to 62% of polr1c-/-; tp53-/- embryos and 35% of polr1d-/-; tp53-/- embryos, with 
the remainder of the embryos showing a mild phenotype.  
Despite the improvement in formation and patterning, the cartilage elements in 
polr1c-/-; tp53-/- and polr1d-/-; tp53-/- embryos remained smaller relative to control siblings. 
In addition, these embryos still fail to inflate the swim bladder and die around 10 dpf. This 
would indicate that although the survival of NCC and cartilage patterning is improved in 
these embryos, this is not sufficient to rescue the viability of mutant embryos and an 
insufficient NCC population is not necessarily the cause of lethality. One alternative is that 
the levels of ribosome biogenesis are not improved upon tp53 inhibition to a level sufficient 
for survival of the mutant embryos. The deficiency in ribosome biogenesis in other tissues 
may cause lethality, or other p53-independent pathways may be impacted that are required 
for survival. As a result, it is important to investigate alternative strategies for rescue which 







Figure III-16 Analysis of cell death in polr1c; tp53 embryos. 
 A-D) TUNEL staining in polr1c-/-; tp53 embryos reveals a decrease in cell 
death depending on the dosage of tp53. E-F) Cross sections confirm 
diminished levels of cell death within and around the neural tube. Scale bars 





Figure III-17 Analysis of cell death in polr1d; tp53 embryos.  
 A-D) TUNEL staining in polr1d; tp53 embryos reveals a decrease in cell 
death depending on the dosage of tp53. E-F) Cross sections confirm 





Figure III-18 Skeletal staining shows improved cartilage formation in polr1d; p53 
embryos. 
 A-D) Alcian blue and Alizarin red staining reveal an improvement in 
cartilage formation in polr1d mutant embryos with increasing inhibition 
of tp53. Improvement is especially noticeable in the jaw (E-H) and the 
elements of the viscerocranium (I-L). Upon removal of one copy of tp53, 
improved patterning of the ceratohyal is evident (G, K) and a greater 
improvement is observed upon removal of both copies of tp53 (H,L). 
Abbreviations: M - Meckel’s cartilage; pq – palatoquadrate; ch – 




MTOR AS AN ALTERNATIVE PATHWAY FOR RESCUE 
If deficient ribosome biogenesis is the cause of the lethality in polr1c and polr1d 
mutant embryos, then stimulating ribosome biogenesis may be an alternative to p53 
inhibition in the prevention of the mutant phenotype. Improved ribosome biogenesis could 
also alleviate tp53 activation and eliminate the need for introducing a tumorigenic mutation 
for rescue. Hence, I investigated Mammalian target of rapamycin (mTOR) signaling, which 
has known functions in ribosome biogenesis, as a potential target for rescue. mTOR is a 
positive regulator of cell growth and proliferation and plays an important role in regulating 
 
 
Figure III-19 Quantification of skeletal phenotypes upon tp53 inhibition. 
 Percentage of embryos with wild-type (wt, blue), mild (red), and severe 
(green) phenotypes upon tp53 inhibition. The percentage of embryos with 
wild-type appearance upon removal of one copy of tp53 is around 20% in 
polr1c and polr1d embryos. This percentage increases with removal of 
both copies of tp53, with the percentage of severe phenotype accounting 
for less than 10% of the mutants. 
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many cellular processes which are essential for development including nutrient sensing, 
cell growth, and apoptosis (Wyllie, 2010). The rapamycin-sensitive complex TORC1, 
which incorporates mTOR, is of most interest as it is known that growth factors and 
nutrients signal through this complex, which in turn signals to downstream targets and 
leads to changes in translation and autophagy. Changes in translation are controlled through 
regulating phosphorylation of proteins involved in stimulating or inhibiting initiation. 
mTOR will phosphorylate 4E-BP1, which disrupts the interaction between 4E-BP1 and 
eIF4E, allowing eIF4E to interact with other components of the translation initiation 
complex (Powers and Walter, 1999). Activation of mTOR also leads to phosphorylation of 
multiple proteins by p70S6K, including ones that regulate rRNA transcription by RNAPI 
(Hannan et al., 2003; Mayer et al., 2004). mTOR regulates RNAPIII, as transcription by 
RNAPIII is sensitive to rapamycin (Zaragoza et al., 1998; Tsang et al., 2010), and has been 
shown to stimulate rDNA transcription in different ways. One study in 3T3 cells showed 
that rDNA transcription required p70S6K activation and that it was regulated through 
phosphorylation of UBF. The phosphorylation of UBF in its carboxy-terminal domain 
promotes interaction with SL1(TIF-IB) and stimulation of RNAPI transcription (Hannan 
et al., 2003). A separate study showed that TIF-IA phosphorylation on specific residues 
was required for stimulating rDNA transcription (Mayer et al., 2004). Thus, all components 
of the ribosome biogenesis pathway – rRNA transcription by RNAPI and RNAPIII and 
ribosomal protein translation by RNA polymerase II – can be affected through mTOR 
signaling. 
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In order to determine if there was an alteration in the mTOR pathway, I examined 
the protein levels of downstream targets of the mTOR pathway, including RPS6. Western 
blot analysis revealed a decrease in the levels of RPS6 in both polr1c and polr1d mutant 
embryos (p = 0.005 and 0.03, respectively; Figure III-20). The levels of phosphorylated 
RPS6 (pRPS6), the activated form of the protein, were also examined. In polr1c and polr1d 
mutant embryos, the levels of pRPS6 were about 20% lower. This difference was not 
significant in the polr1d embryos, but did show a slight difference in polr1c embryos (p = 
0.035). Finally, as a readout of the overall activity of the protein, I examined the ratio of 
pRPS6 to RPS6 and found that there was no significant difference between mutant embryos 
and control siblings. This would indicate that although the total levels of RPS6 tend to be 
lower in polr1c and polr1d mutant embryos, the activity of the protein is comparable to 
their wild-type siblings. Western blot analysis of other mTOR pathway components 
including p70S6K and 4E-BP1 also showed slight reductions (data not shown), so I 
anticipated that leucine treatment would be one approach to stimulate ribosome biogenesis 
through the mTOR pathway.  
 It is well known that the mTOR pathway is responsive to changes in nutrients, such 
as leucine. TIF-IA can sense nutrient availability in an mTOR-dependent manner (Mayer 
et al., 2004), indicating that rDNA transcription may be dependent upon available nutrients. 
The amino acid L-leucine stimulates protein synthesis through mTOR. Leucyl-tRNA 
synthetase (LeuRS), which charges the tRNA with leucine, functions to signal leucine 
availability to mTOR through Rag/Gtr GTPases in mammalian and yeast cells (Bonfils et 
al., 2012; Han et al., 2012). The Rag GTPases, when in a GTP-bound heterodimeric state, 
 118 
are known to bind TORC1 and stimulate mTOR signaling (Sancak et al., 2008). mTOR 
resides in the cytoplasm in a starved state, but upon amino acid stimulation, the Rag-bound 
Raptor induces recruitment of mTOR to the lysosome membrane, which contains the 
mTOR activator Rheb (Sancak et al., 2008). Further upstream of this pathway, LeuRS 
interacts directly with GTP-bound RagD in an amino acid-dependent manner and 
translocates to the lysosome where mTOR becomes activated (Han et al., 2012).  
Leucine has been used as a mechanism to increase activation of mTOR, and 
subsequently translation, in the ribosomopathy Diamond Blackfan Anemia (DBA). DBA 
is a ribosomopathy in which 40% of patients have a variety of malformations including 
craniofacial defects that arise due to mutations in ribosomal protein genes (Cmejlova et al., 
2006). Some DBA patients have been successfully treated through L-leucine 
supplementation (Cmejlova et al., 2006; Pospisilova et al., 2007). More recently, L-leucine 
treatment rescued the mutant phenotype in mouse and zebrafish DBA models (Jaako et al., 
2012; Payne et al., 2012). Treatment of zebrafish embryos injected with rps14 or rps19 
morpholinos with 100mM L-leucine results in the rescue of craniofacial defects (Payne et 
al., 2012). Given the rescue of craniofacial defects in these models, I hypothesized that L-
leucine treatment could ameliorate the TCS phenotype of the polr1c and polr1d mutant 
zebrafish.  
To determine the minimum dosage of leucine necessary for rescue, I examined the 
consequences of L-leucine treatment at concentrations from 1 mM to 100 mM. 
Concentrations of 100 mM were used previously to rescue the phenotype of DBA in 
zebrafish, however, I found this concentration to be too high for the viability of wild-type 
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embryos beyond 3 dpf. Treatment with 100 mM L-leucine resulted in early embryonic 
lethality of nearly all embryos. In subsequent studies, a maximum concentration of 50 mM 
L-leucine was used. Alcian blue and Alizarin red staining was used to examine any 
improvement in the craniofacial phenotype in polr1c and polr1d mutant embryos after L-
leucine treatment. These results showed no improvement of the mutant phenotype with 1 
mM, 5 mM, or 10 mM of L-leucine added to the embryo media (Figure III-21, D-K; Figure 
III-22, D-L). Upon treatment with the higher dosage of 50 mM of L-leucine, mutant 
embryos showed either no improvement of the phenotype (Figure III-21 N; Figure III-22 
O) or an even more severe phenotype (Figure III-22 Q). In addition, heterozygous fish 
which are phenotypically wild-type could also be severely affected by the higher dosage 
of L-leucine (Figure III-22 P). These results indicate that leucine supplementation is not a 
viable treatment for the successful prevention of the craniofacial anomalies that result from 
mutations in polr1c and polr1d. The higher dosages of leucine used in previous studies to 
rescue embryonic defects increased embryonic lethality in the polr1c and polr1d zebrafish. 
Lower dosages of L-leucine which did not increase lethality were not able to improve the 
mutant phenotype. This could be due to the way ribosome biogenesis is affected in the 
polr1c and polr1d mutants. Since these mutations are in subunits of RNAPI and RNAPIII, 
they affect the production of rRNA. The mechanism by which L-leucine stimulates mTOR 
would increase production of rRNA and ribosomal proteins. With decreased function of 
RNAPI in polr1c and polr1d mutants, stimulation by mTOR may not be able to sufficiently 
increase rRNA production, but ribosomal protein synthesis would be increased. As a result, 
the balance between ribosomal protein and rRNA production undergoes further 
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perturbation. The balance between rRNA and ribosome biogenesis is carefully regulated 
by the cell and disruptions lead to p53 stabilization (Donati et al., 2011a). Therefore, further 
altering this balance likely amplified the p53 response and resulted in increased lethality. 
Consequently, I concluded that other alternate pathways to improve the mutant phenotype 





Figure III-20. Western blots for RPS6 and pRPS6 (A).  
 RPS6 levels are quantified for polr1c embryos (B) and polr1d embryos 




Figure III-21 Alcian blue and Alizarin red staining of 5 dpf polr1c embryos after L-
leucine treatment reveals no improvement of the mutant phenotype.  
 A-C) Control embryos raised in E2 media alone show the expected 
phenotypes. D-F) Embryos raised in E2 media with 1 mM Leu show no 
improvement. G-I) Embryos raised in E2 media with 5 mM Leu show no 
improvement.  J-K) Embryos raised in E2 media with 10 mM Leu show 









Figure III-22 Alcian blue and Alizarin red staining of 5 dpf polr1d embryos after L-
leucine treatment reveals no improvement of the mutant phenotype. 
 A-C) Control embryos raised in E2 media alone show the expected 
phenotypes. D-F) Embryos raised in E2 media with 1 mM Leu show no 
improvement. G-I) Embryos raised in E2 media with 5 mM Leu show no 
improvement.  J-L) Embryos raised in E2 media with 10 mM Leu show no 
improvement. M-O) Embryos raised in E2 media with 50 mM Leu show 







RNA-SEQ ANALYSIS TO DETERMINE ALTERNATIVE PATHWAYS FOR RESCUE 
In order to further our understanding of the mechanisms underlying the polr1c and 
polr1d mutant phenotypes in an unbiased manner, RNA-Seq analysis was performed at 24 
hpf. I hypothesized that the pathways altered at the onset of the mutant phenotype could 
reveal other potential pathways for manipulation that are not tumorigenic like the Tp53 
pathway, and more successful than leucine stimulation of the mTOR pathway. Many of the 
genes showing the greatest changes between wild-type and mutant embryos were those 
involved in p53 signaling, cell cycle arrest, and apoptosis (Table III-1). cdkn2b (ink4b), 
cdkn1a (p21), ccng1, cdkn1ba (p27), and rbl2 (p130) are all regulators of the cell cycle. 
Notably, upregulation of Ccng1 (cyclin G1), which functions to arrest cells in G1 as a part 
of the p53 response (Zhao et al., 2003b), was also identified by microarray in the Tcof1+/- 
mice (Jones et al., 2008). Cyclin dependent kinase inhibitors (cdkn) also inhibit progression 
through the cell cycle, with cdkn1a being a main target of p53. Retinoblastoma-like 2 (rbl2, 
also known as p130) is involved in negative regulation of the cell cycle and results in a 
stall in G1 phase (Helmbold et al., 2009). Genes involved in the apoptotic response include 
pleckstrin homology-like domain family member A3 (phlda3), caspase 8 (casp8), bcl2 
binding component 3 (bbc3, also known as puma), and bcl2-associated X protein (bax). 
phlda3 is a p53 target gene and functions to induce apoptosis through inhibiting Akt, which 
functions in cell proliferation and survival (Kawase et al., 2009). Interestingly, casp8 is 
involved in the extrinsic apoptosis pathway, while bbc3 and bax function to permeabilize 
the mitochondrial membrane for cytochrome c release in the intrinsic apoptosis pathway. 
Although increased transcription of mdm2 was also found, it is unlikely that an increase in 
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mdm2 would be able to overcome the increases in cell cycle arrest and apoptosis genes. 
Therefore, the primary response in polr1c and polr1d mutant embryos is one of cell cycle 
arrest and apoptosis. This is consistent with upregulated genes found in rps29 mutant 
zebrafish, a model of DBA, which include cdkn1b, cdkn2b, phlda3, bbc3, and casp8 
(Taylor et al., 2012). The commonality of these upregulated genes in the polr1c, polr1d, 
and rps29 mutants are indicative of a mechanism of an increased p53 response upon 
disruption of ribosome biogenesis. Other genes which showed a high degree of differential 
expression in polr1c and polr1d mutant embryos currently do not have known functions 
and will be interesting targets to investigate in the future (see Appendix for a listing of 
genes up and down-regulated). In order to understand how the differentially expressed 
genes might be involved in the mutant phenotype, KEGG pathway analysis was performed. 
This analysis revealed both activated and inhibited pathways in polr1c and polr1d mutants 
(Table III-2 and Table III-3). Interestingly, the mTOR pathway was up-regulated in polr1c 
mutant embryos, although not significantly. This supports the previous RPS6 data which 
showed a slight, but not significant, increase in the activity of RPS6. The other up-regulated 
pathway, MAPK signaling, is typically involved in the process of proliferation and 
differentiation, but can also be involved in signaling apoptosis. The down-regulated 
pathways in polr1c mutants are consistent with alterations in expression of collagens and 
laminins, which are involved in extracellular matrix interactions and focal adhesions. The 
genes down-regulated in the Jak-Stat pathway, including osmr and il11ra, are consistent 
with diminished cytokine activity and potentially reduced proliferation. Cell cycle was 
significantly decreased in polr1d mutants, which is congruent with an increase in p53 
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signaling. However, none of the down-regulated pathways showed significant overlap 
between polr1c and polr1d. The p53 pathway was the only common pathway significantly 
upregulated in both polr1c and polr1d mutant embryos, which confirmed my previous 
results in which inhibition of p53 was able to improve the mutant phenotype. However, as 
p53 inhibition was unable to improve the viability of the mutant embryos, it is possible that 
other mechanisms are involved at later stages of development which are necessary for 
survival. Alternatively, there may be p53 independent mechanisms which are critical for 
embryo survival that act at times either prior to 24 hpf or at later stages. RNA-Seq analysis 




gene polr1c Fold Change polr1d Fold Change 
cdkn2b 47.96 15.04 
rbl2 11.71 12.01 
casp8 10.68 7.75 
bbc3 9.57 8.08 
mdm2 7.89 8.25 
phlda3 7.65 5.89 
cdkn1a 6.02 4.20 
tp53 5.89 4.79 
ccng1 4.88 4.83 
cdkn1ba 2.75 2.07 
baxa 2.11 2.65 
 
Table III-1. Genes upregulated by RNA-Seq analysis involved in tp53 signaling.  



















accumulation p Value Status 
p53 signaling pathway 13 1.185659 0.003499 Activated 
MAPK signaling 
pathway 
30 6.071711 0.030131 Activated 
mTOR signaling 
pathway 
8 1.24254 0.052998 Activated 
ECM-receptor 
interaction 
13 -5.53103 0.000773 Inhibited 
Focal adhesion 26 -19.1086 0.005824 Inhibited 
Jak-STAT signaling 
pathway 
13 -1.01411 0.033624 Inhibited 
 
Table III-2: KEGG pathway analysis of polr1c RNA-Seq data reveals up- and down-
regulated pathways.  









accumulation p Value Status 
p53 signaling pathway 10 0.695385 0.000169 Activated 
MAPK signaling 
pathway 
11 1.633288 0.378988 Activated 
Cell cycle 8 -10.7538 0.009492 Inhibited 
Jak-STAT signaling 
pathway 
2 0 0.955322 Inhibited 
 
Table III-3 KEGG pathway analysis of polr1d RNA-Seq data reveals up and down-
regulated pathways. 





In summary, I found polr1c and polr1d to be important for normal craniofacial 
development in zebrafish and establish the polr1c and polr1d mutants as new genetic 
models for TCS. Given the similarity of the cartilage anomalies with both the human TCS 
phenotype and the Tcof1 mouse model, these zebrafish will be useful models to investigate 
the pathogenesis of TCS.  
In these studies, I found polr1c and polr1d to be dynamically expressed during 
embryonic development, suggesting that there may be different tissue-specific 
requirements for these genes and the process of ribosome biogenesis at different stages of 
development. Ubiquitous expression was observed at early stages, including the stages of 
NCC formation and early NCC migration. Expression is enriched in cranial regions at 
stages after 24 hpf, and these regions are disrupted in polr1c and polr1d mutant embryos, 
while regions such as the tail develop normally. This observation supports the idea that 
some tissues require a greater amount of polr1c and polr1d, and perhaps ribosome 
biogenesis, for normal development. The mutant embryos show disrupted craniofacial 
development, particularly of the NCC-derived craniofacial cartilage. This disruption, 
however, is not due to any alteration in the genetic programming of NCC specification and 
migration as the proper genes are expressed at the correct time in development at similar 
levels between wild-type and mutant embryos. Despite the proper programming of NCC 
in polr1c and polr1d mutant embryos, there was a significant decrease in the size of the 
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pharyngeal arches at 36 hpf, which are populated by NCC. This reduction was likely due 
to an increase in neuroepithelial cell death at 24 hpf, which diminished the NCC progenitor 
pool and therefore the number of migrating NCC, similar to the Tcof1+/- mice (Dixon et al., 
2006). 
An increase in p53-dependent cell death is a common mechanism among several 
ribosomopathies including TCS (Jones et al., 2008) and DBA (Chakraborty et al., 2009; 
Barlow et al., 2010), which is thought to arise from the stress of alterations in ribosome 
biogenesis. I hypothesized a similar mechanism was involved in the polr1c and polr1d 
mutants. Consistent with this, I found diminished production of rRNA and an overall 
decrease in ribosome biogenesis. Previous studies have shown that an alteration in the 
balance between ribosomal protein production and rRNA production can result in 
activation of p53. In one study, it was shown that upon inhibition of Polr1a, the catalytic 
subunit of RNAPI, ribosomal proteins RPL5 and RPL11 bound MDM2 and led to p53 
activation; if both rRNA and RPL5 and RPL11 synthesis was reduced, then p53 activation 
was not observed (Donati et al., 2011a). This result is consistent with previous studies 
showing a role for RPL5 and RPL11 in regulating MDM2, which normally functions to 
polyubiquinate p53, targeting it for degradation (Marechal et al., 1994; Honda et al., 1997; 
Lohrum et al., 2003; Zhang et al., 2003). In our hypothetical model (Figure III-23), 
mutations in polr1c or polr1d disrupt the production of rRNA, which disrupts the balance 
between rRNA and ribosomal protein synthesis and leads to nucleolar stress. As a result, 
ribosomal proteins such as RPL5 and RPL11 will bind MDM2, causing it to undergo a 
conformational change in which it will no longer polyubiquinate p53. As a result, p53 
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becomes active and then leads to cell cycle arrest and apoptosis. Recent studies have 
revealed an important role for the 5S rRNA in mediating binding of RPL5 and RPL11 to 
MDM2 (Donati et al., 2013; Sloan et al., 2013). Given this new mechanism for binding, in 
the future it will be important to evaluate the production of the 5S rRNA by RNAPIII in 
polr1c and polr1d mutants to determine if it is involved in mediating the p53 response. 
Regardless of the precise mechanism, p53 activation is clearly involved in the resulting 
phenotype of polr1c and polr1d mutant embryos. This function for p53 is supported by 
both the RNA-Seq data and the improved phenotype of mutant embryos upon genetic 
inhibition of tp53. The result is also consistent with the Tcof1+/- mouse model in which p53 
inhibition rescued the craniofacial defects of the mice (Jones et al., 2008), and indicates a 





One question that remains is to the specificity of the disruption of ribosome 
biogenesis and subsequent activation of p53 and apoptosis within the cranial NCC. 
Craniofacial cartilage is particularly affected in humans with TCS, as well as the zebrafish 
and mouse models of TCS. However, the polr1c and polr1d mutant zebrafish do have 
phenotypes outside of the craniofacial skeleton including cardiac and liver defects. A recent 
study indicates that mutations in POLR1D may result in phenotypes outside of the 




Figure III-23 The cellular mechanism of disrupted ribosome biogenesis and activation 
of p53 in polr1c and polr1d mutant embryos. 
 Ribosomal proteins (RP) from the cytoplasm associate with rRNA to make 
ribosomes under normal conditions (A). Upon reduction of rRNA 
synthesis due to mutations in polr1c or polr1d, fewer RPs associate with 
rRNA, and more are available to bind Mdm2 (B). This prevents 
degradation of p53, leading to increased p53 levels and cell cycle arrest 
and apoptosis in polr1c or polr1d mutants.  
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individuals, there were phenotypes characteristic of Klipel-Feil syndrome, including a 
short neck and fusion of cervical vertebrae, in addition to craniofacial anomalies. One of 
the affected individuals also presented with Sprengel deformity and rib segmentation 
anomalies. These anomalies would suggest some role for POLR1D in the development of 
mesodermal structures in addition to cranial NCC-derived structures.  
 It will be important to investigate the function of polr1c and polr1d in all of the 
different tissue types in order to understand the role these genes may have in other regions 
of the body. It is currently unknown if Polr1c and Polr1d have functions outside of RNAPI 
and RNAPIII, and proteomics studies will be useful in identifying new potential binding 
partners. With the increase in whole genome sequencing to find new mutations in human 
patients, this could further our understanding of the full spectrum of phenotypes arising 












The cause of many craniofacial anomalies is unknown and approaches such as 
whole exome sequencing and whole genome sequencing are being used to identify new 
mutations. Whole exome sequencing involves sequencing the known protein coding genes 
in the human genome, thus only sequencing exons of genes and not the introns. 
Alternatively, whole genome sequencing covers both introns and exons and can identify 
mutations that would not be found by whole exome sequencing. Whole genome sequencing 
was used to identify mutations in POLR1D in Treacher Collins syndrome (TCS) patients 
who did not have mutations in TCOF1 and subsequently mutations in POLR1C were also 
identified (Dauwerse et al., 2011). However, there are some patients diagnosed with TCS 
who do not have mutations in TCOF1, POLR1C, or POLR1D (Cesaretti et al., 2011). A 
recent study used whole exome sequencing to identify the mutations present in an 
individual with features of TCS but lacking a mutation in any of the known genes (Weaver 
et al., 2015). This led to the identification of mutations in POLR1A in association with a 
new syndrome, Acrofacial dysostosis, Cincinnati Type. So far, three individuals have been 
identified with mutations in POLR1A and their phenotypes and mutations are described 
below. 
Individual 1 was identified with multiple craniofacial anomalies prior to birth, and 
both parents were healthy and unaffected. At birth, Individual 1 displayed severe 
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micrognathia, downward slanting palpebral fissures, lower eyelid clefts, and midfacial 
hypoplasia, which are features characteristic of TCS (Figure IV-1 A). In addition, 
Individual 1 had bilateral anotia and conductive hearing loss. At 18 months of age, these 
features were still present after multiple reconstructive surgeries (Figure IV-1B,C). A 
computed-tomography (CT) scan revealed severe hypoplasia of multiple skeletal elements, 
including the zygomatic arches and maxillary bones, and agenesis of the mandibular rami 
(Figure IV-1 D). In addition, X-rays revealed short, bowed femurs (Figure IV-1 F) which 
are not part of the TCS phenotype. Based on the features of mandibulofacial dysostosis 
characteristic of TCS, TCOF1 sequencing was performed but did not detect any pathogenic 
variants. Whole-exome sequencing was subsequently revealed a G to C point mutation in 
POLR1A. This results in an amino acid change from Glu to Gln at position 593, which is 
within the active site of POLR1A. 
After identification of POLR1A as a candidate gene, 48 other individuals with a 
diagnosis of mandibulofacial dysostosis but no known mutation underwent Sanger 
sequencing for POLR1A. Two additional individuals were identified with mutations in 
POLR1A. Individual 2 was identified to carry a frameshift mutation in POLR1A, inherited 
from her mildly affected father, which is predicted to be pathogenic. The mutation occurs 
at amino acid position 1217 (of 1666), within one of the cleft domains of POLR1A. 
Individual 2 displayed craniofacial anomalies including downward slanting palpebral 
fissures, upper and lower eyelid clefts, hypoplastic zygomatic arches and maxilla, and 
choanal atresia (Figure IV-2 A-C). CT scans confirmed a moderate hypoplasia of the 
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midface, including the zygomatic arches (Figure IV-2 B), as well as choanal atresia (Figure 
IV-2 C). Microcephaly was also present in Individual 2.  
Individual 3 was identified with a missense variant in POLR1A, in which a G to T 
transition results in an amino acid change from valine to phenylalanine at position 1299. 
The variant is predicted to be pathogenic. While mildly affected, Individual 3 displays 
some craniofacial anomalies including downward slanting palpebral fissures, 
micrognathia, low-set ears, and a dysplastic helix of the left ear (Figure IV-2 D, E). 
Examination of the limbs of Individual 3 revealed short, broad fingers and toes (Figure 





Figure IV-1 Affected individual 1 displays multiple craniofacial anomalies.  
 A) Individual 1 at birth showing severe craniofacial anomalies. B,C) 
Individual 1 at 18 months after reconstructive surgeries. D) 3D CT 
image showing severe hypoplasia of the zygomatic and maxillae (dashed 
arrow) as well as retrognathia (white arrow). F) X-ray showing hip 





Facial dysostosis syndromes, which account for a proportion of congenital skeletal 
disorders, can be broadly characterized into mandibulofacial dysostoses and acrofacial 
dysostoses (Trainor and Andrews, 2013). TCS is a well characterized example of 
mandibulofacial dysostosis in which derivatives of the first and second pharyngeal arches 
fail to develop properly. Acrofacial dysostoses can be characterized by similar disruptions 
of craniofacial development with the addition of defects in limb development. As two of 
 
Figure IV-2 Phenotypes of Individuals 2 and 3. 
 A) Individual 2 displays several craniofacial anomalies including downward 
slanting palpebral fissures and clefts in the upper and lower eyelids. B) CT 
scan of Individual 2 shows hypoplasia of the zygomatic arch (white arrow), 
absent nasal bones (open arrow) and hypoplasia of the midline alveolar 
process (dashed arrow). C) CT image confirms bilateral choanal atresia 
(white arrows) as well as hypoplasia of the left ethmoid and maxillary sinus 
(black arrows). D,E) Individual 3 shows a mild craniofacial phneotype 
including micrognathia, anomalies of the ear, and malar hypoplasia. F) 
Individual 3 also displays short, broad fingers. Figure is from Weaver, Watt, 
et al., 2015.  
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the three individuals with mutations in POLR1A have both craniofacial and limb anomalies, 
the syndrome was therefore characterized as acrofacial dysostosis, distinct from TCS. The 
syndrome was named Acrofacial dysostosis, Cincinnati Type to reflect the location of 
where the first individual was diagnosed and sequenced. Interestingly, all three individuals 
identified carry mutations in POLR1A, which is the largest subunit of RNAPI. Also known 
as A190, this subunit contains the active site of the enzyme complex (Engel et al., 2013). 
RNAPI plays a key role in regulating ribosome biogenesis through the synthesis of rRNA 
(Laferté et al., 2006). Given the similarities in the craniofacial phenotypes to TCS, it is 
likely that POLR1A has an important role in craniofacial development. In order to 
understand the function of POLR1A in the etiology and pathogenesis of acrofacial 
dysostosis, we investigated the role of polr1a during zebrafish embryogenesis and 
craniofacial development. 
Results 
EXPRESSION OF POLR1A 
To understand the spatiotemporal requirements for polr1a during zebrafish 
embryonic development, we examined the mRNA expression of polr1a by in situ 
hybridization. This revealed a surprisingly dynamic pattern of polr1a activity (Figure IV-
3). polr1a is expressed as early as the 2-cell stage which is indicative of maternal 
contribution and polr1a continues to be ubiquitously expressed at 12 hours post 
fertilization (hpf) (Figure IV-3 A-F). As early as 18 hpf the expression of polr1a becomes 
more specific with elevated levels in the developing eye and brain (Figure IV-3 G), and by 
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24 hpf polr1a expression is strongly enriched in regions of the brain, eyes, and otic vesicle 
as well as in the somites (Figure IV-3 I). Beyond 36 hpf, polr1a is maintained broadly at 
low levels throughout the embryos but with elevated levels remaining at the midbrain-
hindbrain boundary and the lens of the eye (Figure IV-3 K). At 48 hpf expression begins 
in the liver (Figure IV-3M). By 72 hpf, expression in the cranial regions is reduced, 
however, expression persists within the liver (Figure IV-3 O). These dynamic patterns of 
expression reveal that polr1a is initially highly expressed in the cranial regions during the 
stages of NCC formation and migration. At later stages, other tissues exhibit elevated levels 
of polr1a expression. It is therefore possible that polr1a is required at different levels in 
different tissues during development, which would help to explain why only some tissues 




PHENOTYPE OF POLR1A MUTANT ZEBRAFISH 
To better understand the function of polr1a during embryonic development, I 
examined zebrafish with an insertional mutation (Amsterdam et al., 1999; Amsterdam et 
al., 2004) in the 5’UTR of polr1a, polr1ahi3639Tg. This insertional mutation disrupts the 
 
Figure IV-3 In situ hybridization reveals the expression of polr1a during zebrafish 
embryonic development.  
 Expression is evident at the 2 cell stage (A), is downregulated at 6 hpf (C), 
and ubiquitous at 12 hpf (E). Restricted expression is evident at 18 hpf (G), 
with enriched expression in the eye and regions of the brain. There is 
enrichment in these same regions at 24 hpf (I). At 36 hpf and 48 hpf, 
expression becomes reduced in the cranial regions (K, M). At 72 hpf, there 
is an increase in expression within the liver (O). Sense probe controls show 
no signal at any of the stages examined (B, D, F, H, J, L, N, P). 
Abbreviations: e – eye; mb – midbrain; pa – pharyngeal arches; mbhb – 
midbrain-hindbrain boundary; L – liver. Scale bar = 200 µm. Figure 




transcription of polr1a (Figure IV-4), resulting in a severe hypomorphic phenotype in 
polr1ahi2639Tg/hi3639Tg embryos. Homozygous polr1a mutant embryos exhibit a phenotype 
which is evident from 15 hpf onwards (Figure IV-5). At 15 hpf, mutants are identifiable by 
smaller, misshapen eyes and tissue with a necrotic appearance in the cranial region (Figure 
IV-5 A,B). By 24 hpf, the craniofacial phenotype is well pronounced, including a smaller 
head and abnormalities of the eye, brain, and somites (Figure IV-5 C,D). These more 
strongly affected tissues in the mutant embryos are consistent with the regions of enriched 
polr1a expression. A granulated cell pattern could be observed in the head and the end of 
the tail which is indicative of extensive cell death. The phenotype becomes more 
pronounced and severe by 36 - 48 hpf, with the head being proportionally smaller in size 
together with a reduction in the amount of pigmentation (Figure IV-5 E, F). At 3 days post 
fertilization (dpf), polr1a embryos are smaller overall (Figure IV-5 I, J) and appear to lack 
the developing pharyngeal cartilage (arrows, Figure IV-5 G, H). By 4 dpf, mutant embryos 
remain smaller in size and exhibit a severe lack of the cranial skeleton and jaw, smaller 
eyes, abnormal pigmentation, and defects in heart, ear and pectoral fin development (Figure 
IV-5 I, J).  The majority of mutant embryos die by 4 - 5 dpf, likely due to cardiovascular 
defects.  
In order to examine the pharyngeal skeleton in mutant embryos, Alcian blue 
staining was performed. This revealed that polr1ahi3639Tg/hi3639Tg zebrafish have almost no 
NCC-derived cartilage at 5 dpf (Figure IV-6 A-D), which is consistent with the observation 
of jaw agenesis in live embryos. Small portions of cartilage were able to form in mutant 
embryos including portions of the trabeculae (red arrows) and what may be a portion of 
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Meckel’s cartilage (black arrows). Mesoderm-derived cartilage elements were also reduced 
in size in the polr1a mutant embryos. The pectoral fins were present (green arrows), but 
much smaller, in mutant embryos which is consistent with the limb phenotype observed in 
humans. Further analysis of limb phenotypes and the axial skeleton could not be performed 




Figure IV-4 qRT-PCR reveals a significant decrease in the level of polr1a expression 
in polr1a mutant embryos at 24 hpf.  
 * p = 0.0095, error bars represent 95% confidence intervals. Figure is from 




   
 
Figure IV-5 Live phenotype of polr1a mutant embryos.  
 A,B) At 15 hpf, polr1a mutant embryos are distinguished by increased 
death in the cranial region. C,D) At 24 hpf, a smaller head and eye are 
evident, and this difference persists at 34 hpf (E, F). By 3 dpf, polr1a 
mutants are smaller in size (I,J), and appear to lack jaw structures (arrows 
G, H). By 4 dpf (K,L), mutant embryos are smaller, lack jaw structures and 
develop cardiac edema. Scale bar = 200 µm. Figure is from Weaver, Watt, 







NEURAL CREST CELL DEVELOPMENT 
As much of the craniofacial skeleton is derived from NCC, I hypothesized that NCC 
development would be reduced or disrupted in polr1a mutant embryos. Analysis of NCC 
development through in situ hybridization revealed that a NCC precursors form and 
migrate properly early in development (Figure IV-7). At 12 hpf, sox2 expression reveals 
 
Figure IV-6 Cranial NCC derivatives are hypoplastic in polr1a mutant embryos. 
 A-D) Alcian blue staining reveals a severe loss of cartilage formation in 
polr1a mutant embryos. Regions of the neurocranim, such as the 
trabeculae (red arrows), are present. Regions of the viscerocranium are 
more  severely affected, with only a remnant of what may be 
Meckel’scartilage (black arrows) present. In addition, the pectoral fin 
cartilage (green arrows) is much smaller in mutant embryos. Scale bars = 
200 µm.  E,F) HuC immunostaining reveals reduced cranial ganglia 
formation in polr1a mutants. Scale bars = 100 µm. Abbreviations: 
Tg/aLLG/F trigeminal/anterior lateral line/facial ganglion complex; SA 
statoacoustic ganglion; pLLg posterior lateral line ganglion; G 
glossopharyngeal ganglion; V vagal ganglia. Figure is from Weaver, Watt, 
et al., 2015. 
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that the neural plate has formed in both wild-type and mutant embryos (Figure IV-7 A-D). 
At the same time, sox10 staining reveals the appearance of the early migratory NCC to 
similar levels in control and mutant embryos (Figure IV-7 E-H). These results suggest that 
early NCC programming and formation occurs in polr1a mutant embryos prior to the onset 
of the mutant phenotype. Alterations in NCC are recognizable concomitant with the 
appearance of the mutant phenotype. At 17 hpf, there is a reduction in sox10-positive 
migratory NCC, especially in the population migrating towards pharyngeal arch 1. This 
reduction is also present at 24 hpf (see Figure IV-12 A,B). Consistent with a reduction in 
sox10-positive NCC, immunostaining for HuC revealed a hypoplasia of the cranial ganglia 
(Figure IV-6 E, F), which is derived in part from the sox10-expressing NCC (Culbertson 
et al., 2011). In addition to the reduction in sox10 expression, there was a striking reduction 
of the cartilage precursor population labeled by sox9a in polr1ahi3639Tg/hi3639Tg embryos 
(Figure IV-7 M-P). The population of cells within pharyngeal arch 1 and 2 is particularly 
reduced. Furthermore, dlx2a expression, which is a marker of NCC in the pharyngeal 
arches (Akimenko et al., 1994), shows that arches are smaller and reduced in number in 
mutants compared to controls (Figure IV-7 Q-T). Only 4 arches are visible in mutant 
embryos while there are 5 arches present in controls. This loss of sox9a cartilage precursors 
in combination with a reduced population of NCC within the pharyngeal arches could 
explain the resulting loss of much of the craniofacial cartilage in polr1a mutants.  
To determine if the NCC were not migrating properly to populate the pharyngeal 
arches, I analyzed NCC migration using time-lapse confocal microscopy of sox10:gfp 
transgenic zebrafish. By examining NCC migration from approximately 15 hpf until 20 
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hpf, it was found that the NCC migrate in the proper pattern towards the pharyngeal arches 
of polr1a mutant embryos (Figure IV-8). The population of sox10:gfp cells was reduced in 
the polr1a mutant embryos, which is consistent with the reduction in sox10 labeled cells 
observed by in situ (Figure IV-7 I-L).  This study indicates that the reduction in NCC within 
the pharyngeal arches is not due to improper migration, but rather a deficiency in the NCC 
population itself. Altogether, these results suggest that a reduction in the number of 
migratory NCC that populate the pharyngeal arches underlie the defects in cranioskeletal 




Figure IV-7 In situ hybridization for markers of NCC development in polr1a mutant 
embryos.  
 (Legend continues on next page)A-D) sox2 at 12 hpf shows normal 
neural plate formation in mutant embryos. E-H) sox10 at 12 hpf shows 
that NCC induction occurs at relatively normal levels in mutant embryos. 
I-L) At 17 hpf, soon after the onset of a visible mutant phenotype, a 
reduction can be seen in the level of sox10 in pharyngeal arch 1 (pa1) of 
mutant embryos, indicating a reduced migratory NCC population. (ov = 
otic vesicle) M-P) At 24 hpf, the population of cartilage precursors 
labeled by sox9a shows a strong reduction throughout mutant embryos, 
especially in the pharyngeal arches (arrows). Q-T) dlx2a at 36 hpf shows 
a reduced population of NCC in the pharyngeal arches (pa) as well as a 
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A-D) sox2 at 12 hpf shows normal neural plate formation in mutant 
embryos. E-H) sox10 at 12 hpf shows that NCC induction occurs at 
relatively normal levels in mutant embryos. I-L) At 17 hpf, soon after the 
onset of athe onset of a visible mutant phenotype, a reduction can be seen 
in the level of sox10 in pharyngeal arch 1 (pa1) of mutant embryos, 
indicating a reduced migratory NCC population. (ov = otic vesicle) M-P) 
At 24 hpf, the population of cartilage precursors labeled by sox9a shows a 
strong reduction throughout mutant embryos, especially in the pharyngeal 
arches (arrows). Q-T) dlx2a at 36 hpf shows a reduced population of NCC 
in the pharyngeal arches (pa) as well as a reduced number of pa in mutant 




Figure IV-8 Time-lapse microscopy reveals NCC migration in sox10:gfp embryos 
from approximately 15 hpf – 20 hpf.  
 The migration pattern of polr1a mutant embryos (B, D, F, H) occurs 
properly relative to controls (A, C, E, G). However, the overall sox10:gfp 
population is reduced in polr1a mutant embryos. Experiment performed in 
collaboration with Joaquin Navajas-Acedo. Scale bars = 100 µm. 
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CELL DEATH AND PROLIFERATION 
As polr1a mutants displayed a reduced population of NCC, I next hypothesized 
that this reduction could be the result of an increase in cell death. Prior to the onset of the 
mutant phenotype, increased cell death is observed throughout polr1a mutant embryos at 
14 hpf (Figure IV-9 C, D).  Extensive TUNEL staining is not evident in the migratory NCC 
labeled with sox10:gfp, indicating that death within the migratory NCC is not the primary 
cause for the reduced NCC population. At 24 hpf, TUNEL staining showed an increase in 
cell death in polr1ahi3639Tg/hi3639Tg embryos especially along the neuroepithelium (Figure 
IV-10 A, B). Cross-sections through the neural tube revealed cell death in the dorsal 
portion, where NCC progenitors are located (Figure IV-10 C-F). These embryos were also 
immunostained for Sox10, and there was not significant co-localization with the TUNEL 
stain. This suggests that the reduction in NCC number is mainly due to a reduction of the 
NCC progenitor pool, and not cell death within the migratory NCC population. In vitro 
studies of human cancer cells have demonstrated that silencing POLR1A leads to increased 
apoptosis through both p53 dependent and independent mechanisms (Donati et al., 2011a; 
Donati et al., 2011b). To determine if cell death was p53-dependent, I examined p53 levels 
by qPCR and Western blot. Transcript levels of tp53 showed a greater than 4-fold increase 
in mutant embryos at 24 hpf, while the protein levels showed a 1.2 fold increase at 4 dpf 
(Figure IV-11).  
In addition to an increase in cell death, I hypothesized that an alteration in 
proliferation could also have a role in the reduced number of NCC observed in mutant 
embryos. To assess proliferation, I examined the amount of phospho-histone H3 (pHH3) 
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in control and mutant embryos. At 24 hpf, there was an overall decrease in the level of 
pHH3 staining in polr1a mutant embryos (Figure IV-12 A-D). Co-staining with Sox10 
revealed that this decrease was not restricted to migratory NCC. In fact, the regions with 
the most obvious reductions were in the eye, the neural tube, and within the pharyngeal 
arches. Cross sections through the neural tube confirmed a diminished number of pHH3+ 
cells within the neural tube of polr1a mutant embryos. This, in combination with the 
increased neuroepithelial cell death, suggests that an alteration in both the ability of NCC 





Figure IV-9 TUNEL staining at 14 hpf reveals increased cell death in polr1a mutant 
embryos.  
 A,B) TUNEL staining within sox10:gfp embryos shows cell death 
occuring within multiple regions of polr1ahi3639Tg/hi3639Tg embryos and not 
solely within the migratory NCC population. C,D) TUNEL stain alone is 
increased in polr1a mutant embryos. Scale bar = 100 µm. Figure adapted 




Figure IV-10 TUNEL staining at 24 hpf shows increased neuroepithelial cell death in 
polr1a mutant embryos (A,B).  
 C-F) Cross-sections through the neural tube confirm increased levels of 
cell death within the dorsal portion of the neural tube (D,F), which is the 
NCC-progenitor domain. Scale bar = 100 µm. Figure adapted from 








Figure IV-11 Quantification of Tp53 in polr1a mutant embryos. 
 A) qPCR for tp53 at 24 hpf reveals a significant increase in expression in 
polr1a mutant embryos. B) Western blot analysis for Tp53 at 4 dpf. Red 
signal is α-tubulin, green signal is Tp53. Lane 1 is control embryos, lane 2 
is polr1ahi3639Tg/hi3639Tg embryos, and lane 3 is the negative control. C) 
Quantification of the Western blot normalized to α-tubulin reveals a 
significant increase in the levels of Tp53 in polr1a mutant embryos. * p < 
0.01. Error bars represent 95% confidence intervals. Figure adapted from 






Figure IV-12 pHH3 staining reveals diminished proliferation in polr1ahi3639Tg/hi3639Tg 
embryos.  
 A,B) Immunostaining for Sox10 and pHH3 revealed a diminished 
population of NCC and reduced proliferation. C,D) The diminished 
proliferation is evident in regions around the eye and neural tube. E,F) 
Cross-sections through the neural tube confirm that there are fewer pHH3+ 








RNAPI function is essential for the transcription of the majority of rRNAs. As 
Polr1a contains the catalytic site of the enzyme (Engel et al., 2013), mutations in this 
subunit would be predicted to severely disrupt rRNA production and therefore ribosome 
biogenesis. I therefore hypothesized that alterations in proliferation and cell survival could 
be the result of altered ribosome biogenesis in polr1a mutant embryos. It has previously 
been shown that alterations in ribosome biogenesis can lead to p53 activation in multiple 
ribosomopathy syndromes (Jones et al., 2008; McGowan et al., 2008; Barlow et al., 2010; 
Pereboom et al., 2011). I hypothesized that mutations in polr1a would disrupt rRNA 
transcription, leading to nucleolar stress and activation of Tp53 (Rubbi and Milner, 2003). 
The levels of rRNA transcription were determined using quantitative RT-PCR (qPCR) in 
24 hpf embryos, with primers designed against regions of the initial, unprocessed transcript 
(47S). All three regions of the unprocessed transcript showed a significant reduction (p < 
0.01) in polr1ahi3639Tg/hi3639Tg embryos to less than half of the levels of transcript production 
in wild-type controls (Figure IV-13 A). In polr1a mutant embryos, the 5’ETS was reduced 
by 73%, ITS1 by 77%, and ITS2 by 59% relative to control levels. The 18S transcript, 
which includes both the stable processed form as well as the unprocessed 47S, was reduced 
in polr1ahi3639Tg/hi3639Tg embryos, although this result was not statistically significant. These 
results indicate that the 47S rRNA production is reduced in polr1a mutant embryos. As 
47S rRNA production is considered a rate-limiting step for ribosome biogenesis, we next 
examined the consequences of a polr1a mutation on ribosome biogenesis by polysome 
profiling. The polysome profiles of polr1a mutant embryos show a strong decrease in all 
 156 
of the peaks – 40S, 60S, 80S, and polysomes – which is an indication of an overall decrease 
in ribosome biogenesis. Altogether, these results are consistent with a mechanism of 
diminished rRNA production and ribosome biogenesis leading to nucleolar stress and 







Figure IV-13 Analysis of rRNA and ribosome biogenesis in polr1a mutant embryos. 
 A) qPCR for regions of the 47S transcript reveal diminished production of 
rRNA in polr1a mutant embryos. The 5’ETS, ITS1, and ITS2 regions all 
showed significant decreases in rRNA levels in polr1a mutant embryos * 
p < 0.01. The 18S transcript was reduced, but not significantly (p = 0.095). 
Error bars represent 95% confidence intervals. Figure adapted from 
Weaver, Watt, et al., 2015. B) Polysome profiling reveals a strong 
difference in the overall level of ribosome biogenesis in polr1a mutant 
embryos. 40S, 60S, 80S, and plysome peaks all show a reduction. 
Experiment performed in collaboration with Cynthia Neben and Amy 
Merrill.  
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RNA-SEQ ANALYSIS OF POLR1A MUTANT EMBRYOS 
To determine if there were alterations outside of p53 signaling involved in the 
polr1a mutant phenotype, RNA-Seq analysis was performed. Two stages were examined: 
15 hpf, at the onset of the mutant phenotype, and 24 hpf, when the phenotype and p53-
dependent cell death within the neuroepithelium are established.  Consistent with the up-
regulation of tp53, genes involved in p53 signaling, cell cycle, and apoptosis were 
increased in polr1a mutant embryos at both 15 hpf and 24 hpf (Table IV-1). A detailed list 
of the differentially expressed genes can be found in the Appendix. In order to understand 
the pathways that may be affected in the polr1a mutants, KEGG pathway analysis was 
performed. Pathways with significant changes included p53 signaling and cell cycle at 15 
hpf (Table IV-2). 
 The upregulation of several cyclin dependent kinase inhibitors (cdkns) including 
cdkn2b (ink4a), cdkn1a (p21), cdkn1ba (p27), along with retinoblastoma-like 2 (rbl2) and 
cyclin G1 (ccng1) was consistent with a decrease in cell cycle progression, similar to what 
was found in polr1c and polr1d mutant embryos. In addition, several genes were 
upregulated that have functions in apoptosis including casp8, phlda3, bbc3, baxa, and 
tp53inp. These all corresponded to the genes upregulated in polr1c and polr1d mutants, 
with the exception of tp53inp1. The Tp53inp1 protein binds Bcl2 to release Bax and 
eventually leads to cytochrome c release from the mitochondria (Matsuda et al., 2002). At 
24 hpf, p53 signaling and cell cycle were significantly altered as well, with the addition of 










gene 15 hpf Fold Change 24 hpf Fold Change 
cdkn2b 185.4 335.3 
rbl2 38.9 19.2 
mdm2 25.3 22.3 
casp8 18.1 18.5 
bbc3 17.4 18.1 
phlda3 16.3 21.2 
cdkn1a 8.5 17.5 
tp53inp1 8.0 2.9 
ccng1 4.4 7.2 
baxa 3.9 3.1 
cdkn1ba 3.8 2.9 
tp53 3.7 6.5 
 
Table IV-1 List of genes with up-regulation in polr1a mutant embryos involved in p53 
signaling and cell cycle regulation.  







p53 signaling pathway 20 -7.31764 9.60E-08 
Cell cycle 28 -10.9737 1.72E-06 
 







p53 signaling pathway 19 -3.47237 2.38E-05 
Cell cycle 24 -10.5521 1.27E-03 
Notch signaling pathway 12 -8.69548 9.15E-03 
 
Table IV-3 KEGG pathway analysis of 24 hpf polr1a embryos 
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An alteration in Notch signaling is interesting since this signaling pathway has 
many functions during embryogenesis, including craniofacial, neuronal, and brain 
development. There are two ligands for the Notch receptor, Jagged and Delta. Signaling 
activated by either of these ligands leads to cleavage of the Notch receptor, releasing the 
Notch intracellular domain (NICD). The NICD then bind co-factors within the nucleus to 
activate its target genes (see Figure IV-14). Some of the co-factors include RBPJs, which 
are down-regulated in polr1a mutant embryos (Table IV-4). Interestingly, inhibitors of 
Notch are also down-regulated including ctbp1 and dvl1b, although not to the same extent 
as some of the Notch activators, indicating an overall decrease in Notch signaling. The 
levels of some downstream target genes, which are considered a readout of the overall 
activity of Notch signaling, are decreased in the polr1a mutants. Down-regulation of Notch 
targets her15.1, her12, and her4, but not her9 were found. In addition, down-regulation of 
all of the delta ligands – dla, dlb, dlc, dld – were observed, but there was not a consistent 
down-regulation of jagged ligands. Levels of jag1a were decreased while there was a slight 
increase in jag1b. However, as her9 expression is induced by Jag1-Notch signaling and 
her9 expression was only slightly increased (fold change = 1.36), this would indicate that 
Jag-Notch signaling is not significantly altered. This is particularly interesting since jag1b 
is known to play a role in craniofacial development in zebrafish. In particular, jag1b 
confers dorsal identities within the pharyngeal arches (Zuniga et al., 2010). This would 
indicate that the proper signals are in place for development of the craniofacial skeleton in 
the polr1a mutants, but that the reduction in the NCC population is too extensive to 
generate the cartilage elements. Delta-Notch signaling is more significantly affected, as 
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many genes in this pathway were down-regulated in the polr1a mutant embryos. There are 
several potential consequences for alterations in these genes. notch1a, notch1b, and notch3 
are all expressed in the hindbrain and notch1a and notch3 have been shown to be required 
for rhombomere boundary maintenance (Qiu et al., 2009). It would be interesting to 
investigate whether there is any alteration of rhombomere structure in polr1a mutant 
embryos. In addition, Delta-Notch signaling has important roles in neuronal development. 
Mutations in dla result in a decrease of trunk NCC derivatives and an increase in Rohon-
Beard neuron formation (Cornell and Eisen, 2000). A downstream target of Delta-Notch 
signaling, her4 (an ortholog of mammalian Hes5), has roles in neuronal development 
within the trigeminal ganglia outgrowth (So et al., 2009) and the inner ear (Radosevic et 
al., 2014). Given the hypoplastic cranial ganglia in the polr1a mutants (Figure IV-6 E,F), 
an alteration in neural development is likely. Further examination of the Notch signaling 





Figure IV-14 Diagram of Notch signaling . 
 The Notch ligands Delta and Jagged interact with the Notch receptor. 
The Notch intracellular domain (NICD) is cleaved and then binds to co-
factors within the nucleus to activate target gene expression. CSL is also 







In summary, I analyzed the function of polr1a during zebrafish embryogenesis 
which revealed the importance of polr1a for craniofacial development, in support of the 
human acrofacial dysostosis phenotype. I found dynamic expression of polr1a during 
zebrafish embryonic development. At early stages, polr1a is ubiquitously expressed, later 
it becomes enriched in the eye, brain, and cranial regions, and at even later stages it is 
expressed in the liver. This dynamic pattern would suggest that polr1a is needed at different 
levels in certain tissues at different times during development. The presence of specific 
phenotypes in human patients with Acrofacial Dysostosis, Cincinnati Type, namely the 
gene fold change p-value 
her4.2  -3.25 1.57E-04 
dld -2.70 9.66E-51 
dla -2.63 7.52E-48 
her4.1 -2.55 8.20E-05 
rbpjb -2.13 4.98E-12 
jag1a -2.10 3.68E-15 
her15.1 -1.93 1.95E-05 
her12 -1.83 1.59E-04 
notch1a -1.77 1.93E-09 
dvl1b -1.74 1.55E-03 
ctbp1 -1.73 5.05E-20 
dlb -1.68 2.37E-13 
dlc -1.63 2.69E-14 
notch3 -1.62 4.85E-11 
notch1b -1.57 1.97E-10 
jag1b 1.63 3.25E-08 
 




cranioskeletal and limb, would also suggest that POLR1A may have tissue-specific 
requirements. 
Consistent with the pattern of polr1a expression, polr1ahi3639Tg/hi3639Tg embryos 
display a number of craniofacial defects, smaller size, an underdeveloped liver, and cardiac 
edema by 4 dpf. One striking feature was the apparent lack of a jaw, which was confirmed 
by staining with Alcian blue. By 5 dpf, polr1a mutant embryos have formed very little 
cartilage. This severe hypoplasia of the jaw is reminiscent of the phenotype of Individual 
1 with Acrofacial dysostosis, Cincinnati Type. In addition to severe hypoplasia of the 
craniofacial cartilage, polr1a mutant embryos also displayed hypoplasia of the cranial 
ganglia; both of these tissues have a NCC contribution. Analysis of NCC development by 
in situ hybridization revealed that early stages of NCC formation occur normally in polr1a 
mutant embryos. However, correlating with the onset of the mutant phenotype, alterations 
in NCC development were apparent. There was reduced expression of sox10 and sox9a 
labeled NCC, which contribute to neuronal (Culbertson et al., 2011) and cartilage (Yan et 
al., 2002) lineages, respectively. By 36 hpf, alterations in the pharyngeal arches were 
visible in the mutant embryos and the domain of dlx2a expression revealed the arches were 
smaller and reduced in number. This also suggests a decrease in NCC number in the polr1a 
mutant embryos. Time-lapse analysis of NCC migration showed that, while reduced in 
number, the NCC migrate in the proper pattern in polr1a mutant embryos. Together, the 
expression of NCC markers and the proper migration of NCC suggest that polr1a is not 
necessary for proper genetic programming of NCC, but is important in the survival and/or 
proliferation of the NCC population. I hypothesized that the reduction in NCC would be 
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due to p53-dependent cell death, and increased cell death was found at both 14 hpf and 24 
hpf along with increased levels of tp53. Interestingly, the majority of the cell death 
occurred within the neuroepithelium and not within the migratory NCC population which 
was labeled with Sox10. This suggests that a loss of NCC progenitors underlies the 
reductions in the sox10 and sox9a populations, and ultimately the skeletal and neuronal 
defects observed in polr1a mutants. As alterations in ribosome biogenesis are known to 
activate p53 signaling (Azuma et al., 2006; Chakraborty et al., 2009; Donati et al., 2011a) 
and Polr1a contains the catalytic site of RNAPI which synthesizes rRNA (Engel et al., 
2013), we examined the levels of rRNA production. Multiple regions of the initial 47S 
rRNA transcript showed a significant reduction in polr1a mutant embryos ranging from 
~60-80% reduction relative to control siblings. Given this strong reduction, and that 47S 
production is considered a rate-limiting step in ribosome biogenesis (Laferté et al., 2006), 
I hypothesized that there would be a subsequent alteration in ribosome biogenesis. 
Polysome profiling confirmed this alteration, with polr1a mutants showing a strong 
decrease in the 40S, 60S, 80S, and polysome peaks. The alteration in every peak indicates 
that the overall level of ribosome biogenesis is diminished, and that the decrease is not due 
to any specific alteration in either small or large subunit assembly. Given the decrease in 
ribosome biogenesis, it is not surprising that a reduction in proliferation, shown by pHH3, 
was observed in polr1a mutants. Altogether, the data suggests a similar mechanism to that 
of polr1c and polr1d mutant embryos in the pathogenesis of TCS. That is, diminished 
levels of rRNA production lead to stress and accumulation of p53, resulting in cell cycle 




Figure IV-15 Mechanism of the polr1a mutant phenotype.  
 Cells, particularly those within the neuroepithelium, have reduced 
production of rRNA and ribosome biogenesis, leading to stress and 
activation of p53, resulting in cell death. This cell death particularly affects 
the NCC progenitor population and reduces the number of NCC that 




Given the similarity of mechanism between polr1a, polr1c, and polr1d mutant embryos, 
studies are currently underway to examine if genetic inhibition of tp53 is able to improve 
the polr1a mutant phenotype. 
Remarkably, mutations in POLR1C and POLR1D which are known to cause TCS, 
have craniofacial anomalies but not limb phenotypes. Thus, despite the common functions 
of polr1a, polr1c, and polr1d, there may be different threshold requirements for each of 
these genes. RNA-Seq analysis of the three mutants revealed a common alteration in p53 
signaling. One intriguing difference was the alteration in the Notch signaling pathway only 
in polr1a mutant embryos at 24 hpf. While alterations in the Notch pathway genes have 
not yet been validated, it represents an interesting pathway potentially involved in the 
polr1a mutant phenotype. Notch signaling has roles in the development of many different 
tissue types, including cardiac, neuronal, vascular, and cartilage. It remains to be seen if 
alterations in this pathway could have a role in the limb phenotype associated with 
mutations in POLR1A. In order to understand the differences in phenotype between patients 
with POLR1A mutations and those with POLR1C or POLR1D mutations, the functions of 
each individual RNAPI subunit will require further study. 
In summary, we have identified mutations in POLR1A in association with 
Acrofacial dysostosis, Cincinnati type and developed a zebrafish model of the syndrome. 
These zebrafish studies reveal that polr1a functions specifically in NCC and craniofacial 
development. In addition, we have shown that the loss of polr1a results in diminished 
ribosome biogenesis, p53-dependent neuroepithelial apoptosis, a loss of NCC, and 
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consequently craniofacial anomalies. This mechanism underlies the etiology and 





Craniofacial anomalies account for approximately one third of all congenital birth 
defects. These anomalies are typically classified according to the extent of disruption to 
the craniofacial skeleton, which arises from NCC. Understanding normal NCC 
development and identifying the perturbations that occur in a disease state are important in 
understanding the pathogenesis of individual anomalies. Ultimately, this will aid in the 
design of new therapies for preventing craniofacial syndromes.  
In this thesis, I examined zebrafish models of TCS and Acrofacial dysostosis, 
Cincinnati type in an effort to understand the pathogenesis of these syndromes. TCS is a 
mandibulofacial dysostosis which is characterized by hypoplasia of the mandible and 
zygomatic complex in addition to downward slanting palpebral fissures and anomalies of 
the external and middle ear, although the phenotype and penetrance is variable. Autosomal 
dominant mutations in TCOF1 account for the majority of individuals diagnosed with TCS. 
TCOF1 encodes a nucleolar phosphoprotein known as Treacle, which has roles in rRNA 
transcription and processing. A mouse model of Tcof1 haploinsufficiency demonstrated 
that the cranioskeletal anomalies arise from p53 dependent apoptosis within NCC 
progenitors and deficient NCC proliferation. Tcof1 haploinsufficiency disrupts ribosome 
biogenesis, leading to nucleolar stress and activation of p53. Therefore, TCS is classified 
as both a ribosomopathy and neurocristopathy.  
Consistent with the classification of TCS as a ribosomopathy, two other genes 
involved in ribosome biogenesis were identified to cause TCS – POLR1C and POLR1D 
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(Dauwerse et al., 2011). These genes encode subunits of RNAPI and RNAPIII and are 
important for rDNA transcription. Interestingly, the mutations identified in POLR1C are 
autosomal recessive while both autosomal recessive and autosomal dominant mutations 
have been identified in POLR1D (Dauwerse et al., 2011; Schaefer et al., 2014). However, 
TCOF1, POLR1C, and POLR1D do not account for all cases of TCS, so other genes remain 
to be identified. Other syndromes also have mandibulofacial dysostosis as a primary 
characteristic and identifying the genetic mutations assist in the diagnosis of these 
syndromes. One example is Acrofacial dysostosis, Cincinnati type in which the craniofacial 
phenotype has extensive overlap with TCS, but the addition of limb phenotypes makes it a 
distinct syndrome. In an effort to diagnose these patients with craniofacial anomalies 
similar to TCS, sequencing was performed for TCOF1, POLR1C, and POLR1D and no 
mutations were located in these genes. Whole exome sequencing identified a mutation in 
POLR1A as the likely causative mutation and, to date, three individuals with POLR1A 
mutations have been identified. POLR1A is a subunit of RNAPI and is critical for rRNA 
synthesis. Phenotypes arising from mutations in POLR1A were confirmed through my 
studies in zebrafish polr1a mutants which showed diminished rRNA production and 
disrupted craniofacial development and therefore suggest a role for polr1a in craniofacial 
morphogenesis (Weaver et al., 2015).  
The functions of Polr1a, Polr1c, and Polr1d in craniofacial development are not 
well understood. I therefore characterized the role of these genes during zebrafish 
development to gain an understanding of how RNAPI subunits function in the developing 
craniofacial skeleton. I found that polr1a, polr1c, and polr1d are dynamically expressed 
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during embryonic development in very similar patterns, including enriched expression in 
the cranial region at 24 hpf. Mutations in polr1a, polr1c, and polr1d result in craniofacial 
anomalies, with mutations in polr1a producing the most severe phenotype. This is 
consistent with Polr1a having a more important role in RNAPI, as it contains the active site 
of the enzyme, in contrast to Polr1c and Polr1d which localize to the periphery of RNAPI 
and RNAPIII. I also show that reduced rRNA production and ribosome biogenesis underlie 
p53-dependent apoptosis of NCC progenitors and a diminished NCC population in these 
models. Remarkably, the mechanism of action for polr1a, polr1c, and polr1d is very 
similar and is also consistent with that previously reported for Tcof1 in mice. The existence 
of a common mechanism for TCS and Acrofacial dysostosis, Cincinnati type is exciting 
for the development of therapies, as one therapy may be applicable to many syndromes. In 
this chapter I discuss the possibilities for tissue specificity arising from mutations in polr1a, 
polr1c, and polr1d, the mechanism of action involving p53, and speculate on the future of 
research in this area.  
Tissue Specificity in Ribosome Biogenesis 
The phenotypes of polr1a, polr1c, and polr1d mutant embryos suggests that there 
are tissue specific effects of mutations in RNAPI. The global nature of ribosome biogenesis 
and requirement for rRNA makes it surprising that alterations in this process elicit tissue 
specific effects. Specificity may be mediated through threshold requirements, ribosome 
composition, RNAPI composition, RNAPI regulation, or any combination of these. How 
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these tissue specific effects are facilitated during embryonic development remains an area 
of active research, and below I present several possibilities.  
TISSUE-SPECIFIC THRESHOLDS FOR RIBOSOME BIOGENESIS 
One attractive hypothesis that arises from my studies is that there may be tissue 
specific requirements for ribosome biogenesis. The similarly dynamic expression of 
polr1a, polr1c, and polr1d is indicative of higher levels of these genes being expressed in 
different tissues during development. This would suggest that these tissues have a higher 
requirement for RNAPI and thus ribosome biogenesis. polr1a, polr1c, and polr1d all show 
ubiquitous expression at 12 hpf, when the neural plate has formed and the NCC are 
beginning to migrate. During NCC migration, the expression of these RNAPI genes 
changes such that certain tissues express higher levels. By 24 hpf, expression levels of 
polr1a, polr1c, and polr1d are higher in areas such as the eye, midbrain hindbrain 
boundary, and the developing pharyngeal arches. At 36 hpf, elevated expression within the 
pharyngeal arches remains (See Figures III-1 and IV-3). These areas of enriched expression 
are congruent with the tissues affected by mutations in polr1a, polr1c, and polr1d. 
Interestingly, another RNAPI subunit, polr1b, shows enriched expression in gut and 
craniofacial tissues (Stuckenholz et al., 2009). These areas of higher expression correspond 
to rapidly proliferating tissues, including the neural plate and pharyngeal arches, where 
NCC are born and migrate. This suggests that NCC development has a high threshold 
requirement for ribosome biogenesis.  
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In addition to polr1c and polr1d, expression of Tcof1, also suggests a higher 
threshold for ribosome biogenesis in craniofacial tissues in the etiology of TCS. Treacle 
functions to stimulate rDNA transcription by RNAPI through interactions with Upstream 
Binding Factor (UBF) and also has functions in rRNA modification (Valdez et al., 2004; 
Gonzales et al., 2005). Tcof1 is broadly expressed with elevated activity in the 
neuroepithelium at E8.5 and the pharyngeal arches and frontonasal process at E9.5 
indicating a tissue-specific role in craniofacial development, consistent with the TCS 
phenotype. Similarly, the gene nolc1, a nucleolar phosphoprotein which interacts with 
RNAPI (Chen et al., 1999), has been used to model TCS in zebrafish. Expression of nolc1 
is enriched within the pharyngeal arches at 26 hpf (Weiner et al., 2012), which corresponds 
to the areas of stronger expression of polr1a, polr1c, and polr1d and suggests a role for 
increased ribosome biogenesis in the developing pharyngeal arches.  
 Further evidence for tissue-specific levels of ribosome biogenesis comes from 
analyses of genes involved in rRNA processing. Wdr43 is a component of the small subunit 
processome which functions in the formation of the 40S subunit and the maturation of the 
18S rRNA. wdr43 is expressed ubiquitously during early zebrafish development, but at 
later stages shows tissue-specific expression in the neuroepithelium and pharyngeal arches. 
It is worth noting that these are the same regions where Tcof1 is highly expressed. 
Mutations in wdr43 in zebrafish result in tissue specific phenotypes including disrupted 
development of craniofacial cartilages (Zhao et al., 2014). Similarly, zebrafish bap28 has 
homology to yeast Utp10, which functions in rDNA transcription and in the small subunit 
processome. Expression of bap28 at 24 hpf reveals elevated levels in the eye, brain, and 
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pharyngeal arch region, and the disrupted craniofacial development in bap28 mutants 
support a need for higher levels of ribosome biogenesis within these tissues (Azuma et al., 
2006). The bap28 mutation disrupted development of neuronal precursors, however, the 
development of NCC was not investigated. Given the similarity in appearance to polr1a 
mutant embryos at 24 hpf, it seems highly likely that NCC development would be affected 
in bap28 mutant embryos. Another example comes from examination of nol11, a nucleolar 
protein implicated in North American Indian childhood cirrhosis. In Xenopus, nol11 is 
strongly expressed within the neural tube and pharyngeal arches and knock down of nol11 
resulted in reduced craniofacial cartilage formation (Griffin et al., 2015). Altogether, these 
examples illustrate the importance of normal ribosome biogenesis for proper craniofacial 
development and suggest that cranial NCC have a high threshold for ribosome biogenesis. 
Disrupting ribosome biogenesis in different ways – either in rRNA transcription, 
processing, or RP synthesis – often results in a disruption of craniofacial development. 
Highly proliferative tissues, such as cranial NCC, may have a greater need for ribosome 
biogenesis. Therefore, the different ribosome biogenesis co-factors and RNAPI subunits 
are highly expressed within the same cranial regions to produce enough ribosomes for the 
growth and proliferation. Mutations in polr1a, polr1c, and polr1d all lead to perturbations 
of NCC development and cranioskeletal anomalies. Mutations in polr1a lead to especially 
severe hypoplasia of cartilage, more so than mutations in polr1c and polr1d (compare 
Figure III-4 and Figure IV-6). While all of the cartilage elements are present, although 
smaller, in polr1c and polr1d mutant embryos, polr1a mutant embryos fail to form the 
majority of the craniofacial cartilage. This difference in the phenotypes can be explained 
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as a result of the degree to which ribosome biogenesis is affected. The phenotypes of polr1c 
and polr1d mutants are very similar, as would be predicted by their function as a 
heterodimer, and ribosome biogenesis is diminished slightly as evidenced by polysome 
profiling (Figure III-15).  In contrast, polr1a mutants exhibit a more severe reduction in 
the level of ribosome biogenesis, as demonstrated by reduced 40S, 60S, 80S, and polysome 
peaks (Figure IV-13). This more severe reduction in ribosome biogenesis can explain the 
greater reduction of NCC in these mutants (Figure IV-7). polr1a mutant embryos have lost 
the majority of sox9 expression in the pharyngeal arches at 24 hpf, which results in the 
absence of craniofacial cartilage development at 5 dpf.  Numerous other examples across 
multiple organisms, including Tcof1 mutant mice, nolc1 and wdr43 mutant zebrafish, and 
nol11 mutant frogs, show disrupted cranioskeletal development upon impeded ribosome 
biogenesis.  
Mutations in ribosomal proteins, such as those that occur in Diamond-Blackfan 
anemia (DBA), display variable phenotypes. DBA is characterized by disruptions of the 
erythroid precursor population with the addition of other craniofacial and digit anomalies 
in some individuals. The majority of DBA cases are caused by mutations in RPs, 
components of either the 40S or 60S subunits (Narla and Ebert, 2010). Interestingly, 
mutations in RPL5 and RPL11 are more frequently associated with craniofacial phenotypes 
(Gazda et al., 2008). Mouse and zebrafish models of DBA have also shown specific 
phenotypes affecting erythroid and craniofacial development (Danilova et al., 2008; 
Danilova et al., 2011; Jaako et al., 2011), which is consistent with the idea that NCC and 
other highly proliferative tissues require a high level of ribosome biogenesis. 
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    The extent of NCC loss and craniofacial cartilage anomalies varies among the 
different models and may reflect the extent to which ribosome biogenesis is disrupted. 
Other affected tissues may not require the same level of ribosome biogenesis. However, 
not all ribosomopathies exhibit the same phenotypes, which raises questions concerning 
tissue specific threshold requirements for ribosome biogenesis. For example, if cranial 
NCC have a high threshold for ribosome biogenesis, alterations in this process would be 
expected to impact their development and thus all ribosomopathies would have craniofacial 
phenotypes. As ribosomopathies exist which do not have a known alteration in NCC 
development or a craniofacial phenotype, this suggests that there may be more to regulating 
ribosome biogenesis than mere levels.  
TISSUE SPECIFICITY IN RIBOSOME FUNCTION 
Another explanation for tissue-specific phenotypes which arise due to altered 
ribosome biogenesis is tissue-specific functions for ribosomes. Work from the Barna Lab 
has suggested that ribosomes may have tissue-specific functions. In a mouse containing a 
mutation in Rpl38, tissue specific homeotic transformations were observed in the head and 
axial skeleton. These axial skeleton patterning defects were found to be the result of altered 
Hox gene expression. The mutation in Rpl38 did not affect global protein synthesis, but 
did specifically impact translation of Hox genes, suggesting a specific role for Rpl38 in 
these tissues (Kondrashov et al., 2011). Furthermore, investigation of  the expression levels 
of 72 ribosomal proteins in different tissues revealed a surprising level of differential 
expression (Kondrashov et al., 2011). The differential expression of some ribosomal 
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proteins is due to their extra-ribosomal functions, such as RPL5 and RPL11 which can 
mediate the p53 response. Another intriguing interpretation is that the composition of the 
ribosome may differ in different tissue types, with some ribosomal proteins being critical 
for ribosome function only in certain tissues. These studies have raised the fascinating 
possibility that ribosome function may be more heterogeneous than once thought, and that 
the regulation of ribosomal protein modifications or perhaps even the composition of the 
ribosome may be altered in a tissue specific manner to provide the necessary level of 
activity.  
Tissue specificity in RNAPI composition.  
Tissue specificity in RNAPI composition. An attractive extrapolation of these studies is 
that there may be alternative regulation of RNAPI for rRNA synthesis. An example of cell-
type specific rRNA synthesis comes from the malaria parasite Plasmodium. This organism 
has two different genes that encode the small subunit rRNA and these are expressed at 
different times during its lifecycle. (Gunderson et al., 1987). While different rRNA genes 
are not known to exist in zebrafish, the modification and regulation of RNAPI subunits 
could confer tissue specific activity. Co-factors for RNAPI and RNAPIII transcription are 
known to be regulated by multiple signals within the cell to coordinate the transcription of 
rRNA with the need for ribosome biogenesis. These include the mTOR, MAPK, IGF, and 
EGF pathways (Stefanovsky et al., 2001; Hannan et al., 2003{Mayer, 2004 #114; Zhao et 
al., 2003a; Drakas et al., 2004; Mayer et al., 2004). Different factors, such as Tcof1, may 
have tissue-specific functions and therefore only regulate ribosome biogenesis in some 
tissues. It is not known whether there are modifications of the RNAPI/III subunits 
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themselves, such as phosphorylations or acetylations, which could add another level of 
regulation.  
Polr1c and Polr1d form a dimer that is located on the periphery of RNAPI and 
RNAPIII and therefore would be in a location to interact with or be modified by other 
proteins. There may be tissue-specific interactions which lead to the TCS phenotype. 
Finding co-factors that could interact with Polr1c and Polr1d in a tissue specific manner 
remains to be investigated. Polr1a contains the active site of RNAPI and is located more 
centrally (Engel et al., 2013; Fernandez-Tornero et al., 2013), making it less likely to 
interact with proteins or cofactors external to RNAPI. The expression of polr1a, polr1c, 
and polr1d all revealed areas of enriched expression in specific tissues, however, there are 
some differences in the expression of polr1a compared to polr1c and polr1d.  The 
differences in expression could indicate functions for these proteins outside of RNAPI/III 
which have yet to be identified, or that the composition of RNAPI/III could also vary. 
Studies of RNAPI and RNAPIII structure have been conducted in yeast (Fernández-
Tornero et al., 2011; Engel et al., 2013; Fernandez-Tornero et al., 2013), but the structure 
in vertebrates has not been characterized. Interestingly, the polr1a and polr1c genes have 
two protein coding transcripts in zebrafish (see Figure II-2), so it is possible that the 
proteins resulting from these transcripts have different functions. These alternate 
transcripts may be incorporated into RNAPI in a tissue specific manner, or they may have 
roles outside of RNAPI. Further examination of RNAPI function in vertebrates is needed 
to understand how the structure and function of RNAPI might change in distinct tissues or 
if RNAPI/III subunits have alternate tasks during embryogenesis. 
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LINEAGE SPECIFIC REGULATION OF RIBOSOME BIOGENESIS 
Another layer of regulation of ribosome biogenesis and rRNA transcription comes 
from lineage-specific sensitivity to alterations in ribosome biogenesis during embryonic 
development. Regulation of rRNA transcription in a tissue-specific manner is one possible 
explanation for phenotypes arising from alterations in this seemingly ubiquitous process. 
An interesting example comes from studies in the Drosophila ovarian germline stem cell 
lineage. CG18316, referred to as udd, localizes to nucleoli and co-immunoprecipitation 
identified an association with proteins homologous to TAF1B and TAF1C, which are 
components of SL1 and required for initiation of RNAPI transcription. Expression of udd 
is generally higher in germline stem cells and mutations in udd reduced rRNA transcription 
and also affected the expression of proteins that regulate cell fate decisions (Zhang et al., 
2014). Altogether, these studies indicate that altering rRNA transcription can affect cell-
fate decisions of a specific lineage as well as affecting decisions of growth and 
proliferation.  
TCS provides another example of lineage-specific regulation of rRNA 
transcription. Treacle, while widely expressed during embryogenesis, displays tissue-
specific elevated expression in regions important in NCC development. Treacle localizes 
to the nucleolus (Marsh et al., 1998; Winokur and Shiang, 1998) where it interacts with 
Upstream Binding Factor (UBF) to stimulate transcription of rDNA by RNAPI (Valdez et 
al., 2004). Mutations in TCOF1 show variable phenotypes and penetrance, and this lack of 
genotype-phenotype correlation is indicative of potential modifier genes of the TCS 
phenotype (Trainor et al., 2008). How mutations in POLR1C and POLR1D also result in 
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the tissue-specific phenotypes of TCS is less understood, but is likely mediated through 
their regulation.  
Numerous ribosomopathies have skeletal anomalies as a part of the phenotype, 
including Postaxial acrofacial dysostosis, Acrofacial dysostosis, Cincinnati type, TCS, and 
DBA (Trainor and Merrill, 2014). In fact, a number of ribosomopathies with disruption of 
RNAPI affect similar tissues, including craniofacial tissues (reviewed in (Hannan et al., 
2013)). Alterations in craniofacial development are indicative of a specific disruption of 
NCC, and suggests that there is something about the NCC and craniofacial cartilage 
progenitors that are particularly sensitive to changes in ribosome biogenesis. It may be that 
the bone and cartilage lineage has specific requirements for high levels of active rDNA, 
and obstruction of ribosome biogenesis then results in the inability of these tissues to 
develop properly. Therefore, another possibility for tissue-specific phenotypes observed in 
polr1a, polr1c, and polr1d mutants may be due to differential control of ribosome 
biogenesis in the cartilage/bone lineage. For example, Runx2, a gene involved in osteoblast 
differentiation, represses activity at the rDNA promoter in mammalian cells through 
association with UBF, a component of the RNAPI regulator complex (Young et al., 2007). 
Mutations in RUNX2 may cause cleidocranial dysplasia, which is characterized in part by 
skeletal anomalies and decreased bone density (Otto et al., 2002). Further evidence for 
lineage specific disruption of ribosome biogenesis in bone and cartilage comes from a 
mouse model of Bent Bone Dysplasia Syndrome (BBDS). BBDS is characterized by 
skeletal dysplasia including bent long bones, poor mineralization of the skull and other 
craniofacial anomalies and is caused by mutations in FGFR2 (Merrill et al., 2012). Further 
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study of the nature of FGFR2 mutations in BBDS revealed that FGFR2 functions to 
activate rDNA transcription. FGFR2 and FGF2 interact with UBF at the rDNA promoter, 
stimulating production of rRNA. This blocks the repression of rDNA transcription by 
Runx2, which is necessary in osteoblast differentiation, resulting in altered bone 
development (Neben et al., 2014). Thus a link can be established between ribosome 
biogenesis and bone formation. Further studies are needed to understand any role that 
Polr1a, Polr1c, and Polr1d might have specifically in bone and cartilage development and 
the levels of active rDNA in various tissues in the embryo. 
Mechanisms in the prevention of craniofacial anomalies 
In my studies of polr1a, polr1c, and polr1d, I found that mutations in these genes 
diminish rRNA production, which leads to tp53 activation and neuroepithelial cell death, 
reducing the NCC progenitor population and resulting in craniofacial defects. Thus the 
mechanism by which craniofacial phenotypes arise in these models appears to revolve 
around Tp53 (p53) activity. Disrupted ribosome biogenesis leading to p53 activation and 
cell death is a common mechanism among many ribosomopathies, but not all. The role of 
p53 in the phenotypes of ribosomopathies such as TCS and Acrofacial dysostosis, 
Cincinnati type will be discussed in the following section. In addition, I consider 
contributions form p53-independent pathways in the phenotype of these syndromes 
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TP53 DEPENDENT APOPTOSIS IS A UNIFYING MECHANISM UNDERLYING TCS AND 
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE 
The craniofacial phenotypes present in polr1a, polr1c, and polr1d mutant embryos 
are a result of alterations in the NCC population. These alterations are two-fold: first, a 
reduction in the NCC progenitor pool as a result of neuroepithelial apoptosis (See Figure 
III-12 and Figure IV-9), and second, reduced proliferation of NCC within the pharyngeal 
arches (See Figure III-14 and Figure IV-11). While disruptions in ribosome biogenesis are 
known to lead to nucleolar stress and activate Tp53, the specific disruption of NCC in these 
models is curious. One possibility is that NCC death indicates that they require higher rates 
of ribosome biogenesis. A recent study showed that when the rate of ribosome biogenesis 
is high, cells are more likely to undergo apoptosis in the event of a disruption in ribosome 
biogenesis. If there is a lower rate of ribosome biogenesis, then cells will undergo cell cycle 
arrest  in response to disruption of ribosome biogenesis (Scala et al., 2015). However, this 
study was completed in cell lines, so it remains to be seen if the same is true in the 
developing embryo. If the rate of ribosome biogenesis varies among different embryonic 
tissues and is higher within NCC, then this would help explain why the NCC progenitor 
population specifically undergoes cell death in TCS and Acrofacial Dysostosis, Cincinnati 
type. 
The phenotypes of polr1c and polr1d mutant embryos can be improved greatly 
upon tp53 inhibition (Figure III-18), indicating that much of the phenotype arises as a 
failure of NCC progenitors to survive. The degree of rescue is variable, indicating that the 
reduction in NCC proliferation may also function in diminished cartilage development. 
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RNA-Seq data revealed a similar activation of the p53 response in polr1a mutant embryos. 
Studies are currently underway to determine if a similar improvement in cartilage 
development can be observed in polr1a mutant embryos with inhibition of tp53. 
Preliminary results suggest there is some improvement in cartilage formation, revealing a 
consistent mechanism with polr1c and polr1d. 
These studies are consistent with the mechanism underlying TCS in mouse models. 
Tcof1+/- embryos have a reduced population of NCC, which is due to apoptosis and 
decreased proliferation in the neuroepithelium (Dixon et al., 2006). Microarray analysis of 
Tcof1+/- embryos revealed an increase in genes which are associated with p53-dependent 
transcription; these genes have roles in cell cycle regulation, apoptosis, and DNA repair 
(Jones et al., 2008). An increase in p53 activity and specific neuroepithelial apoptosis is 
observed in Tcof1+/- mice. Furthermore, Tcof1+/- embryos have diminished production of 
mature 28S rRNA and it was hypothesized that perturbations of ribosome biogenesis in 
NCC underlies the pathogenesis of TCS (Jones et al., 2008). Pharmacological inhibition of 
p53 using pifithrin-α, as well as genetic inhibition using p53+/- mice, reduced 
neuroepithelial apoptosis and rescued the TCS phenotype in Tcof1+/- mice (Jones et al., 
2008). In contrast to what was observed in the polr1c and polr1d zebrafish, Tcof1+/- mice 
are viable to adulthood upon inactivation of tp53.  
Other ribosomopathies show a similar mechanism of alterations in ribosome 
biogenesis and Tp53 activation. These include both zebrafish and mouse models of 5q- 
syndrome, DBA, and dyskeratosis congenita. Dyskeratosis congenita (DC) is a genetically 
heterogeneous ribosomopathy primarily characterized by bone marrow failure and 
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defective telomere maintenance. A zebrafish model of DC carries a mutation in nop10, 
which results in 18S rRNA processing defects and activation of the p53 pathway. Upon 
p53 inhibition, there was improvement in formation of the hematopoietic stem cell 
population (Pereboom et al., 2011). Similarly, both wrd43 and nol11 phenotypes can also 
be improved upon tp53 inhibition (Zhao et al., 2014; Griffin et al., 2015). An overlapping 
feature of 5q- syndrome and DBA is macrocytic anemia, and interestingly, both syndromes 
have been linked to mutations in ribosomal protein genes. A mouse model of 5q- syndrome 
carrying a mutation in Rps14 is rescued upon p53 inhibition (Barlow et al., 2010). In 
addition, zebrafish models of DBA have shown improvement upon p53 inhibition. rpl11 
morphant zebrafish show reduced cell death and improved craniofacial development upon 
co-injection of p53 morpholino, but hematopoiesis was not investigated (Chakraborty et 
al., 2009). A separate study showed improved hematopoiesis in rpl11 mutant zebrafish 
injected with p53 morpholino (Danilova et al., 2011). Mutations in other ribosomal protein 
genes in mice and zebrafish including Rps6, Rps19/rps19, and rps29 have shown 
upregulation of p53 with improved phenotypes upon its inhibition (Danilova et al., 2008; 
McGowan et al., 2008; Taylor et al., 2012). Additionally, mutations in nucleostemin, a 
protein which localizes to the nucleolus and regulates p53 activity, result in loss of 5.8S 
rRNA processing and p53 activation (Essers et al., 2014). Collectively, all of these studies 
provide strong evidence for activation of the p53 pathway upon perturbation of ribosome 
biogenesis, regardless of where in ribosome production the disruption occurs.  
Nucleolar stress, or disruption of nucleolar structure, occurs upon alterations in 
ribosome biogenesis (Rubbi and Milner, 2003). It has been hypothesized that nucleolar 
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stress is a primary mechanism by which p53 is activated in ribosomopathies. However, in 
human cancer cell lines, inhibition of POLR1A led to p53 activation without altering 
nucleolar structure (Donati et al., 2011a). Interestingly, if both rRNA and ribosomal protein 
production are diminished, p53 activation does not occur. These studies indicate that the 
balance between rRNA synthesis and ribosomal protein synthesis is carefully regulated in 
the cell, and disrupting the balance activates the p53 response.  
The major regulator of p53 activation in response to altered ribosome biogenesis is 
Mdm2. Mdm2 regulates p53 stability, targets it for proteasomal degradation, and is 
required to suppress p53 activity and function (Haupt et al., 1997; Kubbutat et al., 1997; 
Ringshausen et al., 2006). Ribosomal proteins can bind to Mdm2 and prevent its interaction 
with p53, and recently it was found that RPL5 and RPL11 are specifically required along 
with the 5S rRNA to inhibit Mdm2 and allow for p53 stabilization (Donati et al., 2013; 
Sloan et al., 2013). Thus, if rRNA production by RNAPI is diminished, there is an excess 
of ribosomal proteins, of which Rpl5 and Rpl11 will bind the 5S rRNA and Mdm2, leading 
to activation of p53. The presence of the 5S rRNA as a part of the complex to induce p53 
is curious, since p53 activation is observed in polr1c and polr1d mutant embryos. Polr1c 
and Polr1d are subunits of both RNAPI and RNAPIII which are involved in transcribing 
all of the rRNAs, however it remains to be understood how an alteration in 5S rRNA might 
impact p53 activation in the polr1c and polr1d zebrafish. 5S rRNA production was not 
examined in my studies, so the level to which it may or may not be reduced remains to be 
resolved. It is possible that the milder phenotype in polr1c and polr1d mutant embryos 
compared to polr1a mutants is in part due to the disruption of 5S rRNA production. If the 
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mutations in polr1c and polr1d diminish transcription of the 5S rRNA and the 47S rRNA, 
then reduced levels of 5S rRNA would diminish the binding of RPL5 and RPL11 to Mdm2 
and blunt the p53 response. As mutations in polr1a only reduce the levels of 47S rRNA, 
there is no abrogation of the p53 response by this mechanism, and more cell death is 
observed in these embryos. However, this explanation does not preclude the possibility that 
the more severe phenotypes observed in polr1a mutant embryos are a result of the critical 
function of Polr1a in the catalytic site of RNAPI. In fact, this explanation is also more 
likely because there is a greater reduction in rRNA production in polr1a mutants as are the 
alterations in ribosome biogenesis (compare Figure IV-12 to Figure III-15).  
In summary, mutations in polr1a, polr1c, and polr1d disrupt ribosome biogenesis 
which in turn activates the p53 response and results in cell death within the NCC progenitor 
population. Inhibiting the function of Mdm2 is the primary path through which disruptions 
of ribosome biogenesis produce enhanced p53 activity. This has been demonstrated by 
numerous animal models of ribosomopathies in which inhibition of p53 is capable of 
ameliorating defects caused by mutations in ribosome related genes (Danilova et al., 2008; 
McGowan et al., 2008; Chakraborty et al., 2009; Danilova et al., 2011; Pereboom et al., 
2011; Taylor et al., 2012; Zhao et al., 2014; Griffin et al., 2015). Some phenotypes can be 
completely prevented by p53 inhibition, as in the Tcof1 model of TCS (Jones et al., 2008), 
but most fail to completely rescue the phenotypes. This could be due to i) the failure to 
rescue defects in ribosome biogenesis necessary for proper growth and proliferation (as in 
(Griffin et al., 2015) and/or ii) the role of p53-independent pathways in the phenotype that 
remain to be investigated. 
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TP53-INDEPENDENT DEFECTS ARISE FROM DISRUPTED RIBOSOME BIOGENESIS 
tp53 inhibition is not sufficient to completely rescue the phenotype and viability of 
polr1a, polr1c, and polr1d mutant embryos, indicating that there may be additional p53 
independent causes for the observed phenotypes.  While the levels of ribosome biogenesis 
may simply not be enough for normal development in these models, other studies indicate 
that it is important to consider alternate pathways. First, despite the complete rescue and 
viability of Tcof1+/- mice upon Tp53 inhibition, an increase in ribosome biogenesis was not 
observed (Jones et al., 2008). Therefore in this rescued TCS model, the level of ribosome 
biogenesis was enough, provided the cells survived. However, this does not seem to be the 
case in polr1a, polr1c, or polr1d mutant embryos. In these embryos it is likely that the 
disruption of RNAPI function and ribosome biogenesis in the cells to be circumvented by 
p53 inhibition, although the level of ribosome biogenesis in double homozygous mutant 
embryos has not been determined. Second, not all disruptions in ribosome biogenesis can 
be improved by p53 inhibition (see below). This could indicate that disruptions in ribosome 
biogenesis can be mediated either with or without p53. 
Several studies have implicated p53-independent mechanisms in ribosomopathies 
outside of the ribosomal protein-Mdm2-p53 pathway which include the response to DNA 
damage, the mTOR pathway, and autophagy. A role for Treacle was recently implicated in 
the DNA damage response. Two separate studies identified interactions between Treacle 
and NBS1, which is a protein involved in recruitment of ATM to sites of double-strand 
breaks (Ciccia et al., 2014; Larsen et al., 2014). These studies suggest a mechanism 
whereby Treacle and NBS1 interact at the rDNA promoter as well as along the rDNA to 
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inhibit rRNA transcription upon DNA damage. The mechanism by which rRNA 
transcription is repressed remains to be investigated; however, Ciccia et al. identified 
subunits of RNAPI as a part of the Treacle complexes, including POLR1A, POLR1B, and 
POLR1E. This indicates that there could be direct regulation of RNAPI upon DNA damage 
or that these subunits function in the DNA damage response separately from their 
association with RNAPI.  Moreover, this indicates a possible role for DNA damage in the 
polr1a, polr1c, and polr1d phenotypes. If mutations in these genes alter RNAPI such that 
Treacle-NBS1 binding is hindered upon DNA damage, the necessary inhibition of rRNA 
during repair may not occur. This could then lead to proliferation of genomically unstable 
cells, which then undergo apoptosis. In the embryo, DNA damage may arise from the rapid 
proliferation necessary for development. In support of this, the neuroepithelium in mouse 
embryos, which is a rapidly proliferating tissue, has a naturally higher level of reactive 
oxygen species (ROS), and excessive ROS can be associated with DNA damage (Sakai et 
al., 2016). Furthermore, examination of mouse embryonic fibroblasts show that there is 
delayed DNA damage repair in Tcof1+/- fibroblasts, confirming the previously reported 
interaction of Treacle with sites of DNA damage. Thus, in the Tcof1+/- embryos, the 
neuroepithelium has a reduced capacity to respond to the effects of ROS such as DNA 
damage, and neuroepithelial apoptosis is induced by oxidative stress. Importantly, reducing 
oxidative stress by in utero treatment with the antioxidant N-acetyl-cystein (NAC) 
improves the phenotype of Tcof1+/- embryos such that a greater percentage of embryos 
display mild phenotypes (Sakai et al., 2016). However, a complete rescue of the phenotype 
such that embryos survive to adulthood was not observed upon NAC treatment, which is 
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in contrast to the rescue upon genetic inhibition of tp53. This could indicate that there are 
multiple triggers of the p53 response underlying the pathogenesis of TCS: i) the response 
to oxidative stress and DNA damage and ii) the response to disrupted ribosome biogenesis. 
The increased sensitivity to ROS and impaired response to DNA damage could then 
contribute to some of the increased cell death in the polr1c and polr1d mutant zebrafish in 
the absence of high levels of 5S rRNA that is involved in the ribosome-Mdm2-p53 
response. In addition to ROS, there may be an alternate mechanism for DNA damage in 
mutant zebrafish. Less efficient transcription of the rDNA by RNAPI occurs in polr1a, 
polr1c, and polr1d mutants as 47S rRNA transcription is reduced, but not eliminated, in 
these embryos. In an effort to increase the availability of rRNA, the cell could potentially 
increase the number of active rDNA repeats. However, if too many rDNA repeats are active 
this could lead to genome instability, as a certain amount of silent rDNA repeats are needed 
for sister chromatid cohesion (Ide et al., 2010). DNA damage may then be induced in these 
mutants and lead to cell cycle arrest and apoptosis, demonstrating another link between 
ribosome biogenesis and DNA damage. Further examination of DNA damage in the 
polr1a, polr1c, and polr1d zebrafish is necessary to determine if it similarly functions in 
the pathogenesis of these mutations or if there are other mechanisms mediating apoptosis. 
The mTOR pathway, which regulates cell growth and proliferation through 
phosphorylation events impacting all three RNA Polymerases, has been associated with 
the treatment of DBA. Mutations in ribosomal proteins result in diminished ribosome 
biogenesis, and stimulation of ribosome biogenesis through the mTOR pathway is an 
attractive alternative to p53 inhibition in the development of therapies for prevention. In 
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DBA, treatment with L-leucine can ameliorate macrocytic anemia in human patients as 
well as the phenotypes of zebrafish and mouse models of the syndrome (Cmejlova et al., 
2006; Pospisilova et al., 2007; Jaako et al., 2012; Payne et al., 2012). L-leucine functions 
through Leucyl-tRNA synthetase to activate mTOR signaling and stimulate protein 
synthesis (Bonfils et al., 2012; Han et al., 2012). mTOR activation also leads to 
phosphorylation of factors involved in initiating rRNA transcription (Hannan et al., 2003; 
Mayer et al., 2004), thus stimulating both rRNA synthesis and increased translation of 
ribosomal proteins. Investigation of this pathway in the polr1c and polr1d mutants revealed 
a slight reduction in mTOR pathway component RPS6 (Figure III-20), however, 
stimulation of mTOR through L-leucine treatment exacerbated the mutant phenotype 
(Figure III-22). This is likely due to the increased disruption in the rRNA/ribosomal protein 
balance. The mutations in polr1c and polr1d reduce the function of RNAPI, and so, 
hypothetically, stimulation of RNAPI by mTOR is not able to increase rRNA transcription 
in coordination with ribosomal protein synthesis. Consequently, stimulation of mTOR 
signaling to improve ribosome biogenesis is not a viable therapy for all ribosomopathies 
and the pathogenesis must be understood in order to develop viable therapies for their 
prevention.  
Another p53-independent pathway implicated in ribosome biogenesis is autophagy, 
demonstrated by the titania mutant zebrafish. Autophagy is a mechanism used by the cell 
to promote intracellular recycling of organelles and often occurs under starvation 
conditions. The titania mutation was identified in the gene pwp2h, which is involved in 
18S rRNA maturation as a part of the small subunit processome. Mutations in pwp2h result 
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in craniofacial and intestine defects and also result in increased autophagy as well as 
increased p53 (Boglev et al., 2013). Notably, the phenotypes arising from mutations in 
pwp2h were not prevented by p53 inhibition and neither was autophagy (Boglev et al., 
2013). This indicates that the autophagy response is independent of p53 and that alterations 
in ribosome biogenesis can somehow stimulate autophagy.  
In other ribosomopathies, such as the zebrafish model of Shwachmam-Bodian-
Diamond syndrome (SBDS), p53-independent phenotypes are also present, but the 
underlying mechanisms are not well understood. In a zebrafish model of SBDS, 
morpholino knockdown of the sbds gene results in pancreatic and craniofacial defects as 
well as an absence of neutrophils, which are consistent with the human phenotype (Provost 
et al., 2012). Disruptions in subunit assembly induce the ribosome defects associated with 
SBDS. Co-injection of p53 morpholino in sbds morphants could improve the gross 
morphology of the embryos but not the cranioskeletal, pancreatic, or neutrophil 
phenotypes, suggesting a p53-independent pathway is involved in the mutant phenotype. 
The improvement upon p53 inhibition could be due to the nature of morpholino injections 
which can also induce cell death (Robu et al., 2007), and a genetic model for sbds would 
reveal more about the role of p53. Two other genes investigated in this study were 
identified by microarray, rpl3 and pes. rpl3 and pes mutants have similar phenotypes to 
sbds morphants and also fail to show improvement of pancreas development upon p53 
inhibition (Provost et al., 2012). 
A recent study has implicated a p53-independent role for Rpl3 in cell cycle arrest 
and apoptosis. In human cells, RPL3 overexpression leads to increased levels of p21, also 
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known as Cdkn1a, an inhibitor of the cell cycle (Russo et al., 2013).  This increase required 
a complex of RPL3, Sp1 (a regulator of p21), and nucleophosmin (a nucleolar protein) and 
the level of RPL3 overexpression governs whether cell cycle arrest or apoptosis is activated 
(Russo et al., 2013). p53-independent functions on ribosome biogenesis and cell 
proliferation have also been observed for another ribosomal protein, RPL11. Again in 
human cell lines, over expression of RPL11 reduced c-Myc activity at the promoters of c-
Myc target genes (Dai et al., 2007). c-Myc, an oncogene, has multiple functions in 
ribosome biogenesis as it is involved in the regulation of RNAPI, II, and III. Of particular 
interest, c-Myc will increase rRNA transcription and proliferation (Dai et al., 2007). It 
would be fascinating to learn whether these p53-independent functions for RPL3 and 
RPL11 might be tissue-specific. Further study of these interactions in vertebrate models 
may illuminate whether extra-ribosomal functions occur only in certain tissues during 
development. 
In summary, events outside of p53 activation have roles in ribosome biogenesis and 
ribosomopathies. In TCS, there may be a role for DNA damage, although this remains to 
be investigated in the RNAPI mutants. Autophagy is one mechanism by which altered 
ribosome biogenesis can lead to cell cycle arrest and apoptosis independent of p53, as 
demonstrated by the titania mutants. Stimulation of the mTOR pathway by L-leucine can 
increase rRNA transcription and translation and is capable of improving the phenotype of 
DBA and potentially other ribosomal protein mutants. Finally, extra-ribosomal functions 
of ribosomal proteins may also play a p53-independent role in mediating cell proliferation. 
Examination of p53-independent pathways in other ribosome biogenesis mutants will 
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potentially uncover tissue-specific functions of these pathways and aid in our 
understanding of their pathogenesis.  
General Conclusions and Future Directions 
 In this thesis, I examined the roles of RNAPI subunits Polr1a, Polr1c, and Polr1d 
in zebrafish craniofacial development. In my examination of polr1a, polr1c and polr1d, I 
found spatiotemporally dynamic expression during zebrafish embryogenesis, suggesting 
tissue specific levels or functions for these genes. Curiously, there were differences 
between the expression of polr1a and polr1c and polr1d which could indicate functions for 
these genes outside of RNAPI that contribute to tissue specificity. In support of tissue 
specific functions for these RNAPI subunits, mutations in polr1a, polr1c, and polr1d result 
in specific phenotypes of the craniofacial skeleton, which is derived primarily from cranial 
NCC. Increased levels of tp53, neuroepithelial cell death, and reduced proliferation of NCC 
underlies the cranioskeletal anomalies in these models. Activation of p53 likely occurs due 
to nucleolar stress, as reduced rRNA synthesis perturbs ribosome biogenesis. These 
findings establish a common mechanism for TCS, regardless of the mutation. Importantly, 
I establish the first genetic models of polr1c and polr1d to examine their function in the 
pathogenesis of TCS. Furthermore, my studies established polr1a zebrafish as a model for 
a newly identified ribosomopathy, Acrofacial dysostosis, Cincinnati type. polr1a mutant 
embryos exhibit a similar phenotype to models of TCS, indicating a common mechanism 
underlying disruptions of RNAPI function. Questions remain concerning the tissue 
specificity of the phenotypes arising from mutations in polr1a, polr1c, and polr1d and will 
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be an area of future research. Additionally, a central role for tp53 in the polr1a, polr1c, and 
polr1d mutant phenotypes was identified; however, additional pathways need to be 
investigated for the prevention of ribosomopathies and neurocristopathies such as TCS and 
Acrofacial dysostosis, Cincinnati type. Future directions in the examination of these 
models are discussed below.  
TISSUE SPECIFICITY OF RNAPI FUNCTION 
The phenotypes of polr1a, polr1c, and polr1d mutant embryos suggest that tissue 
specificity exists in RNAPI transcription, however, how this specificity is obtained remains 
under investigation. The first question to address is how much of the phenotype is specific 
to NCC and whether Acrofacial dysostosis, Cincinnati type and TCS are primarily 
neurocristopathies or ribosomopathies. While NCC are critical for the generation of the 
craniofacial skeleton, they must interact with endoderm, mesoderm, and ectoderm during 
their development. It is currently unknown whether the expression of RNAPI subunits 
Polr1a, Polr1c, and Polr1d is absolutely required in each of these tissue types. In order to 
address the tissue-specific requirements for these genes, the Trainor lab is currently 
generating mice with conditional deletions of each of these genes. Polr1c conditional 
mutant embryos have been generated in the lab and reveal similar disruption of craniofacial 
development to polr1c mutant zebrafish after temporal removal of Polr1c from E8.5. In 
support of a critical role for Polr1c in NCC, Wnt1-Cre conditional deletion of Polr1c 
phenocopies the whole-organism removal at E8.5 (unpublished data, Annita Achilleos). A 
conditional allele of Polr1d has not yet been generated, but mutations in Polr1d are pre-
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implantation lethal, demonstrating a requirement for Polr1d in early embryonic 
development (unpublished data, Annita Achilleos). We are currently in the process of 
generating the Polr1a conditional mouse mutant in the lab using CRISPR technology, and 
anticipate that Polr1a will be required for early embryonic development, similar to Polr1c 
and Polr1d. 
The generation of mouse models will also aid in our understanding of RNAPI 
regulation in different tissues and at different times. How polr1a, polr1c, and polr1d 
function in a tissue specific manner is unknown. It could be due to different requirements 
for ribosome biogenesis, ribosome composition, RNAPI composition, or the regulation of 
RNAPI. Mice are advantageous for these questions because of the greater amount of tissue 
available in the embryo as well as a better library of available antibodies. Dissection of 
different tissues for use in proteomics studies could also aid in identification of tissue 
specific factors interacting with Polr1a, Polr1c, and Polr1d. 
In addition to specific functions of Polr1a, Polr1c, and Polr1d, mutations in RNAPI 
subunits could differentially alter levels of rRNA and ribosome biogenesis in certain 
lineages. In order to investigate this, tissue-specific fluorescent reporters in combination 
with flow cytometry will be used to isolate a cell population of interest. For example, 
sox10:gfp zebrafish can be used to examine NCC. In sorted NCC, 47S rRNA levels will be 
examined to understand if NCC specifically exhibit high levels of rRNA transcription. 
Using sox10:gfp bred into the background of polr1a, polr1c, and polr1d mutant embryos, 
I can determine if rRNA synthesis levels are more greatly reduced specifically in NCC. 
Once the conditional mice are generated, I can also take advantage of available fluorescent 
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reporters and perform similar experiments to see if there is greater importance of rRNA 
synthesis in NCC and if this is conserved from zebrafish to mammals.  
Another question arising from the RNAPI mutants is if protein synthesis, as a 
readout of ribosome function, is altered in either a global or tissue-specific manner. If 
global protein synthesis is reduced in mutant embryos, this would indicate a globally 
important role for Polr1a, Polr1c, or Polr1d. However, if global protein synthesis is not 
significantly different between mutant and wild-type embryos, this could indicate a tissue-
specific difference. Isolating particular tissues for examination could then confirm if there 
is, for example, a NCC specific attenuation of protein synthesis, similar to what was shown 
in Rpl38 mutants (Kondrashov et al., 2011). 
ALTERNATIVE PATHWAYS FOR THE PREVENTION OF CRANIOFACIAL ANOMALIES 
Activation of p53 is central to the mechanism which underlies the TCS phenotype, 
as well as Acrofacial dysostosis, Cincinnati type, and many other ribosomopathies 
previously mentioned.  The phenotypes of polr1c and polr1d embryos were improved upon 
inhibition of tp53, and studies currently underway suggest a slight improvement in cartilage 
formation in polr1a mutant embryos upon tp53 inhibition. It will be important to determine 
whether ribosome biogenesis is also improved on the tp53 mutant background. p53 
inhibition fails to completely rescue polr1c and polr1d embryos, as these embryos still die 
at approximately 10 dpf. This could be due to either a failure to rescue ribosome biogenesis 
to a functional level for survival, or indicate important p53-independent functions. 
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To examine potential genes that may function in the phenotypes of the polr1a, 
polr1c, and polr1d embryos, RNA-Seq was performed. As expected, genes involved in the 
p53 pathway were significantly upregulated in all three mutants (Table III-I, Table IV-I). 
Indeed, KEGG pathway analysis revealed a significant change in p53 signaling and this 
was the only pathway in common among polr1a, polr1c, and the polr1d results. While this 
fails to identify new therapeutic avenues that would be applicable to all three mutants, it 
does confirm the role of p53. Interestingly, MAPK was an activated pathway in polr1c 
mutants, which has multiple roles in the cell related to proliferation or alternatively to 
responses to DNA damage or oxidative stress. Phosphorylation events by MAPK lead to 
increased rDNA transcription by RNAPI and increased tRNA synthesis by RNAPIII 
(Felton‐Edkins et al., 2003; Zhao et al., 2003a). This could indicate a compensatory 
mechanism by which polr1c mutants are attempting to increase rRNA production despite 
reduced functionality of RNAPI. Alternatively, it will be interesting to learn if DNA 
damage or oxidative stress has a role in the polr1c phenotype as Treacle was recently 
implicated in the DNA damage response. The genes altered in the MAPK pathway will 
need to be validated by qPCR and in situ hybridization to determine if upregulation of the 
pathway occurs in a tissue-specific manner in polr1c mutant embryos. Another interesting 
finding coming from the RNA-Seq data was the downregulation of Notch signaling in 24 
hpf polr1a mutant embryos. Similar validation experiments will be performed and it will 
be interesting to learn how Notch signaling may be related to ribosome biogenesis or an 
independent function of Polr1a. Further analysis of these pathways may reveal new insights 
about the roles of RNAPI genes in zebrafish development.  
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While the RNA-Seq results confirm the importance of the p53 pathway in the 
phenotype of the polr1a, polr1c, and polr1d mutant embryos, another common therapeutic 
target was not identified. Identification of other targets will be important for the treatment 
of TCS and Acrofacial dysostosis, Cincinnati type due to the tumorigenic effects of p53 
inhibition. Current methods for improving defects associated with craniofacial anomalies 
are primarily surgical (Trainor and Andrews, 2013). Mechanisms to improve craniofacial 
development during the critical time frame of NCC development have the potential to 
improve the quality of life in individuals with TCS and other neurocristopathies. Therefore, 
to identify mechanisms beyond p53 inhibition, a chemical screen could be performed. 
Zebrafish are an excellent model for such a screen because of the quantity of embryos 
generated from a single breeding pair and the ability to rapidly identify phenotypes. Using 
mutants with sox10:gfp, the formation of cartilage can be visualized directly with 
fluorescence microscopy and analyzed for rescue. The generation of mouse models in the 
lab will complement these studies as any chemical identified to rescue or improve cartilage 
formation in zebrafish can next be tested on a mammalian model. 
 In conclusion, the polr1a, polr1c, and polr1d zebrafish will serve as useful models 
to understand the pathogenesis of Acrofacial dysostosis, Cincinnati type and TCS. These 
models indicate that there may be tissue specific regulation of ribosome biogenesis, adding 
to the body of work which suggests ribosome biogenesis is not as ubiquitous as initially 
perceived. Further examination of these zebrafish models and the generation of conditional 
mouse mutants has the potential to uncover previously unknown functions and interactions 
of Polr1a, Polr1c, and Polr1d that will facilitate an understanding of the pathogenesis of 
 198 
TCS and Acrofacial dysostosis, Cincinnati type. Finally, these models will aid in the 
identification of new treatments that have the potential to improve the quality of life in 
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Appendix A: polr1c and polr1d RNA-Seq Data 
UPREGULATED GENES 
The following list of genes was found to be upregulated in both polr1c and polr1d 







CDKN2B 47.96 15.04 ENSDARG00000037262 cyclin-dependent kinase 
inhibitor 2B (p15, inhibits 
CDK4)  
rspo1 45.72 26.23 ENSDARG00000039957 R-spondin homolog (Xenopus 
laevis) 
ms4a17a.2 13.27 31.01 ENSDARG00000093546 membrane-spanning 4-domains, 
subfamily A, member 17a.2 
rnf14 12.92 7.22 ENSDARG00000078683 ring finger protein 14 
rbl2 11.71 12.01 ENSDARG00000045636 retinoblastoma-like 2 (p130) 
ghrh 11.50 18.96 ENSDARG00000069481 growth hormone releasing 
hormone 
casp8 10.68 7.75 ENSDARG00000058325 caspase 8, apoptosis-related 
cysteine peptidase 
cx36.7 9.97 5.54 ENSDARG00000017927 connexin 36.7 
bbc3 9.57 8.08 ENSDARG00000069282 BCL2 binding component 3 
tnnc1a 9.14 6.22 ENSDARG00000011400 troponin C type 1a (slow) 
atxn1b 9.04 10.21 ENSDARG00000060862 ataxin 1b 
OSBP2 8.61 5.97 ENSDARG00000022772 oxysterol binding protein 2 
rasl11b 8.13 4.08 ENSDARG00000015611 RAS-like, family 11, member B 
mdm2 7.89 8.25 ENSDARG00000033443 transformed 3T3 cell double 
minute 2 homolog (mouse) 
phlda3 7.65 5.89 ENSDARG00000037804 pleckstrin homology-like 
domain, family A, member 3 
cmlc1 7.56 10.91 ENSDARG00000032976 cardiac myosin light chain-1 
lnx1 7.33 6.23 ENSDARG00000043323 ligand of numb-protein X 1 
crygn1 7.12 7.60 ENSDARG00000087437 crystallin, gamma N1 
zak 6.37 5.53 ENSDARG00000006978 sterile alpha motif and leucine 
zipper containing kinase AZK 
myl7 6.26 10.47 ENSDARG00000019096 myosin, light polypeptide 7, 
regulatory 
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ms4a17a.1 6.11 8.88 ENSDARG00000043798 membrane-spanning 4-domains, 
subfamily A, member 17A.1 
vrk2 6.09 5.42 ENSDARG00000021547 vaccinia related kinase 2 
cdkn1a 6.02 4.20 ENSDARG00000076554 cyclin-dependent kinase 
inhibitor 1A 
tp53 5.89 4.79 ENSDARG00000035559 tumor protein p53 
rps27.2 5.87 5.68 ENSDARG00000090186 ribosomal protein S27, isoform 
2 
gtpbp1l 5.71 6.15 ENSDARG00000042900 GTP binding protein 1, like 
tnni1b 5.61 2.22 ENSDARG00000052708 troponin I, skeletal, slow b 
fhl2a 5.50 7.16 ENSDARG00000042018 four and a half LIM domains 2a 
tnnt2a 5.50 5.59 ENSDARG00000020610 troponin T2a, cardiac 
foxo3b 5.34 4.79 ENSDARG00000042904 forkhead box O3b 
ccng1 4.88 4.83 ENSDARG00000076667 cyclin G1  
ace 4.73 3.64 ENSDARG00000079166 angiotensin I converting 
enzyme (peptidyl-dipeptidase 
A) 
nppa 4.67 7.30 ENSDARG00000052960 natriuretic peptide precursor A 
bmb 4.67 4.78 ENSDARG00000096603 brambleberry 
gadd45aa 4.64 4.23 ENSDARG00000043581 growth arrest and DNA-
damage-inducible, alpha, a 
TAF1C 4.36 4.18 ENSDARG00000096310 TATA box binding protein 
(TBP)-associated factor, RNA 
polymerase I, C, 110kDa 
loxhd1b 4.35 9.29 ENSDARG00000074638 lipoxygenase homology 
domains 1b 
mat2al 4.35 5.01 ENSDARG00000063665 methionine adenosyltransferase 
II, alpha-like 
slc8a1a 4.27 4.51 ENSDARG00000013422 solute carrier family 8 
(sodium/calcium exchanger), 
member 1a 
rnf169 4.16 2.86 ENSDARG00000042825 ring finger protein 169 
sesn3 4.12 3.87 ENSDARG00000015822 sestrin 3 
rlbp1b 4.10 2.98 ENSDARG00000045808 retinaldehyde binding protein 
1b 
ITPR1 4.04 2.91 ENSDARG00000074149 inositol 1,4,5-trisphosphate 
receptor, type 1 
zbtb38 3.96 8.70 ENSDARG00000077426 zinc finger and BTB domain 
containing 38 
igf2a 3.90 2.64 ENSDARG00000018643 insulin-like growth factor 2a 
ms4a17a.4 3.88 3.25 ENSDARG00000014024 membrane-spanning 4-domains, 
subfamily A, member 17A.4 
nfe2l2b 3.88 3.04 ENSDARG00000089697 nuclear factor (erythroid-
derived 2)-like 2b 
 237 
pik3r3a 3.84 2.78 ENSDARG00000071219 phosphoinositide-3-kinase, 
regulatory subunit 3a (gamma) 
ms4a17a.5 3.70 3.77 ENSDARG00000092204 membrane-spanning 4-domains, 
subfamily A, member 17A.5 
cpn1 3.59 2.56 ENSDARG00000096728 Carboxypeptidase N, polypeptide 1 
isg15 3.56 30.88 ENSDARG00000086374 ISG15 ubiquitin-like modifier 
lrrc10 3.52 3.56 ENSDARG00000045612 leucine rich repeat containing 
10 
cenpv 3.34 3.82 ENSDARG00000092285 centromere protein V 
mmp13b 3.23 2.54 ENSDARG00000015797 matrix metalloproteinase 13b 
tspan18a 3.20 2.23 ENSDARG00000056656 tetraspanin 18a 
lyrm1 3.19 3.77 ENSDARG00000026281 LYR motif containing 1 
asic1a 3.19 3.01 ENSDARG00000008329 acid-sensing (proton-gated) ion 
channel 1a 
TRIM29 3.16 2.18 ENSDARG00000034707 tripartite motif containing 29 
gig2p 3.09 2.38 ENSDARG00000088260 grass carp reovirus (GCRV)-
induced gene 2p 
mmp2 3.08 2.35 ENSDARG00000017676 matrix metalloproteinase 2 
abcc5 3.08 2.30 ENSDARG00000061233 ATP-binding cassette, sub-
family C (CFTR/MRP), 
member 5 
METRNL 3.04 2.38 ENSDARG00000007289 meteorin, glial cell 
differentiation regulator-like 
fsta 3.04 2.17 ENSDARG00000052846 follistatin a 
nudt6 2.88 3.18 ENSDARG00000087321 nudix (nucleoside diphosphate 
linked moiety X)-type motif 6 
rnf24 2.83 2.44 ENSDARG00000036965 ring finger protein 24 
vmhc 2.82 3.16 ENSDARG00000079564 ventricular myosin heavy chain 
isg20 2.79 2.66 ENSDARG00000079783 interferon-stimulated protein 
f8 2.78 2.02 ENSDARG00000015247 coagulation factor VIII, 
procoagulant component 
cdkn1ba 2.75 2.07 ENSDARG00000029018 cyclin-dependent kinase 
inhibitor 1Ba 
PNPLA2 2.70 4.81 ENSDARG00000073955 patatin-like phospholipase 
domain containing 2 
parp3 2.70 3.01 ENSDARG00000003961 poly (ADP-ribose) polymerase 
family, member 3 
cacna2d4b 2.64 4.10 ENSDARG00000023886 calcium channel, voltage-
dependent, alpha 2/delta subunit 
4b 
rd3 2.47 2.13 ENSDARG00000031600 retinal degeneration 3 
PRSS56 2.32 2.14 ENSDARG00000053158 protease, serine, 56 
adarb2 2.32 2.10 ENSDARG00000071823 adenosine deaminase, RNA-
specific, B2 (RED2 homolog 
rat) 
 238 
ms4a17a.6 2.32 2.10 ENSDARG00000007018 membrane-spanning 4-domains, 
subfamily A, member 17A.6 
fhit 2.25 2.36 ENSDARG00000068850 fragile histidine triad gene 
tnfaip6 2.24 2.36 ENSDARG00000093440 tumor necrosis factor, alpha-
induced protein 6 
baxa 2.11 2.65 ENSDARG00000020623 bcl2-associated X protein, a 
gpd1a 2.06 2.27 ENSDARG00000043701 glycerol-3-phosphate 
dehydrogenase 1a 
sb:cb252 2.01 2.44 ENSDARG00000058206 sb:cb252 
 
DOWNREGULATED GENES 
Polr1c: Top 100 downregulated genes with p < 0.01 
gene 
Fold 
Change p-value id description 
qrfpra -63.355 1.10E-06 ENSDARG00000039349 pyroglutamylated RFamide 
peptide receptor a  
LTB4R (1 of 2) -10.789 0.002317 ENSDARG00000032631 leukotriene B4 receptor 
lepb -9.636 0.000469 ENSDARG00000045548 leptin b 
P2RY2 (1 of 3) -9.213 0.0069 ENSDARG00000063545 purinergic receptor P2Y, G-
protein coupled, 2 
H2AFX  -9.117 0.005718 ENSDARG00000087235 H2A histone family, 
member X 
RPS6KA2 -8.515 0.000117 ENSDARG00000028469 Ribosomal protein S6 
kinase 
TRIM29  -7.779 0.000484 ENSDARG00000087711 tripartite motif containing 
29 
ATP6V1C2 -7.604 0.005796 ENSDARG00000070440 ATPase, H+ transporting, 
lysosomal 42kDa, V1 
subunit C2  
hspb2 -7.527 0.000442 ENSDARG00000052450 heat shock protein, alpha-
crystallin-related, b2 
ch25hl1.2 -7.247 0.001622 ENSDARG00000068138 cholesterol 25-hydroxylase 
like 1, tandem duplicate 2 
elnb -6.667 0.000193 ENSDARG00000069017 elastin b 
nyx -6.462 1.66E-05 ENSDARG00000061791 nyctalopin 
mrap -6.317 0.007977 ENSDARG00000091992 melanocortin 2 receptor 
accessory protein 
cyp8b2 -6.175 0.009526 ENSDARG00000097556 cytochrome P450, family 8, 
subfamily B, polypeptide 2 
TGFBR3L -5.926 0.003366 ENSDARG00000088795 transforming growth factor, 
beta receptor III-like 
 239 
polr1c -5.868 1.19E-29 ENSDARG00000039400 polymerase (RNA) I 
polypeptide C 
plaua -5.709 0.000254 ENSDARG00000075265 plasminogen activator, 
urokinase a 
bgna -5.549 0.003626 ENSDARG00000017884 biglycan a  
spns3 -5.456 6.04E-05 ENSDARG00000035459 spinster homolog 3 
(Drosophila) 
EYS -5.370 0.000225 ENSDARG00000089257 eyes shut homolog 
(Drosophila) 
wisp1b -4.653 0.005759 ENSDARG00000076685 WNT1 inducible signaling 
pathway protein 1b 
fgfbp2a -4.559 0.00131 ENSDARG00000039964 fibroblast growth factor 
binding protein 2a  
mtnr1al -4.273 0.000605 ENSDARG00000012057 melatonin receptor type 1A 
like 
kcnj14 -4.272 0.006623 ENSDARG00000075914 potassium inwardly-
rectifying channel, 
subfamily J, member 14  
SLC39A8 -4.216 0.00151 ENSDARG00000056757 solute carrier family 39 
(zinc transporter), member 
8 
slc25a4 -4.197 5.96E-08 ENSDARG00000027355 solute carrier family 25 
(mitochondrial carrier; 
adenine nucleotide 
translocator), member 4 
FBXO40 -4.135 2.76E-06 ENSDARG00000091119 F-box protein 40  
steap4 -4.096 0.000114 ENSDARG00000055901 STEAP family member 4 
YIPF7 -3.994 2.22E-11 ENSDARG00000039726 Yip1 domain family, 
member 7 
lrrc18b -3.900 0.002651 ENSDARG00000076236 leucine rich repeat 
containing 18b 
stat1b -3.880 0.007446 ENSDARG00000076182 signal transducer and 
activator of transcription 1b 
il11a -3.871 0.001106 ENSDARG00000037859 interleukin 11a 
ifih1 -3.870 0.006252 ENSDARG00000018553 interferon induced with 
helicase C domain 1  
clcn1a -3.828 3.19E-05 ENSDARG00000062084 chloride channel 1a  
prph2a -3.802 0.003308 ENSDARG00000038018 peripherin 2a (retinal 
degeneration, slow) 
bmf2 -3.778 0.000508 ENSDARG00000041414 Bcl2 modifying factor 2 
Tat -3.739 0.000388 ENSDARG00000069630 tyrosine aminotransferase 
asb16 -3.710 5.19E-05 ENSDARG00000056468 ankyrin repeat and SOCS 
box-containing 16 
pfkma -3.687 2.87E-07 ENSDARG00000014179 phosphofructokinase, 
muscle a 
 240 
PTAFR -3.676 0.005925 ENSDARG00000042370 platelet-activating factor 
receptor  
hsc70 -3.608 0.001232 ENSDARG00000012381 heat shock cognate 70 
mettl11b -3.573 1.17E-05 ENSDARG00000042033 methyltransferase like 11B  
ERBB4  -3.465 0.000163 ENSDARG00000089167 erb-b2 receptor tyrosine 
kinase 4 
tlr19 -3.464 0.009153 ENSDARG00000070392 toll-like receptor 19 
scn4ba -3.462 0.009201 ENSDARG00000062416 sodium channel, voltage-
gated, type IV, beta a 
c1qc -3.459 0.007903 ENSDARG00000095627 complement component 1, 
q subcomponent, C chain 
sult1st6 -3.287 0.008468 ENSDARG00000006811 sulfotransferase family 1, 
cytosolic sulfotransferase 6 
KRT23  -3.255 0.009238 ENSDARG00000044973 keratin 23 (histone 
deacetylase inducible) 
nlgn1 -3.234 0.001918 ENSDARG00000077710 neuroligin 1 
pvalb1 -3.221 1.19E-05 ENSDARG00000037789 parvalbumin 1 
neu3.5 -3.219 0.001601 ENSDARG00000096368 sialidase 3, tandem 
duplicate 5  
fancl -3.204 5.78E-08 ENSDARG00000007885 Fanconi anemia, 
complementation group L 
asb15a -3.187 0.001112 ENSDARG00000045633 ankyrin repeat and SOCS 
box containing 15a 
CAPN1  -3.145 0.000171 ENSDARG00000055338 calpain 1, (mu/I) large 
subunit 
col8a1b -3.123 0.004463 ENSDARG00000003533 collagen, type VIII, alpha 
1b 
cbx7a -3.114 0.000902 ENSDARG00000038025 chromobox homolog 7a 
knca7 -3.105 0.000303 ENSDARG00000086571 potassium voltage-gated 
channel, shaker-related 
subfamily, member 7  
c1qa -3.089 0.001888 ENSDARG00000044613 complement component 1, 
q subcomponent, A chain 
cdnf -3.078 0.000443 ENSDARG00000075501 cerebral dopamine 
neurotrophic factor 
SRMS -3.059 0.000504 ENSDARG00000077783 src-related kinase lacking 
C-terminal regulatory 
tyrosine and N-terminal 
myristylation sites 
MYOM2  -3.044 1.09E-05 ENSDARG00000091099 myomesin 2 
PLEKHA4 -3.017 3.58E-06 ENSDARG00000071460 pleckstrin homology 
domain containing, family 
A (phosphoinositide 
binding specific) member 4 
sycp2 -3.006 0.002451 ENSDARG00000088950 synaptonemal complex 
protein 2 
 241 
aqp4 -3.002 1.32E-05 ENSDARG00000010565 aquaporin 4 
myhz2 -2.965 3.94E-05 ENSDARG00000012944 myosin, heavy polypeptide 
2, fast muscle specific 
tcap -2.963 0.005061 ENSDARG00000007344 titin-cap (telethonin) 
rxfp3.3b -2.919 0.005661 ENSDARG00000059348 relaxin/insulin-like family 
peptide receptor 3.3b 
 
evi5a -2.911 4.26E-05 ENSDARG00000077666 ecotropic viral integration 
site 5a 
irf1b -2.887 0.009384 ENSDARG00000032768 interferon regulatory factor 
1b 
glis1b -2.847 0.006496 ENSDARG00000027933 GLIS family zinc finger 1b  
b4galt5 -2.841 0.00625 ENSDARG00000037815 UDP-Gal:betaGlcNAc beta 
1,4- galactosyltransferase, 
polypeptide 5  
PDE2A  -2.827 8.06E-05 ENSDARG00000079064 phosphodiesterase 2A, 
cGMP-stimulated  
myhc4 -2.812 2.10E-05 ENSDARG00000035438 myosin heavy chain 4 
prkcg -2.805 0.009304 ENSDARG00000004561 protein kinase C, gamma 
myha -2.769 1.67E-05 ENSDARG00000095930 myosin, heavy chain a 
fgf6a -2.765 0.000121 ENSDARG00000009351 fibroblast growth factor 6a 
tnfaip2b -2.752 0.003025 ENSDARG00000094072 tumor necrosis factor, 
alpha-induced protein 2b  
myhz1.1 -2.751 5.70E-05 ENSDARG00000067990 myosin, heavy polypeptide 
1.1, skeletal muscle 
myoz1a -2.725 6.76E-06 ENSDARG00000056209 myozenin 1a 
IGFN1  -2.723 0.001856 ENSDARG00000097613 immunoglobulin-like and 
fibronectin type III domain 
containing 1 






MYOM2 -2.697 0.000242 ENSDARG00000089850 myomesin 2 
arl14 -2.695 0.000871 ENSDARG00000063223 ADP-ribosylation factor-
like 14 
myhz1.2 -2.689 6.23E-05 ENSDARG00000067995 myosin, heavy polypeptide 
1.2, skeletal muscle 
myhz1.3 -2.675 0.000119 ENSDARG00000067997 myosin, heavy polypeptide 
1.3, skeletal muscle 
socs2 -2.662 0.007856 ENSDARG00000045557 suppressor of cytokine 
signaling 2 
ryr3 -2.639 3.80E-06 ENSDARG00000071331 ryanodine receptor 3  
 242 
crtac1a -2.637 0.002687 ENSDARG00000059826 cartilage acidic protein 1a 
arl13a -2.622 0.010937 ENSDARG00000052575 ADP-ribosylation factor-
like 13a 
pyroxd2 -2.612 1.33E-16 ENSDARG00000014101 pyridine nucleotide-
disulphide oxidoreductase 
domain 2 
casq1a -2.579 4.36E-06 ENSDARG00000038716 calsequestrin 1a  
CMYA5  -2.577 1.24E-05 ENSDARG00000077716 cardiomyopathy associated 5 
clic5a -2.561 0.00026 ENSDARG00000075993 chloride intracellular 
channel 5a 
opn3 -2.533 0.001905 ENSDARG00000052775 opsin 3 
SYNPO2  -2.529 0.000519 ENSDARG00000077157 synaptopodin 2 
tgm2l -2.506 0.003651 ENSDARG00000093381 transglutaminase 2, like 
COLQ  -2.491 7.45E-05 ENSDARG00000074216 collagen-like tail subunit 
(single strand of 
homotrimer) of asymmetric 
acetylcholinesterase 
tnnt3b -2.483 0.000209 ENSDARG00000068457 troponin T3b, skeletal, fast 
kcnma1a -2.482 0.00017 ENSDARG00000079840 potassium large 
conductance calcium-
activated 
 channel, subfamily M, 
alpha member 1a 
asb14 -2.479 0.001108 ENSDARG00000087741 ankyrin repeat and SOCS 
box containing 14 
 




Change p-value id description 
crygm2d18 -29.103 0.004923 ENSDARG00000086912 crystallin, gamma M2d18  
polr1d -21.319 4.42E-72 ENSDARG00000037570 polymerase (RNA) I 
polypeptide D 
tmem173 -17.487 0.000156 ENSDARG00000091058 transmembrane protein 173 
drd3 -9.466 0.001728 ENSDARG00000032131 dopamine receptor D3 
TRBV28 -8.787 0.001939 ENSDARG00000091233 T cell receptor beta variable 28 
arl13a -7.704 1.07E-06 ENSDARG00000052575 ADP-ribosylation factor-like 
13A  
CD6 -7.012 0.009592 ENSDARG00000075723 CD6 molecule 
crygmxl2 -6.838 0.001979 ENSDARG00000074001 crystallin, gamma MX, like 2 
crygm2d12 -6.748 0.009967 ENSDARG00000069801 crystallin, gamma M2d12 
 243 
crygm2d7 -6.313 0.0099 ENSDARG00000076572 crystallin, gamma M2d7  
ltc4s -6.054 1.63E-06 ENSDARG00000062598 leukotriene C4 synthase 
crygm2d17 -5.800 0.003894 ENSDARG00000076693 crystallin, gamma M2d17 
aqp10b -5.577 0.006091 ENSDARG00000058678 aquaporin 10b 
crygmx -5.523 0.004565 ENSDARG00000053862 crystallin, gamma MX 
gria2b -4.693 7.39E-11 ENSDARG00000052765 glutamate receptor, ionotropic, 
AMPA 2b 
capn3a -4.203 0.007203 ENSDARG00000041864 calpain 3a, (p94) 
 
nitr10a -3.937 0.006304 ENSDARG00000042968 novel immune-type receptor 
10a 
mchr2 -3.858 0.003466 ENSDARG00000036117 melanin-concentrating hormone 
receptor 2 
zgc:113364 -3.560 6.34E-08 ENSDARG00000037192 zgc:113364 
bscl2l -3.443 4.33E-09 ENSDARG00000025912 Bernardinelli-Seip congenital 
lipodystrophy 2, like 
FBXO40 -3.429 0.001496 ENSDARG00000091119 F-box protein 40  
itga6l -3.424 0.001439 ENSDARG00000056018 integrin, alpha 6, like 
BRINP3 -3.335 0.008396 ENSDARG00000075352 bone morphogenetic 
protein/retinoic acid inducible 
neural-specific 3  
sst6 -3.326 0.008252 ENSDARG00000093804 somatostatin 6 
tcap -3.293 0.002647 ENSDARG00000007344 titin-cap (telethonin)  
spon2b -3.269 9.26E-05 ENSDARG00000002732 spondin 2b, extracellular matrix 
protein 
slc25a4 -3.231 1.77E-05 ENSDARG00000027355 solute carrier family 25 
(mitochondrial carrier; adenine 
nucleotide translocator), 
member 4 
rab3b -3.215 0.003084 ENSDARG00000042803 RAB3B, member RAS 
oncogene family 
pvalb1 -3.192 1.54E-05 ENSDARG00000037789 parvalbumin 1 
crfb15 -3.040 0.000921 ENSDARG00000096495 cytokine receptor family 
member B15  




FNDC7  -2.787 0.002275 ENSDARG00000075676 fibronectin type III domain 
containing 7] 
tnnt3b -2.775 3.64E-05 ENSDARG00000068457 troponin T3b, skeletal, fast 
MYOM2 -2.747 0.000206 ENSDARG00000091099 myomesin 2 
cabp2b -2.731 0.000233 ENSDARG00000052277 calcium binding protein 2b 
PLCB1 -2.704 0.009327 ENSDARG00000090084 phospholipase C, beta 1 
(phosphoinositide-specific) 
 244 
asb2a.1 -2.676 0.000606 ENSDARG00000003797 ankyrin repeat and SOCS box-
containing 2a, tandem duplicate 
1 
crtac1a -2.651 0.003999 ENSDARG00000059826 cartilage acidic protein 1a 
pfkma -2.628 0.000304 ENSDARG00000014179 phosphofructokinase, muscle a 
FAM149A -2.453 0.003022 ENSDARG00000073709 family with sequence similarity 
149, member A 
OCEL1 -2.419 0.008566 ENSDARG00000061800 occludin/ELL domain 
containing 1 
gla -2.359 0.000628 ENSDARG00000036155 galactosidase, alpha 
tm4sf18 -2.321 0.009841 ENSDARG00000060668 transmembrane 4 L six family 
member 18 
casq1a -2.307 7.86E-05 ENSDARG00000038716 calsequestrin 1a 
CENPU -2.262 1.58E-06 ENSDARG00000088924 centromere protein U 
rhoua -2.197 2.87E-09 ENSDARG00000019709 ras homolog gene family, 
member Ua 
pvalb3 -2.191 0.00437 ENSDARG00000022817 parvalbumin 3 
GDPD2 -2.150 6.58E-06 ENSDARG00000073870 glycerophosphodiester 
phosphodiesterase domain 
containing 2  
tubb6 -2.149 0.010827 ENSDARG00000055649 tubulin, beta 6 class V 
smtnl1 -2.114 0.001993 ENSDARG00000041257 smoothelin-like 1 
cry5 -2.099 3.30E-06 ENSDARG00000019498 cryptochrome 5 
capn3b -2.086 0.00051 ENSDARG00000043035 calpain 3b 
CPXM1  -2.069 0.000255 ENSDARG00000073716 carboxypeptidase X (M14 
family), member 1 
cacng4 -2.024 0.006359 ENSDARG00000074669 calcium channel, voltage-
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FC id description 
ifit8 146.67 856.30 ENSDARG00000057173 interferon-induced protein with 
tetratricopeptide repeats 8 
CDKN2B 185.39 335.34 ENSDARG00000037262 cyclin-dependent kinase inhibitor 
2B (p15, inhibits CDK4)  
rspo1 43.28 59.39 ENSDARG00000039957 R-spondin homolog (Xenopus 
laevis) 
isg15 53.23 52.24 ENSDARG00000086374 ISG15 ubiquitin-like modifier  
NAMPT  6.04 38.16 ENSDARG00000078738 nicotinamide 
phosphoribosyltransferase 
RNF14  25.06 34.89 ENSDARG00000078683 ring finger protein 14 
gig2p 19.57 34.75 ENSDARG00000088260 grass carp reovirus (GCRV)-
induced gene 2p 
ANKRD34C 36.52 30.77 ENSDARG00000093286 ankyrin repeat domain 34C  
kcnq4 20.45 27.38 ENSDARG00000089490 potassium voltage-gated channel, 
KQT-like subfamily, member 4 [ 
cxcr3.1 22.64 26.67 ENSDARG00000007358 chemokine (C-X-C motif) 
receptor 3, tandem duplicate 1 
atxn1b 34.86 22.32 ENSDARG00000060862 ataxin 1b 
mdm2 25.28 22.32 ENSDARG00000033443 transformed 3T3 cell double 
minute 2 homolog (mouse) 
phlda3 16.27 21.22 ENSDARG00000037804 pleckstrin homology-like domain, 
family A, member 3  
ccdc88aa 20.18 20.70 ENSDARG00000078440 coiled-coil domain containing 
88Aa 
rbl2 38.95 19.23 ENSDARG00000045636 retinoblastoma-like 2 (p130) 
casp8 18.12 18.52 ENSDARG00000058325 caspase 8, apoptosis-related 
cysteine peptidase  
bbc3 17.43 18.09 ENSDARG00000069282 BCL2 binding component 3  
cdkn1a 8.54 17.50 ENSDARG00000076554 cyclin-dependent kinase inhibitor 
1A 
NAMPT  2.63 16.40 ENSDARG00000076694 nicotinamide 
phosphoribosyltransferase 
ms4a17a.5 11.57 14.45 ENSDARG00000092204 membrane-spanning 4-domains, 
subfamily A, member 17A.5 
 246 
lnx1 18.16 14.40 ENSDARG00000043323 ligand of numb-protein X 1 
cbln12 11.78 14.25 ENSDARG00000068232 cerebellin 12 
mat2al 18.18 13.62 ENSDARG00000063665 methionine adenosyltransferase 
II, alpha-like  
bmb 9.73 13.38 ENSDARG00000096603 brambleberry 
LTB4R  15.31 13.02 ENSDARG00000032631 leukotriene B4 receptor 
zak 14.72 12.60 ENSDARG00000006978 sterile alpha motif and leucine 
zipper containing kinase AZK 
ghrh 7.92 12.43 ENSDARG00000069481 growth hormone releasing 
hormone  
crygn1 2.87 11.97 ENSDARG00000087437 crystallin, gamma N1 
gadd45aa 15.59 11.81 ENSDARG00000043581 growth arrest and DNA-damage-
inducible, alpha, a 
zbtb38 7.49 11.36 ENSDARG00000077426 zinc finger and BTB domain 
containing 38  
SHISA8  9.41 11.09 ENSDARG00000088204 shisa family member 8  
ace 15.88 10.73 ENSDARG00000079166 angiotensin I converting enzyme 
(peptidyl-dipeptidase A) 1  
sesn3 21.13 10.20 ENSDARG00000015822 sestrin 3 
rasl11b 4.72 10.17 ENSDARG00000015611 RAS-like, family 11, member B 
LTB4R  15.01 9.68 ENSDARG00000061094 leukotriene B4 receptor 
foxo3b 21.15 9.63 ENSDARG00000042904 forkhead box O3b 
rps27.2 4.42 9.37 ENSDARG00000090186 ribosomal protein S27, isoform 2 
bcl3 7.18 9.30 ENSDARG00000087832 B-cell CLL/lymphoma 3] 
OSBP2  6.79 8.77 ENSDARG00000022772 oxysterol binding protein 2 
ppp4r4 5.45 8.64 ENSDARG00000010407 protein phosphatase 4, regulatory 
subunit 4 
oscp1a 2.65 8.63 ENSDARG00000094130 organic solute carrier partner 1a 
gtpbp1l 8.44 8.29 ENSDARG00000042900 GTP binding protein 1, like 
mmrn2b 14.59 7.92 ENSDARG00000073711 multimerin 2b  
rpz5 18.32 7.43 ENSDARG00000075718 rapunzel 5 
eva1bb 2.87 7.42 ENSDARG00000067742 eva-1 homolog Bb (C. elegans)  
ccng1 4.37 7.24 ENSDARG00000076667 cyclin G1 
vrk2 7.61 7.20 ENSDARG00000021547 vaccinia related kinase 2 
TAF1C 5.03 7.05 ENSDARG00000096310 TATA box binding protein 
(TBP)-associated factor, RNA 
polymerase I, C, 110kDa  
rnf169 8.65 7.01 ENSDARG00000042825 ring finger protein 169  
igfbp7 6.13 6.94 ENSDARG00000017389 insulin-like growth factor binding 
protein 7  
TRIM29  10.61 6.93 ENSDARG00000034707 tripartite motif containing 29  
parp3 7.24 6.91 ENSDARG00000003961 poly (ADP-ribose) polymerase 
family, member 3 
 247 
rd3 8.35 6.84 ENSDARG00000031600 retinal degeneration 3 
tp53 3.66 6.55 ENSDARG00000035559 tumor protein p53 
ms4a17a.1 14.02 6.45 ENSDARG00000043798 membrane-spanning 4-domains, 
subfamily A, member 17A.1 
ms4a17a.2 10.63 6.28 ENSDARG00000093546 membrane-spanning 4-domains, 
subfamily A, member 17a.2 
cenpv 5.54 6.20 ENSDARG00000092285 centromere protein V  
prdm1b 15.02 6.09 ENSDARG00000053592 PR domain containing 1b, with 
ZNF domain  
tnfaip6 5.40 6.07 ENSDARG00000093440 tumor necrosis factor, alpha-
induced protein 6 
lzts2b 5.91 6.02 ENSDARG00000077207 leucine zipper, putative tumor 
suppressor 2b 
crfb1 4.01 5.96 ENSDARG00000068681 cytokine receptor family member 
b1 
ITPR1  6.81 5.86 ENSDARG00000074149 inositol 1,4,5-trisphosphate 
receptor, type 1 
pik3r3a 7.33 5.80 ENSDARG00000071219 phosphoinositide-3-kinase, 
regulatory subunit 3a (gamma) 
PNPLA2 13.51 5.74 ENSDARG00000073955 patatin-like phospholipase 
domain containing 2 
lyrm1 4.06 5.63 ENSDARG00000026281 LYR motif containing 1 
abcc5 10.32 5.57 ENSDARG00000061233 ATP-binding cassette, sub-family 
C (CFTR/MRP), member 5 
RNF14  7.33 5.56 ENSDARG00000090710 ring finger protein 14 
dcdc2b 4.15 5.25 ENSDARG00000053744 doublecortin domain containing 
2B  
cica 6.20 5.20 ENSDARG00000071150 capicua homolog a (Drosophila)  
METRNL  4.10 5.19 ENSDARG00000007289 meteorin, glial cell differentiation 
regulator-like 
pappaa 2.77 5.16 ENSDARG00000059544 pregnancy-associated plasma 
protein A, pappalysin 1a 
gpd1a 3.12 5.05 ENSDARG00000043701 glycerol-3-phosphate 
dehydrogenase 1a  
PRSS56 15.24 5.01 ENSDARG00000053158 protease, serine, 56 
igf2a 5.50 5.01 ENSDARG00000018643 insulin-like growth factor 2a 
CD274 8.29 4.81 ENSDARG00000059310 CD274 molecule 
NIM1K 14.20 4.79 ENSDARG00000074087 NIM1 serine/threonine protein 
kinase 
slc1a8b 6.37 4.79 ENSDARG00000032465 solute carrier family 1 (glutamate 
transporter), member 8b 
isg20 3.10 4.68 ENSDARG00000079783 interferon-stimulated protein 
matn1 3.53 4.57 ENSDARG00000030215 matrilin 1 
fosl1a 3.43 4.57 ENSDARG00000015355 FOS-like antigen 1a 
fgf2 5.44 4.51 ENSDARG00000075031 fibroblast growth factor 2  
 248 
slc5a5 2.16 4.47 ENSDARG00000005392 solute carrier family 5 (sodium 
iodide symporter), member 5 
nudt6 2.21 4.44 ENSDARG00000087321 nudix (nucleoside diphosphate 
linked moiety X)-type motif 6 
nfe2l2b 12.31 4.44 ENSDARG00000089697 nuclear factor (erythroid-derived 
2)-like 2b  
ms4a17a.4 8.06 4.38 ENSDARG00000014024 membrane-spanning 4-domains, 
subfamily A, member 17A.4 
foxi1 2.88 4.32 ENSDARG00000019659 forkhead box i1 
tspan18a 3.71 4.31 ENSDARG00000056656 tetraspanin 18a 
ankef1b 4.98 4.24 ENSDARG00000060211 ankyrin repeat and EF-hand 
domain containing 1b  
atf5a 4.62 4.21 ENSDARG00000068096 activating transcription factor 5a  
lpcat2 4.11 4.19 ENSDARG00000053010 lysophosphatidylcholine 
acyltransferase 2  
rhoub 2.11 4.13 ENSDARG00000012968 ras homolog gene family, 
member Ub  
upb1 2.74 3.97 ENSDARG00000011521 ureidopropionase, beta 
slc1a2a 3.47 3.97 ENSDARG00000052138 solute carrier family 1 (glial high 
affinity glutamate transporter), 
member 2a 
mmp13b 18.92 3.93 ENSDARG00000015797 matrix metalloproteinase 13b 
batf3 2.23 3.92 ENSDARG00000042577 basic leucine zipper transcription 
factor, ATF-like 3 
cpn1 2.54 3.87 ENSDARG00000096728 carboxypeptidase N, polypeptide 
1 
es1 4.15 3.86 ENSDARG00000094516 es1 protein  
arrdc1b 2.96 3.82 ENSDARG00000079839 arrestin domain containing 1b 





DOWNREGULATED GENES IN POLR1A MUTANTS 
The following table shows a list of the top 100 genes that are downregulated in both 






FC id description 
zgc:162144 -9.07 -9.97 ENSDARG00000037603 zgc:162144 
polr1a -6.18 -10.89 ENSDARG00000029172 polymerase (RNA) I 
polypeptide A  
fads2 -5.88 -6.94 ENSDARG00000019532 fatty acid desaturase 2  
rxfp3.2b -5.35 -2.85 ENSDARG00000061846 relaxin/insulin-like family 
peptide receptor 3.2b  
PAX7 (3 of 
3) 
-4.89 -2.23 ENSDARG00000091353 paired box 7  
slc6a15 -4.67 -2.89 ENSDARG00000062821 solute carrier family 6 (neutral 
amino acid transporter), 
member 15  
kcnj14 -4.61 -4.71 ENSDARG00000075914 potassium inwardly-rectifying 
channel, subfamily J, member 
14  
cyp4v7 -4.49 -2.13 ENSDARG00000061585 cytochrome P450, family 4, 
subfamily V, polypeptide 7  
pax7a -4.36 -2.36 ENSDARG00000005173 paired box gene 7a  
cx44.1 -4.06 -2.10 ENSDARG00000015076 connexin 44.1  
mipb -3.99 -20.93 ENSDARG00000013963 major intrinsic protein of lens 
fiber b  
mipa -3.74 -7.21 ENSDARG00000037285 major intrinsic protein of lens 
fiber a 
zgc:165604 -3.62 -2.55 ENSDARG00000021241 zgc:165604  
GRM2 (2 
of 2) 
-3.60 -3.16 ENSDARG00000007195 glutamate receptor, 
metabotropic 2  
prtgb -3.58 -3.64 ENSDARG00000040442 protogenin homolog b (Gallus 
gallus)  
nr2f1b -3.55 -3.05 ENSDARG00000017168 nuclear receptor subfamily 2, 
group F, member 1b  
DLK1 -3.55 -2.48 ENSDARG00000077725 delta-like 1 homolog 
(Drosophila)  
otomp -3.45 -2.12 ENSDARG00000040306 otolith matrix protein  
il15 -3.41 -2.93 ENSDARG00000052361 interleukin 15  
 250 
lrrtm2 -3.38 -2.47 ENSDARG00000071374 leucine rich repeat 
transmembrane neuronal 2  
lrrtm2 -3.35 -2.76 ENSDARG00000090425 leucine rich repeat 
transmembrane neuronal 2  
adamts15b -3.34 -1.71 ENSDARG00000033544 ADAM metallopeptidase with 
thrombospondin type 1 motif, 
15b  
bcl11ab -3.27 -5.52 ENSDARG00000063153 B-cell CLL/lymphoma 11Ab  
lrrtm1 -3.24 -2.05 ENSDARG00000052713 leucine rich repeat 
transmembrane neuronal 1  
cdca7a -3.22 -2.80 ENSDARG00000077620 cell division cycle associated 7a  
zgc:194261 -3.21 -1.63 ENSDARG00000035340 zgc:194261  
lrrc4.2 -3.00 -1.70 ENSDARG00000003020 leucine rich repeat containing 
4.2  
helt -2.96 -4.66 ENSDARG00000056400 hey-like transcription factor  
foxd1 -2.94 -1.72 ENSDARG00000029179 forkhead box D1  
crygn2 -2.91 -2.75 ENSDARG00000030411 crystallin, gamma N2  
plp1a -2.89 -4.86 ENSDARG00000057770 proteolipid protein 1a  
atp2a1l -2.87 -2.71 ENSDARG00000035458 ATPase, Ca++ transporting, 
cardiac muscle, fast twitch 1 
like  
foxg1d -2.81 -1.56 ENSDARG00000070053 forkhead box G1d  
spon2b -2.78 -7.24 ENSDARG00000002732 spondin 2b, extracellular matrix 
protein  
wdr76 -2.76 -2.48 ENSDARG00000053554 WD repeat domain 76  
hells -2.76 -2.34 ENSDARG00000057738 helicase, lymphoid-specific  
vsx1 -2.69 -2.93 ENSDARG00000056292 visual system homeobox 1 
homolog, chx10-like  
dmbx1b -2.67 -2.03 ENSDARG00000002510 diencephalon/mesencephalon 
homeobox 1b  
atp1b4 -2.66 -3.76 ENSDARG00000053262 ATPase, (Na+)/K+ 
transporting, beta 4 polypeptide  
ccdc153 -2.66 -3.52 ENSDARG00000077161 coiled-coil domain containing 
153  
mcm5 -2.64 -2.10 ENSDARG00000019507 MCM5 minichromosome 
maintenance deficient 5 (S. 
cerevisiae)  
bcat1 -2.64 -2.44 ENSDARG00000045568 branched chain 
aminotransferase 1, cytosolic  
GPR112 -2.62 -10.97 ENSDARG00000087813 G protein-coupled receptor 112  
gsx2 -2.62 -1.71 ENSDARG00000043322 GS homeobox 2  
nkx1.2lb -2.62 -2.38 ENSDARG00000012697 NK1 transcription factor related 
2-like,b  
ccng2 -2.61 -4.14 ENSDARG00000017602 cyclin G2 
stmn1a -2.57 -2.66 ENSDARG00000004169 stathmin 1a  
 251 
suv39h1a -2.56 -2.95 ENSDARG00000026799 suppressor of variegation 3-9 
homolog 1a  
phf19 -2.53 -2.14 ENSDARG00000078050 PHD finger protein 19  
psmd10 -2.53 -1.63 ENSDARG00000015628 proteasome (prosome, 
macropain) 26S subunit, non-
ATPase, 10  
dab1b -2.52 -2.74 ENSDARG00000003290 disabled homolog 1b 
(Drosophila)  
csf1b -2.52 -1.46 ENSDARG00000068263 colony stimulating factor 1b 
(macrophage)  
mcm6 -2.52 -2.01 ENSDARG00000057683 MCM6 minichromosome 
maintenance deficient 6, 
mitotin (S. cerevisiae)  
vax1 -2.52 -2.56 ENSDARG00000021916 ventral anterior homeobox 1  
rx3 -2.51 -1.53 ENSDARG00000052893 retinal homeobox gene 3  
mcm3 -2.51 -2.06 ENSDARG00000090802 MCM3 minichromosome 
maintenance deficient 3 (S. 
cerevisiae)  
mcm3 -2.47 -2.11 ENSDARG00000024204 MCM3 minichromosome 
maintenance deficient 3 (S. 
cerevisiae)  
barhl1b -2.47 -2.59 ENSDARG00000019013 BarH-like 1b  
dnmt1 -2.45 -1.85 ENSDARG00000030756 DNA (cytosine-5-)-
methyltransferase 1  
NBL1 -2.45 -1.84 ENSDARG00000031898 neuroblastoma 1, DAN family 
BMP antagonist  
hoxc13b -2.43 -1.44 ENSDARG00000090023 homeo box C13b  
FGFBP3 -2.43 -2.32 ENSDARG00000040162 fibroblast growth factor binding 
protein 3  
ndst3 -2.43 -4.70 ENSDARG00000041776 N-deacetylase/N-
sulfotransferase (heparan 
glucosaminyl) 3  
msh6 -2.41 -1.48 ENSDARG00000011666 mutS homolog 6 (E. coli)  
cdkn2d -2.41 -2.62 ENSDARG00000094176 cyclin-dependent kinase 
inhibitor 2D (p19, inhibits 
CDK4)  
nr2e1 -2.39 -3.09 ENSDARG00000017107 nuclear receptor subfamily 2, 
group E, member 1  
ldb2b -2.38 -1.55 ENSDARG00000034896 LIM-domain binding factor 2b 
ccne2 -2.36 -2.32 ENSDARG00000027918 cyclin E2  
prim1 -2.36 -1.80 ENSDARG00000040163 primase polypeptide 1  
esco2 -2.34 -1.77 ENSDARG00000014685 establishment of cohesion 1 
homolog 2  
pou3f3b -2.30 -2.59 ENSDARG00000095896 POU class 3 homeobox 3b  
unga -2.29 -1.87 ENSDARG00000042527 uracil-DNA glycosylase a  
 252 
zgc:110540 -2.29 -2.10 ENSDARG00000054929 zgc:110540  
mab21l2 -2.29 -1.49 ENSDARG00000015266 mab-21-like 2  
asf1ba -2.29 -1.90 ENSDARG00000087313 ASF1 anti-silencing function 1 
homolog Ba (S. cerevisiae)  
rpl22l1 -2.27 -2.82 ENSDARG00000010244 ribosomal protein L22-like 1  
zgc:174719 -2.27 -1.62 ENSDARG00000074395 zgc:174719  
fancc -2.26 -1.61 ENSDARG00000055232 Fanconi anemia, 
complementation group C 
rx2 -2.26 -5.60 ENSDARG00000040321 retinal homeobox gene 2  
alpl -2.25 -1.55 ENSDARG00000015546 alkaline phosphatase, 
liver/bone/kidney  
mcm4 -2.25 -2.01 ENSDARG00000040041 MCM4 minichromosome 
maintenance deficient 4, 
mitotin (S. cerevisiae)  
tubb1 -2.24 -1.66 ENSDARG00000053066 tubulin, beta 1 class VI  
asf1ba -2.23 -1.87 ENSDARG00000020435 ASF1 anti-silencing function 1 
homolog Ba (S. cerevisiae)  
orc4 -2.22 -1.40 ENSDARG00000029014 origin recognition complex, 
subunit 4  
wdhd1 -2.21 -1.77 ENSDARG00000015998 WD repeat and HMG-box DNA 
binding protein 1  
pde9a -2.20 -1.65 ENSDARG00000060280 phosphodiesterase 9A  
hoxa13b -2.20 -1.82 ENSDARG00000036254 homeo box A13b  
ccl25b -2.19 -4.22 ENSDARG00000070873 chemokine (C-C motif) ligand 
25b  




-2.19 -2.58 ENSDARG00000088409 dishevelled-binding antagonist 
of beta-catenin 3  
uhrf1 -2.18 -1.71 ENSDARG00000091448 ubiquitin-like, containing PHD 
and RING finger domains, 1  
dlx1a -2.18 -2.87 ENSDARG00000013125 distal-less homeobox gene 1a  
pou3f1 -2.18 -3.09 ENSDARG00000009823 POU class 3 homeobox 1  
sox21b -2.18 -2.78 ENSDARG00000008540 SRY-box containing gene 21 b  
hoxa13a -2.17 -1.88 ENSDARG00000007609 homeo box A13a  
st8sia2 -2.17 -2.35 ENSDARG00000018788 ST8 alpha-N-acetyl-
neuraminide alpha-2,8-
sialyltransferase 2  
uhrf1 -2.16 -1.72 ENSDARG00000009946 ubiquitin-like, containing PHD 
and RING finger domains, 1  
pogza -2.16 -1.81 ENSDARG00000054778 pogo transposable element with 
ZNF domain a  
syngr1a -2.15 -1.34 ENSDARG00000002564 synaptogyrin 1a  
orc6 -2.15 -1.45 ENSDARG00000075682 origin recognition complex, 
subunit 6  
 253 
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